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Hemoglobin (Hb) is a redox-active molecule that generates cytotoxic reactive 
oxygen species via its pseudoperoxidase activity. Antioxidant mechanisms 
within erythrocytes tightly regulate the redox activity of Hb. Extensive 
intravascular hemolysis accompanying infection, trauma or inherited 
hemolytic disorders, releases Hb from its protective reducing environment. 
Extracellular Hb exerts toxicity owing to its propensity to undergo 
uncontrolled oxidative processes. Thus, there is a need to regulate the redox 
activity of Hb to minimize cellular injury due to oxidative damage. The 
present work explores mechanisms for regulation of the redox activity of 
extracellular Hb. Two strategies of regulation are investigated here: (i) protein 
modifications that may suppress oxidative reactions of Hb, & (ii) endogenous 
mechanisms that afford protection during a hemolytic infection. 
Infection-specific activation of the redox activity of Hb in response to 
lipopolysaccharide (LPS) and microbial proteases produces microbicidal free 
radicals. As LPS amplifies the redox activity of Hb, our first strategy was to 
map and subsequently modify the LPS-binding ‘hotspots’ on Hb, with a view 
to altering its binding to LPS. We implemented a methodical computational 
analysis to predict the LPS-binding sites on the surface of the Hb molecule. 
An algorithm to predict phospho-group binding sites was applied, followed by 
structure-based sequence comparisons of vertebrate Hbs and docking analysis 
of protein-ligand interactions. Empirical validations using synthetic peptides 
helped define the regions of Hb that interact with LPS. Recombinant Hb 
subunits with selective mutations of lysine to aspartate at positions 56, 60 and 




binding ability. Moreover, mutated Hb subunits failed to undergo an increase 
in their redox activity in the presence of LPS. 
LPS-induced inflammation upregulates the coagulation initiator, tissue factor 
(TF). Increased TF expression drives the coagulation cascade by sequential 
activation of serine proteases. Fibrin clot, the end product of the coagulation 
cascade, increases hemolysis by mechanical damage to erythrocytes. Factors 
released upon hemolysis further fuel coagulation, thus constituting an 
amplification loop. Phylogenetic analysis revealed co-evolution between TF 
and Hb". We thus examined the interactions of Hb with TF as a probable 
endogenous anti-oxidant mechanism for the regulation of redox-active Hb. 
Using cell-free biochemical assays and a model system of TF-expressing 
human macrophages, we demonstrated that TF formed a complex with Hb, 
and competed with LPS for binding Hb. Inhibition of the LPS-induced 
oxidative activity of Hb by TF was observed using a chemiluminescence assay 
for superoxide detection. Further investigation revealed that Hb preserved the 
procoagulant activity of TF at a moderate level, removing its sensitivity to 
antioxidants. In vivo, this may translate into a functional interplay between Hb 
and TF to protect host cells from oxidative damage and maintain coagulation 
to aid host defense.  
The research findings presented in this thesis open up new avenues for the 
development of Hb-based blood substitutes via modification of the LPS-
binding sites of Hb. Furthermore, the elucidation of the crosstalk between Hb 
and TF provides insights into the endogenously active mechanisms for the 
regulation of redox-active Hb.  
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CHAPTER 1  
INTRODUCTION 
 
1.1 Hemoglobin (Hb) – roles beyond respiration 
1.1.1     Hb is a redox active molecule 
Hemoglobin (Hb) is the respiratory protein of vertebrates, contained within the 
red blood cells. It is a globular protein, composed of two ! and two " subunits 
forming the tetramer !2"2 (Perutz et al., 1960) (Figure 1.1A). The tetramer is 
held together by salt bridges, hydrogen bonds, and hydrophobic interactions 
between the subunits. The tetramer may reversibly dissociate into dimers or 
even monomers. The tetramer-dimer equilibrium is affected by dilution, pH, 
temperature and salt (Chu & Ackers, 1981). Each subunit consists of !-helical 
segments connected together by short loops to form a globin-fold. Each 
polypeptide chain is covalently bound to a heme moiety within a cavity lined 
by hydrophobic residues. Heme is made up of a heterocyclic protoporphyrin 
ring, with a central iron ion (Figure 1.1B). The iron is penta-coordinated to 
four nitrogens in the ring and to the imidazole of F8 histidine residue of Hb. 
The sixth co-ordination can be reversibly bound to oxygen. This reversible 
binding of oxygen enables Hb to function as an oxygen transport protein. 
Ligand binding triggers conformational changes in the Hb structure, 
transitioning from the T-state (tense, ligand-free) to R-state (relaxed, ligand-
bound) (Perutz, 1976).  
 
 





Figure 1.1: Tetrameric structure of Hb. (A) Hb is an !2"2 tetramer. ! and " 
chains consist of 141 and 146 residues, respectively. ! chains are colored 
gold, " chains are in pink. The heme moiety is shown in a stick representation. 
His F8 residues are shown in blue. The figure was generated using PyMOL 
(v1.0, DeLano Scientific) based on coordinates from the Protein Data Bank 
(PDB id: 1HGB). (B) Structure of heme. Oxygen binds reversibly to the sixth 
coordination site of the heme Fe atom. Figure adapted from Carlsen et al. 
(2005). 
 
1.1.1.1     Pseudo-peroxidase activity of Hb 
The heme iron exists in the reduced ferrous state (Fe(II)), which can undergo 
spontaneous oxidation to the ferric state (Fe(III)), forming methemoglobin 
(metHb). The sixth coordinate of metHb is occupied by water, and is unable to 
bind oxygen. The conversion to metHb is accompanied by the release of 
superoxide ions, which undergo dismutation to form hydrogen peroxide. In the 
presence of hydrogen peroxide, a catalytic cycle is initiated whereby the 
heme-bound Fe converts between the ferric and ferryl (Fe(IV)) oxidation 
states (Figure 1.2). The end result is that hydrogen peroxide is eliminated in a 
peroxidase-like mechanism (Alayash, 1999). This is known as the pseudo-
peroxidase activity of Hb. An excess of hydrogen peroxide can mediate 
irreversible changes in the Hb molecule itself, forming a protein-bound 
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radical. FerrylHb may undergo self-destruction, producing heme and heme-
degradation products (Nagababu & Rifkind, 2000). It has been shown that Hb 
undergoes structural modifications such as cross-linking of the chains and 
irreversible modifications of amino acid residues upon exposure to hydrogen 
peroxide (Jia et al., 2007; Vallelian et al., 2008). 
 
Figure 1.2: Inter-conversion of the heme-bound iron between the different 
oxidation states. The catalytic cycle between ferric- and ferryl-Hb is the 
pseudoperoxidase cycle, highlighted in yellow. HOOH: hydrogen peroxide. 
Figure adapted from Alayash (1999). 
 
1.1.1.2     Reactions of Hb with Nitric Oxide 
Nitric oxide (NO) is a short-lived free radical produced by endothelial NO 
synthase enzymes. Hb has an extremely high affinity for NO (Cassoly & 
Gibson, 1975; Moore & Gibson, 1976). It reacts with and scavenges NO via 
two different mechanisms. Oxygenated Hb (OxyHb) behaves as a nitric oxide 
dioxygenase and reacts with NO to produce metHb and nitrate, via the 
formation of a transient metHb-peroxynitrite complex (Eq. 1) (Herold, 1999). 
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          Hb(FeII)O2 + NO ! Hb(FeIII)OONO ! Hb(FeIII) + NO3¯       (Eq. 1) 
Methemoglobin reductase within the RBCs converts metHb back to oxyHb, 
which may in turn react with more NO, thus constituting a catalytic cycle 
(Figure 1.3).  
 
 
Figure 1.3: Scavenging of NO by 
oxyHb. NO reacts with oxyHb to form 
metHb, which is reduced by metHb 
reductase to form deoxyHb. DeoxyHb 
becomes oxygenated to form oxyHb 
and reacts with NO to form nitrate. 
MetHbR: Methemoglobin Reductase. 




NO may also bind with high affinity to the cysteine-93 residue of the " subunit 
of Hb, forming S-nitrosylated deoxyHb (Doyle et al., 1981; Jia et al., 1996; 
Huang et al., 2005). S-nitrosylated deoxyHb may react with oxygen to produce 
unreactive nitrate (Eq. 2, 3). 
          Hb(FeII) + NO ! Hb(FeII)NO           (Eq. 2) 
          Hb(FeII)NO + O2 ! Hb(FeIII) + NO3¯               (Eq. 3) 
 
1.1.2     Antioxidant mechanisms of erythrocytes 
Hb contained within the erythrocytes continuously forms metHb as a result of 
endogenous oxidation. Under normal physiological conditions, erythrocytes 
provide a highly reducing environment to maintain low levels of metHb (Bunn 
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& Forget, 1986). The cytochrome b5-methemoglobin reductase system 
comprises the primary mode of conversion of metHb to Hb by reduction of 
ferric iron back to the ferrous state. The reductase system consists of two 
enzymes – cytochrome b5 and cytochrome b5 reductase (Figure 1.4). 
Deficiency of the enzyme manifests itself as methemoglobinemia, i.e. excess 
formation of metHb (Scott & Griffith, 1959; Leroux et al., 1975). Methylene 
blue is administered as a therapy for patients suffering from 
methemoglobinemia (Modarai et al., 2002). An alternative enzyme, NADPH 
metHb reductase reduces methylene blue to leukomethylene blue using 
NADPH (Clifton & Leikin, 2003). The reduced form of the dye then converts 






Figure 1.4: Reduction of 
methemoglobin to hemoglobin. The 
major physiologic pathway for 
reduction of metHb to Hb is through 
cytochrome b5 and cytochrome b5 
reductase, which transfer electrons 
from NADH to metHb to form 
reduced Hb. In an alternative 
pathway, methylene blue reduces 
metHb using reducing equivalents 
from NADPH. metHb: met-
hemoglobin; Hb: hemoglobin. Figure 
adapted from Haymond et al. (2005). 
 
Erythrocytes also contain detoxification mechanisms to eliminate reactive 
oxygen species (ROS). Antioxidant enzymes, catalase and superoxide 
dismutase (SOD), catalyze the degradation of hydrogen peroxide and 
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superoxide radicals. Erythrocyte SOD is a copper-zinc based enzyme, that 
catalyses the conversion of superoxide radicals to hydrogen peroxide and 
oxygen (Heikkila et al., 1976). Catalase converts hydrogen peroxide to water 
and molecular oxygen. Glutathione systems further protect the cell from the 
oxidant species generated via the redox reactions of Hb. Glutathione 
peroxidase neutralizes hydrogen peroxide by converting reduced glutathione 
(GSH) to the oxidized state (GSSG). Glutathione reductase catalyzes the 
reduction of GSSG, regenerating GSH for antioxidant defense (Figure 1.5). 
The activity of these detoxifying enzymes depends upon the availability of the 




Figure 1.5: Mechanisms of ROS detoxification in erythrocytes. SOD: 
Superoxide Dismutase; GSH, reduced glutathione; GSSG, oxidized 
glutathione; NADP: Nicotinamide Adenine Dinucleotide Phosphate; NADPH: 
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1.1.3     Toxicity of extracellular Hb  
Compartmentalization within erythrocytes maintains Hb in a functional non-
toxic state. Inherent intravascular hemolysis releases low concentrations of 
cell-free Hb into the blood. The plasma Hb is efficiently cleared by Hb-
scavenging proteins. Pathological conditions such as sickle-cell disease, 
paroxysmal nocturnal hemoglobinuria, thalassemias, infection and trauma are 
characterized by extensive hemolysis. The consequent high levels of 
extracellular Hb overwhelm the detoxifying mechanisms, and trigger an array 
of pathophysiological effects (Figure 1.6).  
Extracellular Hb is toxic to cells through multiple mechanisms. MetHb 
activates endothelial cells to upregulate the production of cytokines such as 
IL-6, IL-8, and cell adhesion molecules such as E-selectins (Liu & Spolarics, 
2003). In the presence of endogenous hydrogen peroxide, Hb participates in 
the pseudoperoxidase cycle (see Figure 1.2) and becomes oxidized to 
ferrylHb, accompanied by the production of free radicals. FerrylHb exerts pro-
inflammatory effects on endothelial cells through the NF-#B and mitogen-
activated protein kinase signaling pathways (Silva et al., 2009). Extracellular 
Hb may undergo renal filtration and lead to renal iron loading. Free heme and 
iron released upon degradation of Hb may damage lipids, proteins and DNA 
by oxidation or generation of ROS (Aft & Mueller, 1983; Davies, 1987). 
Heme may intercalate into membranes and induce destabilization of the 
cytoskeleton (Schmitt et al., 1993). Free heme and iron trigger signaling 
events that promote inflammation via activation of innate immune responses 
(Hod et al., 2010; Larsen et al., 2010). The reaction of Hb with nitric oxide 
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(NO) scavenges NO and limits its availability to tissues. NO is an 
endothelium-derived relaxing factor that modulates vascular tone by activating 
soluble guanylyl cyclase in smooth muscle. Decreased NO results in inhibition 
of NO-mediated signaling, in turn leading to smooth muscle dystonia, 
hypertension and vasculopathy (Reiter et al., 2002; Rother et al., 2005).  
 
 
Figure 1.6: Pathological effects of extracellular Hb. OxyHb reacts with NO 
and impairs NO homeostasis. The production of free radicals upon 
spontaneous oxidation of oxyHb to metHb causes severe oxidative damage. 
Free Hb may undergo renal filtration and exert oxidative injury in the kidney. 
Free heme and iron activate the innate immune responses in macrophages. 
Figure adapted from Gladwin et al. (2012). 
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The toxicity associated with extracellular Hb necessitates its prompt removal 
from the plasma (Figure 1.7). Haptoglobin (Hp) is a plasma protein that 
rapidly binds to Hb with a high affinity (Levy et al., 2010). Hb-Hp complexes 
are recognized by the Hb scavenger receptor, CD163, present on the surface of 
macrophages and hepatocytes, and subsequently endocytosed and degraded 
(Kristiansen et al., 2001; Philippidis et al., 2004; Schaer et al., 2007). The 
binding of Hb to Hp suppresses the redox activity of Hb (Boretti et al., 2009; 
Buehler & D’Agnillo, 2010) and prevents its renal filtration (Fagoonee et al., 
2005). Depletion of serum Hp is a clinical indicator of hemolysis (Marchand 
et al., 1980). Recent work in our lab has discovered that lipid-free 
apolipoprotein A-1 (apoA1) also binds to Hb, either alone or in collaboration 
with Hp, to suppress the redox activity of Hb (Du et al., 2012). The apoA1-Hb 
complex is eliminated from circulation via the scavenger receptor class B type 
1 (SR-B1) present on the surface of macrophages and hepatocytes. 
Extracellular free heme that arises from degradation of Hb is sequestered by 
lipoproteins, serum albumin and hemopexin (Solar et al., 1989; Miller & 
Shaklai, 1999; Mattu et al., 2002). Heme-hemopexin complexes are 
internalized via CD91 receptor-mediated endocytosis (Hvidberg et al., 2005). 
Heme oxygenase-1 in hepatocytes and macrophages ensures heme catabolism 
(Gozzelino et al., 2010). These defense mechanisms thus scavenge Hb and 
free heme from circulation, thereby providing protection from their harmful 
effects.  
 






Figure 1.7: Mechanisms for scavenging of cell-free Hb and free heme. Hp 
and ApoA1 bind Hb, and the complexes are internalized via CD163 and SR-
B1, respectively. Free heme may be bound by albumin, lipoproteins and !1-
microglobulin. Hx binds heme and internalizes it via CD91. Heme is 
catabolized by HO-1. ApoA1: apolipoprotein A1, Fe: iron, FtH: ferritin, Hp: 
haptoglobin, Hb: hemoglobin, HDL/LDL: high/low-density lipoprotein, Hx: 
hemopexin, HO-1: heme oxygenase-1, SR-B1: scavenger receptor class B type 




1.1.4     Hb-based Oxygen Carriers: Progress and Limitations 
Several clinical problems are associated with blood transfusions, such as 
transmission of blood-borne pathogens, requirements for cross-matching, short 
shelf life and shortage of supply. These limitations have driven the search over 
several decades, for blood substitutes as a safe alternative to blood, that would 
ideally possess characteristics such as rapid uptake and delivery of oxygen, 
long shelf life, minimal toxicity and cost-effectiveness. Moreover, blood 
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substitutes would be readily available for use in medical emergencies such as 
hemorrhagic shock, severe anemia or trauma. One approach has been to 
develop hemoglobin-based oxygen carriers (HBOCs), which are cell-free Hb 
solutions that have been chemically modified to reduce toxicity and improve 
their oxygen carrying capacity.  
During the last several decades, numerous HBOCs have been developed 
(Table 1.1). HBOCs may be derived from human, animal or recombinant 
sources. The first generation HBOCs used stroma-free Hb purified from 
erythrocytes. Stroma-free Hb has two major problems: excessive affinity for 
oxygen, and a short half-life due to the dissociation of tetramers into dimers. 
Subsequent HBOCs have been chemically or genetically modified so as to 
improve their oxygen binding properties and stabilization of the tetrameric 
structure (Haney et al., 2000). The modifications involve cross-linking, 
conjugation to macromolecules, polymerization or encapsulation to stabilize 
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Table 1.1: HBOCs that have been evaluated in Phase II/III clinical trials. 





Figure 1.8: Development of an HBOC, Hemopure®. Bovine tetrameric Hb 
purified from erythrocytes has a tendency to dimerize. The tetramer is 
stabilized by cross-linking and further polymerized using glutaraldehyde. The 
resulting polymer, Hemopure®, is 250 kDa and has a shelf life of more than a 
year. Figure adapted from http://medgadget.com/2008/12/us_navy_to_trial 
_hemopure _stabilized_hemoglobin_1.html. 
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Despite extensive efforts to develop HBOCs for almost 30 years, no product 
has successfully cleared clinical trials. The application of HBOCs as blood 
substitutes has been marred with problems associated with the toxic effects of 
extracellular Hb (see Section 1.1.3). Complications arising due to the use of 
HBOCs include oxidative stress, hypertension, renal failure and myocardial 
lesions (Buehler et al., 2010). In addition, cell-free Hb may interact with 
bacterial endotoxin, which is ubiquitous, to enhance the pathophysiological 
effects of endotoxin in sepsis (Kaca et al., 1994a; b; Su et al., 1999). HBOCs 
have been reported to aggravate endotoxin-induced septic shock and death in 
animal models (White et al., 1986; Su et al., 1997). These problems indicate 
that further research is needed for the improvement of HBOCs to render them 
safe for clinical use.  
 
1.2     Innate immune recognition and effector mechanisms 
Infection results in extensive intravascular hemolysis, mediated by microbial 
hemolytic toxins, or by host defense processes such as coagulation and 
inflammation. To provide a better understanding of the interactions between 
Hb, LPS, and the coagulation initiator, tissue factor (TF), during an infection, 
this section discusses the innate immune response, with emphasis on the 
mechanisms triggered in response to LPS during a Gram-negative bacterial 
infection. We further discuss the importance of extracellular Hb in the innate 
immune response, and the interplay between immunity, coagulation and 
hemolysis. 
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1.2.1     Overview of the innate immune system 
Multicellular organisms have evolved a variety of host-defense mechanisms to 
protect themselves against the plethora of infectious microorganisms that 
threaten their survival. These immune defense mechanisms, classified under 
the innate and adaptive systems, work in collaboration to differentiate self 
from non-self, and mount an appropriate response to eliminate the non-self. 
While the adaptive system is found only in the vertebrates, the innate immune 
system is present in almost all multicellular organisms and is the most ancient 
form of host defense. The innate response comprises of non-clonal constitutive 
and inducible mediators that are promptly activated upon contact with 
pathogen (Medzhitov & Janeway, 1997). Pathogen recognition takes place via 
germ-line encoded receptors, termed as pattern-recognition receptors (PRR), 
which have a broad specificity for microbial structures. The adaptive system, 
on the other hand, relies on antigen-specific receptors present on clonally 
selected effector T and B cells. Although the innate and adaptive systems rely 
on distinct mechanisms for pathogen recognition, they work synergistically 
towards host defense upon microbial invasion. It is becoming evident that the 
signals derived from the innate immune response are essential for the 
activation of the adaptive immune response (Figure 1.9) (Fearon & Locksley, 
1996; Medzhitov, 2007). For example, type I interferons induced by viruses 
upregulate the expression of MHC class I molecules, IL-1 and TNF-! function 
as chemokines to direct the migration of antigen-specific lymphocytes to the 
site of infection and IL-6 induces differentiation of B cells into antibody-
producing effector cells. Moreover, the adaptive system can further activate 
the effector mechanisms of innate immune system in an antigen-specific 
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manner. Thus, there exists a bidirectional crosstalk between the innate and 
adaptive systems.  
 
 
Figure 1.9: Interplay between the innate and adaptive immune defense 
mechanisms. Recognition of pathogen by a variety of PRRs leads to the direct 
activation of the innate immune system within hours after infection. The 
innate immune system is composed of modules that are characterized by 
distinct antimicrobial defense mechanisms. Examples of innate host-defense 
modules include mucosal epithelia, phagocytes, inflammasomes, acute-phase 
proteins and complement system. These modules activate the adaptive 
immune response that further feedbacks the activation of pathogen-specific 
innate defense strategies via T cells and antibodies. Figure adapted from 
Medzhitov (2007). 
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The innate immune system provides a rapid and efficient frontline defense 
strategy against invading microorganisms, by becoming instantaneously 
activated upon infection. A limited set of PRRs is employed for pathogen 
recognition (Figure 1.10). They display broad specificity for molecular 
structures unique to pathogens (Janeway, 1989). PRRs may be present within 
the cellular compartments, on the cell surface, or as soluble proteins 
circulating in the plasma (Medzhitov & Janeway, 1997). Examples of PRRs 
include complement proteins, pentraxins, Toll-like receptors, C-type lectin 
receptors, and Scavenger receptors (Hoffmann et al., 1999; Janeway & 
Medzhitov, 2002). The molecular structures of pathogens that are recognized 
by PRRs are termed pathogen-associated molecular patterns (PAMPs) (Figure 
1.9) (Medzhitov & Janeway, 1997, 2000).  
Several features associated with PAMPs make them ideal targets of PRRs. 
First, PAMPs are molecular features that are unique to microbial pathogens, 
and not found in the host. Second, the general structural motif of a PAMP is 
shared among many different groups of micro-organisms, enabling a limited 
set of PRRs to recognize a wide diversity of pathogens. Third, PAMPs are 
essential for microbial survival and/or virulence, and hence, undergo little 
mutational variation with evolution. Microbial cell wall components, such as 
lipopolysaccharide (LPS) of gram-negative bacteria, lipoteichoic acids (LTA) 
of gram-positive bacteria, mannans of yeast are examples of PAMPs. Other 
examples include viral dsRNA, bacterial flagellin and peptidoglycans. 
 




Figure 1.10: Examples of mammalian PRRs and their representative 
PAMPs. PRRs may be present intracellularly, on the cell surface or secreted 
as soluble plasma proteins. NLR: NOD-Like Receptor, CRD: Carbohydrate 
Recognition Domain; ITAM: Immunoreceptor Tyrosine-based Activation 
Motif. Figure adapted from Medzhitov (2009). 
 
Recognition of PAMPs by PRRs triggers an array of downstream innate 
immune effector responses, broadly termed as the ‘inflammatory response’ 
(Figure 1.11). Immune responsive cells such as macrophages, neutrophils and 
natural killer cells are recruited to the site of infection. Activated macrophages 
and neutrophils generate toxic metabolites termed reactive oxygen 
intermediates and reactive nitrogen intermediates, which have potent 
antimicrobial activity. The complement system is activated and results in the 
formation of a membrane attack complex for opsonization of the microbes. 
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Subsequently, phagocytosis of the opsonized microbes by macrophages and 
neutrophils ensures elimination of the pathogen.  
Transmembrane and intracellular PRRs trigger signaling pathways that lead to 
the production of inflammatory cytokines that further activate the adaptive 
immune system (Medzhitov, 2007). Toll-like receptors (TLRs) are a class of 
transmembrane receptors that recognize viral nucleic acids and bacterial 
molecules, such as LPS and LTA. Upon recognition of the various PAMPs, 
TLRs activate macrophages to release pro-inflammatory cytokines, such as 
TNF!, IL-1" and IL-6. These proinflammatory cytokines mediate various 
effects to boost the innate immune response. For example, TNF! and IL-1" 
activate the endothelial cells to upregulate tissue factor (TF) expression, which 
initiates the coagulation cascade. IL-1" and IL-6 activate hepatocytes to 
produce acute phase proteins that activate the complement system. A C-type 
lectin, called Dectin1, is present on the cell surface of macrophages and 
dendritic cells. It plays an important role in antifungal defense, such as 
phagocytosis of fungal pathogens, cytokine production and activation of 
NADPH oxidase. Among the intracellular PRRs are the Nod-like receptors 
(NLRs) that sense bacterial peptidoglycans. Activation of NLRs results in the 
production of pro-inflammatory cytokines, chemokines, and recruitment of 
neutrophils to the site of infection. Other intracellular PRRs such as RIG-I 
(retinoic acid inducible gene I) and MDA5 (melanoma differentiation-
associated gene 5) are involved in the antiviral immune defense via the 
sensing of viral RNA. Engagement of these two receptors triggers downstream 
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signalling which lead to the production of interferons (IFN) via the activation 
of the transcription factor IFN-regulatory factor 3 (IRF3).  
Antimicrobial peptides, such as defensins, histatins and cathelicidins, that 
display a broad spectrum of activities against bacteria, fungi and viruses, are 
secreted. In addition to their antimicrobial function, these peptides regulate the 
innate and adaptive systems. These diverse spectra of microbicidal 




Figure 1.11: Innate immune effector mechanisms to combat the invading 
pathogens. Upon infection, microbial PAMPs are recognized by PRRs that 
result in activation of the innate immune system. Effector mechanisms include 
phagocytosis, production of toxic metabolites, antimicrobial peptides, pro-
inflammatory cytokines, and chemokines for recruitment of leukocytes. Figure 
adapted from Dempsey et al. (2003). 
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1.2.2   Lipopolysaccharide: a potent bacterial PAMP 
Lipopolysaccharide (LPS) induces a pleiotropic activation of the immune 
system, and has been referred to as ‘endotoxin’ owing to its pyrogenic (fever-
causing) properties in humans and other mammals. LPS is an essential 
component of the outer cell wall of gram-negative bacteria (Figure 1.12). 
Being indispensable for bacterial viability and due to its well-conserved and 
stable structure, LPS serves as a primary PAMP targeted by the innate 
immune system. Specialized proteins for the recognition of LPS have evolved 
in organisms as diverse as horseshoe crabs to humans (Chaby, 2004). 
Endotoxin molecules, which are shed from the bacterial surface, contribute to 
the pathophysiology of bacterial infection (Corriveau & Danner, 1993). 
 
 
Figure 1.12: Structure of the cell wall of Gram-negative bacteria. LPS is 
embedded in the outer membrane via the acyl chains of the lipid A moiety. 
Figure adapted from Raetz & Whitfield (2002). 
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1.2.2.1     Structure of LPS 
Structurally, LPS molecules from different species of gram-negative bacteria 
share a common general architecture (Figure 1.13). They are comprised of a 
hydrophobic domain known as lipid A, a non-repeating core oligosaccharide 
and a distal polysaccharide called O-antigen or O-polysaccharide.  
 
Figure 1.13: Schematic representation of the structure of LPS. GlcN: 
glucosamine; P: phosphate; KDO: 2-keto-3-deoxyoctulosonic acid; Hep: D-
glycero-D-manno-heptose. Figure adapted from Alexander & Rietschel 
(2001). 
 
Bacterial mutants that are defective in LPS biosynthesis genes, synthesize LPS 
molecules with shorter chains. These bacteria are known as ‘rough’ strains as 
opposed to the ‘smooth’ strains which are able to synthesize the full-length 
LPS. The LPS molecules are denoted as Ra, Rb, Rc, Rd and Re in order of 
their decreasing core length (Raetz, 1990). ReLPS contains two KDO (2-keto-








Figure 1.14: Detailed chemical structure of S. minnesota ReLPS. 
Commonly seen partial substitution in the lipid A structure is indicated by a 
dashed box. Figure adapted from García-Verdugo et al. (2007), with 
modifications. 
 
The lipid A component of LPS anchors the molecule to the cell surface by 
insertion of its fatty acyl chains into the outer membrane. It is also known as 
the ‘endotoxic principle’ of LPS (Rietschel et al., 1971). Lipid A is the most 
conserved region of LPS, while the O-polysaccharide is the least conserved. 
Lipid A is typically composed of a phosphorylated diglucosamine moiety, 
carrying long fatty acyl chains via ester or amide linkage (Figure 1.14). The 
phosphates can be further substituted with groups such as ethanolamine, 
ethanolamine phosphate, ethanolamine diphosphate, N-acetylglucosamine, and 
D-arabino-furanose. The nature, number, length, order and saturation of the 
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fatty acyl chains vary considerably between the various species of gram 
negative bacteria. Lipid A is covalently linked to the inner core, made up of 
unusual sugars such as 3-deoxy-D-manno-octulosonic acid (KDO) and L-
glycero-D-manno heptose. The outer core typically consists of common 
hexose sugars such as glucose, galactose, N-acetyl galactosamine and N-
acetylglucosamine and is generally more variable than the inner core. The O-
polysaccharide is also the outermost part of the LPS molecule expressed on 
the bacteria.  
 
1.2.2.2     Innate immune response to LPS 
The early-phase response to bacterial infection involves the recognition of 
LPS by LPS-binding protein (LBP) in the plasma (Figure 1.15), which 
facilitates the transfer of LPS molecules to CD14, the myeloid cell surface 
antigen (Wright et al., 1990). Interaction of membrane-bound CD14 with LPS 
activates macrophages, while soluble CD14 molecules can activate endothelial 
and epithelial cells (Pugin et al., 1993).  
The activation of the macrophages triggers downstream signaling events via 
the Toll-like receptor, TLR4/MD-2 complex, leading to the production of 
proinflammatory cytokines such as TNF-!; interleukins IL-1", IL-6, IL-8, IL-
12, IL-15, and IL-18; lipid-derived mediators like platelet-activating factor; as 
well as reactive oxygen species like the superoxide anion, hydroxyl radicals or 
nitric oxide. The complement system is also activated, leading to serum-
mediated opsonization and killing of the invasive bacteria and induction of 
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cellular host activities by the release of anaphylatoxins, C3a and C5a (Galanos 
et al., 1971).  
 
 
Figure 1.15: Activation of the immune system in response to LPS. (A) LPS 
shedded from the bacteria is recognized by LBP. LBP delivers LPS to CD14 
on neutrophils and macrophages and triggers the shedding of soluble CD14. 
(B) LPS:LBP complexes are recognized by soluble CD14, and further activate 
the endothelial cells. (C) The activated neutrophils, macrophages and 
endothelial cells produce cytokines to mount an immune response. Figure 
adapted from Karima et al. (1999), with modifications. 
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When activated systemically, the combined effects of all these mediators 
manifests as the clinical syndrome of septic shock. Sepsis is characterized by 
an array of pathological symptoms such as circulatory malfunctions, shock 
and multiple organ failure (Figure 1.16). Being a significant cause of 
mortality and morbidity, sepsis remains a major clinical problem worldwide. 
The levels of circulating LPS have been shown to correlate with the 
development of multi-organ failure (Brandtzaeg et al., 1989; Casey et al., 
1993). Plasma LPS levels up to 5 ng/ml have been detected in patients at the 
onset of severe sepsis (Opal et al., 1999), while levels higher than 25 ng/ml 
indicate the likelihood of multi-organ dysfunction and mortality (Brandtzaeg 
et al., 1989). Because of the host’s sensitivity to LPS and the 
pathophysiological effects, LPS is a prime target for the development of 
potentially novel therapeutic approaches for the treatment of Gram-negative 
sepsis. However, due to the complexity of the biological responses implicated 
in sepsis, the development of therapeutic strategies remains elusive (Russell, 
2006).  
 





Figure 1.16: The pathophysiology of the sepsis cascade. LPS activates 
monocytes/macrophages, neutrophils and endothelial cells to secrete an array 
of microbicidal effectors such as pro-inflammatory cytokines, chemokines, 
and reactive oxygen and nitrogen species. Multiple effector mechanisms are 
activated, such as the coagulation cascade, complement system and 
chemotaxis. Complex interactions between the activated pathways produce the 
characteristic features of sepsis physiology. The altered signalling pathways in 
sepsis ultimately lead to tissue injury and multi-organ dysfunction. PAI: 
plasminogen-activator inhibitor. Figure adapted from Cohen (2002). 
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1.2.2.3     Hb augments the innate immune response to LPS 
Kaca et al. demonstrated for the first time that human Hb could form stable 
complexes with LPS (Kaca et al., 1994a). The effects of Hb on the biological 
activity of LPS are well-studied. The interaction of Hb with LPS augments the 
host immune responses to LPS, such as complement activation (Feola et al., 
1988), release of pro-inflammatory cytokines (Carrillo et al., 2002), and the 
production of tissue factor (TF) in endothelial cells (Kaca et al., 1994b; Roth, 
1994). Upon co-administration of Hb with LPS, synergistic toxicity has been 
observed in animal models (White et al., 1986; Su et al., 1999). In contrast to 
the effects of Hb, binding of LPS to globin (i.e. Hb without heme) has been 
shown to antagonize the actions of LPS on cultured macrophages and in mice 
(Yang et al., 2002). It has been construed that the enhancement of LPS-related 
pathophysiology may be attributable to the pseudoperoxidase activity of Hb 
instead of its binding to LPS (D’Agnillo, 2004). Interestingly, other work has 
shown that LPS may oxidize native and cross-linked Hb to metHb, suggesting 
that LPS-induced oxidation of Hb may be responsible for the synergism 
between Hb and LPS (Kaca et al., 1995; Currell & Levin, 2002). Despite these 
findings, the mechanism for the enhancement of the LPS-induced 
pathophysiological responses by Hb is not yet fully understood.  
 
1.2.3     Extracellular Hb induces innate immune response 
1.2.3.1     Hb is a rich source of nutritional iron for pathogens  
The ability to acquire iron from the host is crucial for the survival of the 
invading pathogenic bacteria (Payne, 1993). Host-pathogen interactions are 
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thus representative of a series of measure-countermeasure, wherein the 
bacteria aim to scavenge the iron available in the host for their growth and 
further invasion, while the host protects itself by shielding the iron from the 
microbial intruders. Complex mechanisms have evolved to sequester iron from 
the invading microorganisms. Iron-binding proteins, such as transferrin, 
ferritin and Hb, play a major role in limiting the availability of free iron in the 
blood (Ong et al., 2005; Doherty, 2007). The mammalian host sequesters most 
of the iron in the form of heme (Stojiljkovic & Perkins-Balding, 2002). Hb is a 
potentially rich source of iron and as a result it is targeted by many bacterial 
pathogens such as Escherichia coli (Cavalieri et al., 1984), Vibrio 
parahaemolyticus (Nishibuchi & Kaper, 1995), and Staphylococcus aureus 
(Menestrina et al., 2001; Skaar et al., 2004). These microbe secrete 
extracellular cytolytic toxins, which rupture erythrocytes to release Hb. As a 
result, plasma concentrations of cell-free Hb may reach levels as high as 1-2.5 
mg/ml in infection (De et al., 1954; Sengers, 1971). Bacterial pathogens have 
evolved various mechanisms to ‘steal’ iron from Hb. These include direct 
capture of iron or heme at the bacterial surface (Mietzner & Morse, 1994); 
specialized heme-Hb-uptake systems for capturing Hb, free heme, Hb-
haptoglobin or heme-hemopexin (Wandersman & Delepelaire, 2004); and 
proteins called siderophores, which have a high affinity for iron and can thus 
capture iron from iron-binding proteins (Neilands, 1995). Figure 1.17 
illustrates the uptake of heme by S. aureus (Rouault, 2004).  
 





Figure 1.17: Schematic showing the capture of heme by Staphylococcus 
aureus. Hemolysins secreted from S. aureus rupture erythrocytes to release 
Hb. Extracellular bacterial proteases attack Hb to proteolyse the polypeptide 
chains and to release heme, which is captured via specialized proteins for 
uptake into the bacterial cell. Figure adapted from Rouault (2004). 
 
1.2.3.2     Hb is a pathogen sensor and an antimicrobial effector    
One of the pathophysiological consequences of sepsis is pronounced 
intravascular hemolysis. The host responds to hemolysis during infection by 
employing Hb released from lysed erythrocytes as an antibacterial effector 
molecule at the site of infection. Hb functions as a PRR by recognizing 
bacterial PAMPs, and launching effector responses that are targeted towards 
elimination of the pathogen. Hb can recognize and bind to LPS (Kaca et al., 
1994a; Du et al., 2010). Upon binding to LPS, the pseudoperoxidase activity 
of Hb becomes activated (Jiang et al., 2007), thereby augmenting the 
production of toxic ROS in the vicinity of the bacteria. Moreover, proteolysis 
of Hb by microbial proteases does not impair its ability to bind LPS. 
Proteolysed Hb, instead, displays an intensified pseudoperoxidase activity 
(Jiang et al., 2007; Du et al., 2010). The redox activity of Hb is, thus, 
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employed by the host as a defense mechanism against microbial assault 






Figure 1.18: ROS production by 
Hb is induced by LPS and 
microbial proteases. Hb tetramer, 
or fragments generated by 
proteolysis, bind to PAMPs on the 
bacterial surface and generate ROS 
for microbial killing. Figure 
adapted from Du et al. (2010). 
 
Tetrameric Hb (!2"2), and the isolated subunits, Hb! and Hb", have been 
demonstrated to possess broad spectrum antimicrobial activity against fungi 
and both gram-positive and gram-negative bacteria in vitro (Mak et al., 2000; 
Parish et al., 2001). Moreover, a 30-amino acid long fragment of the C-
terminal of Hb" has been identified to possess potent antimicrobial activity 
(Parish et al., 2001). In vivo proteolytic degradation of Hb generates peptides 
that display a broad spectrum of biological effects (Ivanov et al., 1997). A 
class of Hb-derived peptides, called ‘hemocidins’, have been shown to possess 
broad spectrum antimicrobial activities (Mak et al., 2000). Examples include 
peptides comprising residues 1-32, 3-32 , 33-61 and 98-114 of Hb! (Belmonte 
et al.; Fogaca, 1999; Nakajima et al., 2003); and residues 111-146 and 115-
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146 of Hb", (Liepke et al., 2003; Mak et al., 2007). These findings indicate the 
potential of Hb-derived peptides for use as therapeutic antimicrobial agents. 
 
1.2.4     Interrelationship between coagulation and innate immunity 
Microbial invasion leads to the simultaneous activation of two remarkably 
complex systems, the blood coagulation and the innate immune response. The 
coagulation and the immune systems are highly integrated and work in 
collaboration towards host defense against pathogens (Opal & Esmon, 2003; 
Delvaeye & Conway, 2009). The innate immune responses during infection 
drive the activation and regulation of the coagulation system. The functional 
liaison between the coagulation and the innate immune systems has been 
conserved over 500 million years of evolution from horseshoe crabs to 
humans (Delvaeye & Conway, 2009). Evolutionary history of the linkage 
between coagulation and innate immunity suggests the survival advantage that 
it confers to the organism. In this section, we discuss the interplay between 
coagulation and the innate immune response in the invertebrates and the 
vertebrates, with an emphasis on the LPS-induced activation of the host 
defense systems. 
 
1.2.4.1   Hemocyanin links coagulation and host defense in horseshoe crab 
In horseshoe crabs, circulating hemocytes detect the presence of microbial 
PAMPs, such as cell wall components, and trigger granular exocytosis 
(Iwanaga et al., 1998; Ariki et al., 2004). As a result, serine protease 
zymogens are released from the granules. Factor C and factor G are two such 
zymogens that undergo autocatalytic activation upon recognition of LPS and 
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"-1,3-D-glucans, respectively (Muta & Iwanaga, 1996). The activated factors 
C and G trigger downstream events that ultimately lead to formation of an 
insoluble coagulin gel via activation of the clotting enzyme (Figure 1.19). In 
this manner, microbial recognition by the coagulation factors couples 




Figure 1.19: Schematic of the coagulation pathway in the invertebrate, 
horseshoe crab. LPS activates factor C, which in turn activates factor B. "-
1,3-D-glucans of the fungal cell wall activate factor G. Activated factors B and 
G convert the proclotting enzyme into the clotting enzyme, which converts 
coagulogen into a clot. Figure adapted from Ding & Ho (2001).  
 
The prophenoloxidase (PPO) activation system (Figure 1.20) is a major 
mechanism of host defense in invertebrates such as insects and crustaceans 
(Cerenius & Söderhäll, 2004). Bacterial and fungal PAMPS such as LPS, 
peptidoglycans and glucans activate a serine protease cascade that results in 
the cleavage of the inactive zymogen, prophenoloxidase, to the active 
phenoloxidase (PO) enzyme. The activated PO catalyzes the production of 
highly reactive quinones, via the oxygenation of monophenols and diphenols. 
Being redox-active and cytotoxic, quinones result in killing of pathogens. 
Additionally, quinones undergo non-enzymatic polymerization to form 
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melanin, which limits the spread of pathogens and participates in wound 
healing (Söderhäll & Cerenius, 1998).  
 
Figure 1.20: Schematic of the prophenoloxidase pathway in invertebrates. 
Activation of phenoloxidase occurs in response to bacterial and fungal 
PAMPs. The active enzyme catalyzes the conversion of phenols to cytotoxic 
quinones. Figure adapted from Söderhäll & Cerenius (1998). 
 
The respiratory protein, hemocyanin of horseshoe crabs functions as a 
substitute for phenol oxidase. Hemocyanin harbors a latent PPO activity that 
may be activated by treatment with amphiphilic substances such as SDS and 
phosphatidyl ethanolamine (Nellaiappan & Sugumaran, 1996). During 
infection, activated coagulation protease, factor B, can form a complex with 
hemocyanin and activate its PPO activity (Nagai & Kawabata, 2000). 
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Additionally, the intrinsic PO activity of hemocyanin is also induced by 
antimicrobial peptides such as tachyplesin, tachystatins and tachychitin, that 
are released upon granular exocytosis during infection (Nagai et al., 2001). 
Direct contact with microbial proteases and LPS also activates hemocyanin 
and amplifies the production of cytotoxic quinones for microbial killing (Jiang 
et al., 2007). Thus, it is evident that the coagulation and the prophenoloxidase 
systems work in collaboration for host defense. 
 
1.2.4.2   Coagulation-inflammation cycle in vertebrates: central role of 
tissue factor (TF) 
Vertebrates have two distinct pathways of coagulation, extrinsic and intrinsic, 
which are activated differently but converge towards a common end result of 
formation of fibrin.  
Tissue factor (TF) is the primary physiological initiator of the extrinsic 
coagulation cascade in vertebrates (Nemerson, 1988). TF is a transmembrane 
glycoprotein, with an extracellular domain of 219 amino acids (Scarpati et al., 
1987), a single transmembrane domain, and a C-terminal cytoplasmic tail of 
21 amino acids (Figure 1.21). The extracellular domain of TF is composed of 
two fibronectin type III domains and bears significant structural homology 
with the cytokine receptor superfamily (Bazan, 1990; Muller et al., 1996).  
 









Figure 1.21: Structure of 
Tissue Factor (TF). Full 
length TF is a membrane-
bound protein with an N-
terminal extracellular domain, 
a transmembrane domain and a 
short cytoplasmic tail. The 
extracellular domain has 2 
disulfide bonds (Cys49-Cys57 
and Cys186-Cys209, indicated 
in red). Figure adapted from 
Petersen et al. (1995). 
 
Under normal physiological conditions, negligible levels of functional TF are 
expressed by intravascular cells (Drake et al. 1989). Upon pathogen invasion, 
tissue injury and a variety of pro-inflammatory stimuli such as LPS (Niemetz 
& Morrison, 1977), cytokines (Conkling et al., 1988; Herbert et al., 1992) and 
immune complexes (Lyberg et al., 1982), may induce the expression of TF in 
endothelial and monocytic cells. Exposure of TF to coagulation factors in the 
blood elicits the coagulation cascade (Figure 1.22). TF forms a complex with 
factor VIIa (Banner et al., 1996) that initiates the activation of factor X to Xa. 
Factor Xa associates with factor V to form prothrombinase, which converts 
prothrombin to thrombin. Thrombin then cleaves fibrinogen to form fibrin, 
which polymerizes to form a clot. Therefore, in an infection-driven 
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Figure 1.22: Pathways of blood coagulation. (1) Upon infection, LPS 
activates the macrophages to release pro-inflammatory cytokines. (2) IL-6 and 
TNF-! upregulate TF expression. TF forms a complex with FVII on the cell 
surface and triggers the extrinsic pathway of coagulation. A cascade of serine 
proteases are activated, ultimately leading to conversion of prothrombin into 
thrombin. (3) Thrombin catalyzes the conversion of fibrinogen to fibrin, which 
then polymerizes to form a clot that traps pathogen. (4) The intrinsic pathway 
is initiated by activation of factor XI by thrombin. (5) Thrombin further 
activates macrophages to release pro-inflammatory cytokines that sustains 
coagulation. Figure adapted from Colman (2006), with modifications. 
 
 
The intrinsic pathway is initiated by the activation of factor IX via the TF-VIIa 
complex (Osterud & Rapaport, 1977). Thrombin itself activates factor XI 
upstream of factor IX, which also activates factor IX and contributes to the 
generation of fibrin (Figure 1.22). Thrombin also activates factors V and VIII, 
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thus resulting in amplification via positive feedback. The intrinsic pathway 
plays an important accessory role in the amplification of the coagulation 
events in sepsis (Opal & Esmon, 2003).  
Several findings indicate a close link between coagulation and inflammation. 
Thrombin induces the secretion of pro-inflammatory cytokines from 
endothelial and immune cells, and the release of growth factors and 
chemokines from platelets (Drake et al., 1992; Fujita et al., 2008; Wadgaonkar 
et al., 2008). TF has been found to play a central role at the intersection of 
coagulation and inflammation. The complex of TF with the activated 
coagulation proteases, factor VIIa and factor Xa, binds to and cleaves 
protease-activated receptors. Downstream signalling events eventually lead to 
the production of pro-inflammatory mediators and cytokines (Papapetropoulos 
et al., 1998; Senden et al., 1998; Cunningham et al., 1999), expression of 
adhesion molecules, and release of growth factors. The elicited inflammation 
in turn upregulates TF expression. Thus, there exists a feedback loop, wherein 
inflammation induces TF expression that in turn promotes the inflammatory 
processes that trigger its expression, thereby, augmenting coagulation (Figure 
1.23). Studies in animal models of sepsis have shown that TF inhibition 
attenuates coagulopathy and improves survival (Taylor et al., 1991; Creasey et 
al., 1993). These exemplify the central role of TF in the interplay between 
coagulation and inflammation. Aberrant TF expression by monocytes and 
macrophages has been implicated in coagulopathies associated with sepsis and 
endotoxemia (Osterud & Flaegstad, 1983; Drake et al., 1993; Dohrn et al., 
1998). 





Figure 1.23: TF plays a central role in the coagulation-inflammation 
cycle. (1) Inflammatory mediators released in response to infection upregulate 
TF expression. (2) TF forms a complex with factors VIIa and X, that activates 
factor X. Factor Xa drives coagulation via thrombin generation, fibrin 
formation and platelet activation. (3) TF-VIIa (3a) and TF-VIIa-Xa (3b) 
complexes activate cell surface protease-activated receptors (PAR). (4) The 
resulting intracellular signaling pathways lead to production of pro-
inflammatory mediators that further boost coagulation (1). PAR: protease 
activated receptor. Figure adapted from Ruf (2004), with modifications. 
 
1.2.5     Association between coagulation and hemolysis 
Many pathological conditions such as sickle-cell disease (SCD), thalassemias, 
paroxysmal nocturnal hemoglobinuria (PNH) and infection-induced anemia 
are characterized by extensive intravascular hemolysis. Plasma Hb levels have 
been reported to be 1-2.5 mg/ml in sepsis (De et al., 1954; Sengers, 1971), 0.5-
2 mg/ml in PNH (Hartmann et al., 1966), and up to 0.4 mg/ml in patients with 
SCD (Reiter et al., 2002). Hb levels under these conditions may even reach up 
to 10 mg/ml during episodes of severe hemolysis in PNH (Hartmann et al., 
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1966). An increased incidence of thrombosis has also been reported under 
these conditions (Ataga & Orringer, 2003; Singer et al., 2006; Ziakas et al., 
2007), suggestive of a link between hemolysis and coagulation. Hemolysis 
contributes to the hypercoagulable state via several mechanisms (Figure 
1.24), including exposure of phosphatidyl serine on the surface of RBCs 
(Zwaal & Schroit, 1997), scavenging of nitric oxide (NO) by Hb (Gladwin et 
al., 2003), endothelial dysfunction, and increased expression of TF (Key et al., 
1998; Liebman & Feinstein, 2003). Hb has been shown to augment the LPS-
induced production of TF in endothelial cells (Kaca et al., 1994b; Roth, 1994). 
Intravascular coagulation results in fibrin deposition that increases mechanical 
shear on red blood cells, causing hemolysis (Bull et al., 1968; Brain, 1970). 
Thus, coagulation and hemolysis are associated in a positive feedback loop, 
that contributes to the maintenance of these reactions (Figure 1.24). Such a 
positive feedback may also exacerbate the severity of the pathophysiology 
associated with hemolysis. 
 
 




Figure 1.24: Positive feedback between coagulation and hemolysis. 
Hemolysis causes a hypercoagulable state via various pathophysiological 
mechanisms. Hemolysis is associated with loss of the normal asymmetrical 
distribution of the RBC membrane phospholipids and translocation of PS to 
the external membrane leaflet via flip-flop mechanism. (1) PS exposure 
facilitates the adherence of RBCs to endothelial cells, thereby activating them. 
(2) PS also functions as a docking site for the assembly of prothrombinase 
complex. (3) Thrombin thus formed activates platelets, monocytes and 
endothelial cells to upregulate TF expression. (4) TF activates platelets, 
monocytes and further promotes coagulation. (5) Free heme arising from cell-
free Hb activates the endothelium. (6) Cell-free Hb scavenges NO, leading to 
endothelial dysfunction and enhancement of coagulation. (7) Increased 
thrombus formation promotes hemolysis by mechanical damage to RBCs, 
constituting a feedback loop. NO: nitric oxide; PS: phosphatidyl serine; RBC: 
red blood cell. Figure adapted from Eldor & Rachmilewitz (2002), with 
modifications. 
 
1.3 Hypothesis and research objectives  
This thesis explores potential mechanisms for the regulation of the redox 
activity of extracellular Hb. Hb harbors a pseudoperoxidase enzymatic activity 
that is carefully regulated by a highly reducing environment within the 
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erythrocytes. Intravascular hemolysis accompanying infection, trauma or 
inherited disorders such as sickle-cell disease results in high levels of 
extracellular Hb. Extracellular Hb has a propensity to undergo uncontrolled 
redox reactions, causing oxidative cellular damage. The work presented here 
explores two strategies for controlling the oxidative reactions of extracellular 
Hb – protein modifications, and endogenous anti-oxidant mechanisms. 
During infection, extracellular Hb may come into contact with microbial 
virulence factors, such as proteases and LPS, both of which intensify the redox 
activity of Hb. The ensuing localized burst of free radical production has been 
shown to effectively kill the microbial population in the vicinity, thus 
constituting an effector mechanism of innate immune defense (Figure 1.25). 
The amplified production of free radicals by Hb in the presence of LPS is a 
double-edged sword – it kills the pathogen, but also causes oxidative injury to 
the host. The mechanism of generation of free radicals by Hb upon contact 
with microbial factors is evolutionarily conserved, sharing similarity with an 
ancient host defense mechanism found in invertebrates. In horseshoe crabs, the 
respiratory protein, hemocyanin, is activated by microbial PAMPs to generate 
cytotoxic quinones (Figure 1.25). The redox activity of hemocyanin is also 
triggered by an activated host coagulation protease during infection. Such a 
mechanism of interaction between coagulation proteases and respiratory 
protein is yet unknown in vertebrates. During inflammation, there exists a 
positive feedback loop between coagulation and hemolysis (see Figure 1.24). 
The coagulation initiator, TF, is upregulated during infection and promotes 
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coagulation, resulting in the formation of fibrin clot. The fibrin mesh induces 
hemolysis, releasing factors that in turn promote coagulation.  
 
Figure 1.25: Respiratory proteins from invertebrates and vertebrates 
participate in host defense. (1) Upon infection in invertebrates, the proPO 
activity of HMC is activated by host factors, such as clotting factor B. (2) 
Direct binding to LPS and microbial proteases also activates HMC. (3) This 
mechanism is analogous to that found in the vertebrates, where the redox 
activity of Hb is triggered for microbial killing. HMC: Hemocyanin; PO: 
phenol oxidase. Figure adapted from Bogdan (2007), with modifications. 
 
Based on these observations, we hypothesize that: (i) modifications of the 
LPS binding sites of Hb may suppress the redox reactivity of the protein; and 
(ii) in analogy with the invertebrate system, an interaction between Hb and TF 
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may exist, which modulates the redox activity of Hb. The objectives of this 
thesis are thus to: (i) delineate the LPS-binding sites of Hb and investigate the 
effects of mutations in the LPS-binding sites on the redox activity of Hb; (ii) 
examine the role played by TF in the modulation of the redox activity of Hb; 
and (iii) assess the functional significance of the interplay between Hb and TF. 
Overall, the research findings will provide insights into the mechanisms that 
could regulate redox-active Hb. These may find applications for the 
development of improved Hb-based blood substitutes, with lower risk from 
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CHAPTER 2    
MATERIALS AND METHODS 
 
2.1 Computational Methods 
2.1.1 Prediction of LPS-binding sites on Hb 
As the binding site of LPS on Hb is not yet known, we employed a 
computational approach to predict the LPS-binding sites on the protein (Figure 
2.1). The information gained from computational predictions will provide 
guidance for experimental investigations using peptide-based binding analyses 
and site-directed mutagenesis experiments. 
We envisaged that for optimal antimicrobial potency, Hb would position itself 
in proximity to the bacterial surface by binding to the negatively charged 
phosphate groups on the lipid A structure (see Figure 1.14). Thus, an 
algorithm that computes the propensity of phospho-group binding for a protein 
surface (Joughin et al., 2005) was used to search for LPS-binding sites on Hb 
(Figure 2.1, panel A). Briefly, the algorithm calculates a propensity for 
phospho-group contact based on the amino acid identity, surface curvature and 
electrostatic potential at every point of the discretized protein surface. The 
applicability of the prediction algorithm was assessed by using control 
proteins whose structure in complex with LPS is known. The computed 
binding propensities for each surface point were mapped onto the 
corresponding surface amino acid residues and an average binding propensity 
for each residue was computed. 





Figure 2.1: Workflow of the modules for prediction of LPS binding sites 
on Hb. A. Phospho-group binding site prediction algorithm. For a given 
PDB file, the algorithm obtained a triangular mesh surface. The protein 
surface was discretized and the amino acid identity was assigned to each point. 
The curvature and electrostatic potential at each surface point were calculated. 
Individual propensities were calculated for these properties, and were 
combined to compute a joint propensity. B. Evolutionarily conservation of 
binding sites. Binding propensities were mapped onto surface residues. An 
average binding propensity for each residue was computed, and a propensity 
score was assigned. Structural alignment of vertebrate Hbs was performed. For 
each position in the alignment, a conservation index was calculated, and a 
conservation score was assigned. C. Molecular docking. Propensity and 
conservation scores were combined to rank residues. Binding sites were 
identified that contained paired patches separated by a maximum distance of 
~12 Å which is the maximum distance between the two phosphates in the head 
group of lipid A. Docking was performed using GLIDE. The resulting docking 
models were ranked on the basis of binding energies, and top ranking LPS 
binding sites were identified. nb(i), number of surface points with property i 
and in contact with phospho group; nb, total number of points in contact with 
phospho group; nt(i), number of surface points with property i; nt, total number 
of surface points; Paa, amino acid propensity; Pcurv, surface curvature 
propensity; Pes, electrostatic potential propensity; C, conservation index; Pscore, 
propensity score; Cscore, conservation score. 
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To determine the binding sites which have been conserved across Hbs, twenty 
vertebrate Hb structures were selected from SCOP (Structural Classification of 
Proteins) database classification (Lo Conte et al., 2000). The propensity 
calculation algorithm was repeated on each of these structures. Independently, 
structural alignment of these proteins was performed using the MultiSeq tool 
of VMD (Roberts et al., 2006), with human aquomet Hb as the index structure 
for the alignment. From the structure-based alignments, the degree of 
conservation of the favorable phospho-group binding propensity was 
computed as the normalized sum of the propensity of residues for each column 
of the alignment (Figure 2.1, panel B).  
Potential binding sites were identified by multiplicative combination of scores 
from the binding propensity and conservation(Figure 2.1, panel C). The 
predicted binding sites were further prioritized by seeking paired patches at an 
appropriate distance to interact with the two phosphate groups of the lipid A 
head group (see Figure 1.13 & 1.14). To comprehend the interactions between 
the ligand and the predicted binding sites, docking was performed using 
GLIDE, version 5.0 (Schrodinger, LLC, 2007). The crystal structure of human 
aquomet Hb (PDB id: 1HGB) was used as the receptor. The protein structure 
was prepared using the Maestro protein preparation wizard (Schrodinger). The 
solvent molecules were deleted, bond orders assigned, and hydrogen atoms 
were added to the protein. The orientation of the hydroxyl groups and the 
protonation states of the amino acid residues were optimized. The protein 
structure was then minimized using the OPLS 2001 force field. The ligand 
(1,4’-bisphospho-"-(1,6)-2,2’-N-acetyl-3,3’-O-acetyl-D-glucosamine 
disaccharide) was prepared by replacing the long acyl chains of lipid A with 
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methyl groups, since GLIDE limits the maximum number of atoms for a 
ligand. The Ligprep utility of Maestro was used to generate the protonation 
and tautomeric states. One low energy ring conformation and 32 stereoisomers 
were generated. Prior to docking, grids were generated for each of the 
potential binding sites. For each site, the centre of each grid was defined as the 
centroid of the residues of the patch. Default parameters of the standard 
precision mode specified in GLIDE were used for docking. The ligand was 
flexible while the protein was held rigid. The resulting structures from each 
docking were compared on the basis of their GlideScore. 
 
2.1.2 Design of LPS-binding peptides 
Based on the computational predictions (Section 2.1.1), various Hb peptides 
were designed to validate the predicted LPS-binding sites. Each peptide was 
designed to include a stretch of residues flanking the predicted LPS-binding 
residues. The lengths of the peptide sequences were optimized after analysis of 
the hydrophilicity and solubility of the peptides, with respect to their 
amenability for synthesis. Peptide sequences were submitted for synthesis to 
Genemed Synthesis, Inc. (California, USA). All peptides were purified to 
>95% under pyrogen-free conditions. The purity and quality of the peptides 
were assessed by HPLC and mass spectrometry.  
 
2.1.3 Analysis of co-evolution of Hb and TF 
ComplexCorr (http://webclu.bio.wzw.tum.de/complexcorr) (Gershoni et al., 
2010) was used to perform co-evolutionary analysis of TF and Hb (Figure 
2.1). The sequences of the extracellular domain of human TF (NCBI gi # 
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157830419), Hb! (NCBI gi # 494099) and Hb" (NCBI gi # 494100) were 
used as reference sequences for obtaining homologous sequences from the 
NCBI RefSeq database (Pruitt et al., 2007). Default BLAST search parameters 
were used, except that the stringency was lowered (e-value = 1000), to enable 
identification of distantly related sequences for human TF. Redundant 
sequences with identity greater than 90% were eliminated using CD-HIT 
(http://cd-hit.org) (Huang et al., 2010). If there were multiple sequences from 
a given species, only one sequence with the highest BLAST score was 
retained. ComplexCorr requires a one-to-one pairing between the homologs of 
the interacting proteins from the same species. As there were few species with 
sequences common to all three proteins, TF-Hb! and TF-Hb" interactions 
were analyzed separately. The final set consisted of 31 sequences for TF and 
Hb!, and 39 sequences for TF and Hb". Multiple sequence alignments for 
each set were generated using MUSCLE (Edgar, 2004). The alignments were 
edited to remove gaps in the reference sequences, and were submitted to 
ComplexCorr. ComplexCorr uses two prediction algorithms – explicit 
likelihood of subset covariation (ELSC) (Dekker et al., 2004; Fodor & 
Aldrich, 2004) and observed minus expected squared (OMES) (Larson et al., 
2000; Kass & Horovitz, 2002). The OMES method performs a chi-squared test 
on every possible pair of columns in an alignment, looking for pairs of amino 
acids that occur more frequently than expected. ELSC is based on perturbation 
of a multiple-sequence alignment. It creates sub-alignments based on the most 
prevalent residue in a column, and measures deviation of amino acid 
composition between the sub-alignments and the total alignments.  




Figure 2.2: Schematic of the co-evolutionary analysis. Homologous protein 
sequences were obtained from BLAST searches. Redundant sequences with 
more that 90% similarity were removed, and only one sequence from each 
species, most similar to the reference sequence was retained. Multiple 
sequence alignments (MSA) were obtained using MUSCLE. The MSAs were 
submitted to ComplexCorr, which concatenates sequences from similar 
species. Each position in the MSA for TF was compared with that of Hb! and 
Hb", to calculate ELSC and OMES scores that detect protein interactions by 
identifying co-evolving residue pairs.  
 
 
2.1.4 Molecular Docking of Hb and TF 
To predict the relative binding pose of Hb and TF, Hb (PDB identifier 1HGB) 
was docked onto TF (PDB identifier 1BOY) by a rigid-body docking with 
shape complementarity using the PatchDock server (Schneidman-Duhovny et 
al., 2005). The docking simulation was run by specifying TF as the receptor 
for the docking. The clustering RMSD was 4.0 Å for analysis and the complex 
type was set to default. The top 1000 solutions obtained from PatchDock were 
further refined and scored using FireDock (bioinfo3d.cs.tau.ac.il/FireDock/) 
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(Andrusier et al., 2007; Mashiach et al., 2008). This refinement method 
optimizes the rigid-body docking candidates by incorporating side-chain 
flexibility at the binding interface, followed by repositioning of the proteins 
via minimization of the binding energy. The refined complexes were finally 
ranked by binding energy, and allotted a binding score. This pipeline has 
proven successful in CAPRI predictions (Mashiach et al., 2010) and protein-
protein docking benchmarks (Hwang et al., 2008).  
 
2.2 Preparative Methods 
2.2.1 Microorganisms 
Bacteria strains used for this study were: Escherichia coli TOP10 for cloning 
and mutagenesis; E. coli BL21(DE3) for protein expression; and wild-type 
strain Pseudomonas aeruginosa (PAO1) (Holloway et al., 1979) for peptide 
binding assays. The P. aeruginosa strain PAO1 was kindly provided by Prof. 
B.H. Iglewski (University of Rochester, Rochester, NY). 
 
2.2.2 Reagents 
E. coli LPS, Salmonella minnesota LPS and lipid A were purchased from 
Sigma-Aldrich (St. Louis, MO). S. minnesota ReLPS was from List Biological 
Laboratories (Campbell, CA, USA). Recombinant human TF protein and 
human TF DuoSet ELISA Development kit were from R&D Systems 
(Minneapolis, MN). PyroGene kit for the quantification of endotoxin levels 
was from Lonza Biosciences (Basel, Switzerland). Pyrogen-free water was 
from Baxter Healthcare (Australia). Luria Bertani (LB) broth was from Difco, 
BD Biosciences (Franklin Lakes, NJ). QuikChange® XL site-directed 
Chapter 2: Materials & Methods 
51 
 
mutagenesis kit was purchased from Stratagene (Santa Clara, CA). 
Glutathione Sepharose® 4B, Protein-A Sepharose 4 Fast Flow slurry, 
Thrombin Protease and HiPrep DEAE FF 16/10 chromatography column were 
from GE Healthcare (UK). Isopropyl-1-thio-"-D-galactopyranoside (IPTG), 
Prolong Gold Antifade Reagent with DAPI, Trizol® Reagent, SuperScript® 
III First-Strand Synthesis System for RT-PCR, and Pen-Strep were from 
Invitrogen (Carlsbad, CA). RPMI 1640 was purchased from Gibco-BRL Life 
Technologies (Gaithersburg, MD). High-grade HyClone fetal bovine serum 
(FBS), with extremely low levels of endotoxin (<0.6 EU/ml), was from 
Thermo Fisher Scientific (MA). ACTICHROME® TF assay kit was from 
American Diagnostica Inc. (Stamford, CT). SYBR Green PCR Master Mix 
and horseradish peroxidase substrate, ABTS (2,2’-azino-bis[3-
ethylbenzthiazoline-6-sulfonic acid]) were from Roche Diagnostics 
(Mannheim, Germany). Bovine serum albumin (BSA) was from Merck 
(Billerica, MA). Human Fc Receptor Binding Inhibitor was from eBioscience 
(San Diego, CA). Rabbit anti-Hb polyclonal antibody was from Sigma-
Aldrich. Mouse anti-Hb monoclonal antibody was from Santa Cruz 
Biotechnology (Santa Cruz, CA). Goat anti-human TF antibody was from 
R&D Systems. Goat anti-rabbit and rabbit anti-goat secondary antibodies, 
with HRP conjugation, were from Dako Denmark A/S (Glostrup, Denmark). 
Alexa Fluor-488 conjugated goat anti-mouse and donkey anti-goat antibodies, 
Alexa Fluor-546 conjugated donkey anti-mouse antibody and Phycoerythrin-
conjugated goat anti-rabbit antibody were from Invitrogen (Carlsbad, CA). 
Goat anti-rabbit IgG conjugated with 20 nm colloidal gold was from Ted 
Pella, Inc. (Redding, CA). Maxisorp™ plates for ELISA were from NUNC 
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(Denmark). SuperSignal® West Pico chemiluminescent substrate was from 
Thermo Scientific (Rockford, IL). All other chemicals were of molecular 
biology grade, obtained from Sigma-Aldrich. 
 
2.2.3 Pyrogen-free equipment and buffers 
Endotoxin contamination was minimized by depyrogenation of all equipment 
that were used for experiments. Glassware were baked at 200°C for 2 h. 
Materials that could not be baked, such as chromatography columns, were 
treated with 3% hydrogen peroxide overnight and rinsed with pyrogen-free 
water before use. All buffers and cell culture media were prepared in pyrogen-
free water. 
 
2.2.4 Cell culture, differentiation and stimulation 
Human monocytic cells, THP-1, were obtained from American Type Culture 
Collection (Manassas, VA) and were cultured in RPMI 1640 supplemented 
with 10% FBS and 50 U/ml penicillin with 50 µg/ml streptomycin (Pen-Strep) 
in 5% CO2 at 37°C. To prepare THP-1 macrophages, cells were seeded in 12-
well plates at a density of 4×105 cells/ml, and treated with 10 ng/ml PMA for 
24 h. Cells were rinsed and cultured in fresh RPMI 1640 containing 10% FBS 
and Pen-Strep for a further 48 h. THP-1 macrophages were treated with 10 
ng/ml LPS for 6 h to upregulate TF expression. These cells are referred to as 
‘TF+ macrophages’. Stimulation time was determined on the basis of results 
obtained in preliminary time-course experiments (see Section 3.2.2.2, Figure 
3.28B). For some experiments, TF+ macrophages were treated with anti-TF 
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antibody (4 µg/ml) for 1 h to block the availability of TF. These are referred to 
as ‘TF$ macrophages’. 
 
2.3     Analytical Methods 
2.3.1 Circular Dichroism 
CD spectra for recombinant Hb subunits were measured at a concentration of 
0.2 mg/ml in phosphate-buffered saline (PBS). Spectra for Hb peptides were 
measured at a concentration of 40 µM in PBS. CD spectra were recorded in 
quartz cuvettes using Jasco J-810 spectropolarimeter, at a constant temperature 
of 25°C. The settings used were – data pitch of 0.1 nm, band width of 2 nm, 
response time of 1 sec and scanning speed of 20 nm/min. Data from three 
independent scans were averaged. Buffer alone was used as the control for 
baseline subtraction.  
 
2.3.2 Chemiluminescence assay for superoxide detection 
Principle 
The redox activity of Hb was assayed using Cypridina-Luciferin Analog 
(CLA), 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3(7H)-one. CLA 
is a chemiluminescent probe that reacts with superoxide anions to emit light 
(Nakano, 1990; Kawano et al., 2002). A time-course profile of the change in 
chemiluminescence of CLA shows that the product formation reaches a peak 
and then declines as the substrate is diminished (Figure 2.3). The maximum 
chemiluminescence intensity is proportional to the enzyme activity, and was 
used here as the parameter of analysis. The specificity of CLA for superoxide 
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enables the detection of the pseudoperoxidase activity of Hb (see Figure 1.2) 
in the presence of hydrogen peroxide.  
  
Superoxide production by recombinant Hb subunits 
Recombinant Hb ! and " subunits (see Section 2.3.5 for details on expression 
and purification), with or without pre-treatment with 4-fold molar excess of 
LPS, were subjected to the chemiluminescence assay. The reaction mixture 
contained 10 µM CLA and 5 mM H2O2 with the various proteins, in a total 
reaction volume of 100 µl. Chemiluminescence was measured at 1 s intervals 
using GloMax 20/20 Luminometer (Promega). The redox activity of Hb was 
quantified as the peak chemiluminescence intensity, expressed as relative 
luminescence units (RLU). 
  
Superoxide production by Hb in presence of TF 
Hb (with or without pre-treatment with a 4-fold molar excess of LPS) was 
incubated with TF for 1 h. Hb, TF and LPS separately or in combination were 
used as controls. BSA was added instead of TF as a negative control. The 
reaction complex was then added to a ‘substrate mixture’ containing CLA and 
H2O2. The final reaction mixture consisted of 1 µg Hb (with or without 
various treatments), 10 µM CLA and 5 mM H2O2 in a reaction volume of 100 
µl. Chemiluminescence was measured as described above. 
 
In situ chemiluminescence assay 
TF+ and TF$ macrophages (see Section 2.2.4) were incubated with Hb for 30 
min, washed thrice and then subjected to CLA assay, with or without pre-
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treatment with LPS. The reaction mixture consisted of 2x105 cells, 5 µg LPS, 
10 µM CLA and 5 mM H2O2 in a reaction volume of 100 µl. Untreated cells 
served as negative controls.  
 
2.3.3 Co-crystallization of Hb with LPS 
X-ray crystallographic analysis was attempted for the precise structural 
determination of the structure of Hb in complex with LPS, so as to ascertain 
the molecular details of their interactions. Firstly, anion exchange 
chromatography was used for the purification of human Hb (Sigma-Aldrich) 
as described previously (Sun & Palmer, 2008). Briefly, HiPrep DEAE FF 
16/10 column was equilibrated with 20mM Tris-HCl buffer at pH 8.2 (buffer 
A). Elution was achieved using a linear salt gradient generated by changing 
from 100% buffer A to 75% buffer B (20mM Tris-HCl buffer containing 
200mM NaCl, pH 8.2) in 5 CVs (100 min). The purity of the protein was 
assessed using SDS-PAGE. Purified Hb was mixed with LPS for 30 min to 
allow complex formation. Standard kits from Hampton Research and Qiagen 
were used to explore buffer conditions that favored crystallization of the 
complex. Crystals were grown using hanging-drop method with 1:1 ratio of 
protein solution to crystallization solution. Buffer conditions that produced 
promising crystals were further refined in a grid-like manner to optimize the 
crystallization conditions.  
 
2.3.4 Dansylcadaverine displacement assay 
The binding of Hb peptides to lipid A in solution was examined using 
dansylcadaverine (DC) displacement assay. DC is a fluorescent probe that 
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undergoes an increase in its emission intensity accompanied by a blue shift in 
the wavelength of maximum emission upon binding to lipid A. The 
displacement assay (David et al., 1992) is based on the differences in 
fluorescence intensity of lipid A–bound and –unbound forms of DC. 50 µl of 
100 µM DC was incubated with equal volume of 40 µg/ml lipid A for 5 min. 
Following this, 50 µl of various concentrations of Hb peptides were added, 
and fluorescence intensity was measured using a BIOTEK plate reader. 
Excitation and emission wavelengths were set at 340 nm and 560 nm, 
respectively. The extent of binding of peptide to lipid A was quantified as the  
 ‘occupancy’ of DC on lipid A in presence of the peptide, using the formula: 
 
   
where,  
FD is the fluorescence intensity of DC in the absence of lipid A,  
FL is the fluorescence intensity of DC in the presence of lipid A, and  
FP is the fluorescence intensity of the solution of DC and lipid A upon the 
addition of the different concentrations of the peptides.  
A solution of DC and lipid A without peptides would have an occupancy of 1. 
If a peptide binds lipid A, the bound DC could be displaced, resulting in a 
decrease in occupancy. A DC solution without lipid A would have the 
minimum value of 0 for occupancy. 
 
2.3.5 Expression and purification of recombinant Hb subunits  
Hb ! and " subunits were expressed recombinantly to characterize their 
interactions with LPS, and for mutagenesis experiments. The E. coli 
expression vector, pGEX-4T-1 (Amersham, ampicillinR), was used for 
Occupancy = 
FP !  FD
FL !  FD
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constructing the recombinant clones. The human hemoglobin cDNA clones 
(Accession Numbers: BC101846 and BC007075, encoding Hb!1 and Hb", 
respectively) purchased from Open Biosystems (USA) were used as templates 
for PCR amplification. The recombinant expression constructs were verified 
by DNA sequencing, and transformed into E. coli BL21(DE3) for the protein 
expression. Expression of the recombinant proteins was achieved according to 
the handbook for Glutathione S-transferase (GST) Gene Fusion System from 
the manufacturer (GE Healthcare). Briefly, overnight cultures of the respective 
clones were separately used to inoculate 2X YT broth (1.6% tryptone, 1% 
yeast extract, and 0.5% NaCl) supplemented with 100 %g/ml ampicillin, 0.3 
mM heme precursor, &-aminolevulinate and 0.001% thiamine. The inoculated 
broth culture was shaken at 30°C until the OD600 reached 0.5 – 0.6. The 
cultures were then induced with 0.2 mM IPTG for an additional 6 h. The 
harvested cells were used for purification and assessment of the recombinant 
proteins. It was found that both of the recombinant proteins were present in the 
supernatant of the cell lysate, hence, the purification was achieved by using 
glutathione sepharose affinity chromatography according to the 
manufacturer’s instructions. Protein-bound beads were mildly denatured in 1% 
Triton X-100 for 2 h followed by incubation in chaperonin buffer, pH 7.5 (0.5 
M triethanolamine-HCl, 20 mM MgCl2, 50 mM KCl, 5 mM ATP, 2 mM DTT) 
(Rohman & Harrison-Lavoie, 2000) for 30 min to remove the major 
contaminant, chaperone DnaK. Another washing step with 50 mM Tris-HCl 
pH 8.5 was carried out to completely remove other contaminants. For removal 
of the GST tag, the protein-bound beads were treated with thrombin at room 
temperature for 20 h. 
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2.3.6 ELISA  
Interaction of tetrameric Hb with PAMPs 
1 µM LPS, ReLPS and lipid A from S. minnesota were immobilized on the 
surface of 96-well Maxisorp™ microtitre plates by overnight incubation at 
room temperature. The excess ligands were washed off and the unbound sites 
were blocked with 2% BSA at 37°C for 2 h. Various concentrations of the Hb 
were added to the wells and incubated at 37°C for 2 h. Following three rinses 
with PBST (PBS containing 0.05% v/v Tween 20), the bound proteins were 
detected by incubating the samples with primary rabbit anti-Hb antibody (0.4 
µg/ml) and horseradish peroxidase-conjugated goat anti-rabbit antibody (0.125 
µg/ml) at 37°C for 2 h. After washing the wells three times with PBST, 100 µl 
of peroxidase substrate, ABTS was added and OD405 was read. 
 
Interaction of recombinant Hb subunits, tetrameric Hb and TF with LPS 
1 µg S. minnesota LPS was immobilized on the surface of Maxisorp™ plates 
by overnight incubation at room temperature. After washing off the excess 
ligand, the unbound sites were blocked with BSA. The proteins were allowed 
to bind LPS by incubation for 2 h at 37°C. The bound recombinant Hb 
subunits and tetrameric Hb were detected using rabbit anti-Hb antibody (0.4 
µg/ml) and horseradish peroxidase-conjugated goat anti-rabbit antibody (0.125 
µg/ml). The bound TF was detected using goat anti-TF antibody (0.4 µg/ml) 
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Interaction of Hb with TF 
0.2 %g of TF was immobilized on the surface of Maxisorp™ plates by 
incubating overnight at 4ºC. After three washes with PBST, wells were 
blocked with 2% BSA in PBST at 37ºC for 2 h. After three washes, Hb (with 
or without a 30 min pre-incubation with a 4-fold molar excess of LPS) was 
added to the wells and incubated at 37ºC for 2 h. Following three washes, the 
bound protein was detected with rabbit anti-Hb antibody (0.5 µg/ml), followed 
by HRP-conjugated goat anti-rabbit antibody (0.125 µg/ml). Peroxidase 
enzyme activity was determined by measuring OD405nm after adding the 
peroxidase substrate, ABTS. Wells coated with BSA instead of the 
immobilized proteins served as negative controls.  
Hb-TF interaction was further tested by reversing the order of immobilization. 
0.2 %g of Hb was coated on the well surface and the binding of TF was 
detected using goat anti-TF antibody (0.4 µg/ml), followed by HRP-
conjugated rabbit anti-goat antibody (0.1 µg/ml).  
 
2.3.7 Flow Cytometry 
Binding of Hb B59 peptide to gram-negative bacteria 
Cultures of E. coli and P. aeruginosa (~107 cells/ml) growing at exponential 
phase were treated with 1 mM B59, with or without pre-treatment with 100 
ng/ml LPS, for 30 min at room temperature. The bacteria were then fixed with 
4% paraformaldehyde for 30 min, followed by blocking with 5% BSA for 1 h. 
The bound peptide was detected by incubating the samples for 1 h each with 
primary rabbit anti-Hb antibody (5 µg/ml) and secondary phycoerythrin-
conjugated goat anti-rabbit antibody (10 µg/ml). Untreated samples served as 
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negative controls. The bacteria were resuspended in 0.5% paraformaldehyde 
and data were collected using Dako Cytomation CyAn ADP system. Samples 
stained with secondary antibody alone, or with isotype control antibody, 
served as negative controls.  
 
Detection of surface expression of TF by macrophages 
For assessing cell surface TF expression on THP-1 macrophages, cells (with 
or without treatment with LPS for 6 h) were harvested and washed with PBS. 
To inhibit non-specific binding, cells were incubated in blocking solution 
(Human Fc Receptor Binding Inhibitor) at 4°C for 20 min, followed by 
sequential staining with primary antibody (goat anti-TF, 2 µg/ml) and Alexa 
Fluor 488-conjugated secondary antibody (donkey anti-goat, 10 µg/ml). After 
three washes with PBS, cells were fixed in 0.5% paraformaldehyde, diluted to 
a density of ~1x105 cells/ml and flow cytometry was performed using Dako 
Cytomation CyAn ADP system. Samples stained with secondary antibody 
alone, or with isotype control antibody, served as negative controls.  
 
Binding of Hb to TF-expressing macrophages 
To examine binding of Hb to TF in situ, TF+ macrophages were treated for 30 
min with varying concentrations of Hb (with or without a 30 min pre-
incubation with a 4-fold molar excess of LPS). Cells were washed and treated 
with blocking solution (Human Fc Receptor Binding Inhibitor). Hb bound to 
cell surface was detected by staining with primary mouse anti-Hb antibody (1 
µg/ml) and Alexa Fluor 488-conjugated goat anti-mouse antibody (10 µg/ml). 
Samples stained with isotype control antibody served as negative controls. The 
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specificity of interaction of Hb with TF was verified by examining binding of 
Hb to TF$ macrophages.  
 
2.3.8 PyroGene Assay for LPS endotoxicity  
Principle  
Endotoxin levels in samples were measured using the PyroGene assay (192-
test kit). The assay employs recombinant Factor C (rFC) from horseshoe crab 
to quantify the endotoxicity of LPS (Ding & Ho, 2001). rFC becomes 
activated in the presence of LPS and hydrolyzes a synthetic substrate to 
release a fluorescent product. The fluorescent product is detected using 
excitation and emission wavelengths of 380 and 440 nm, respectively. The 
amount of product formed is proportional to the amount of LPS detected by 
rFC, and is quantified from a standard curve generated using known amounts 
of LPS.  
 
Measurement of endotoxin levels in proteins and peptides 
The levels of endotoxin contamination in the Hb peptides and commercial 
metHb were measured using PyroGene assay. Various 10-fold dilutions of the 
proteins or peptides were prepared and PyroGene assay was performed using 
100 %l of the solutions, according to the manufacturer’s specifications.  
 
Endotoxin neutralization by Hb peptides 
To measure the extent of endotoxin neutralization by Hb peptides, various 
concentrations of peptides were pre-incubated with 10 ng/ml of S. minnesota 
LPS at 37°C for 1 h. Each test sample was diluted 20 times, and 100 %l was 
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aliquoted into the wells of a 96-well plate. PyroGene assay was performed 
according to the manufacturer’s specifications. The relative change in the 
endotoxicity of the solutions was measured by comparison with the peptide-
free LPS samples. The extent of neutralization of the endotoxicity of LPS in 
the presence of peptides was calculated using the formula: 
 
where,  
EL is the endotoxicity of LPS solution, and  
EP is the endotoxicity of the solution in the presence of the peptide.  
 
2.3.9 Quantitative Real-Time PCR (qRT-PCR) 
THP-1 macrophages were treated with various doses of Hb in serum-free 
RPMI 1640. Cells treated with LPS (10 ng/ml) were positive controls. 
Untreated cells served as negative controls. Stimulation time was 2 h, as 
determined from preliminary time-course experiments using LPS (see Section 
3.2.2.2, Figure 3.28A). After 2 h, the level of expression of TF mRNA was 
examined by real-time PCR.  
 
RNA extraction 
Total cellular RNA was extracted using Trizol, according to manufacturer’s 
instructions. Briefly, THP-1 macrophages were treated as described in Section 
2.2.5, culture media was removed and cells were homogenized in 0.5 ml 
Trizol® Reagent. Samples were incubated for 10 min at room temperature to 
allow dissociation of the nucleoprotein complexes. 0.1 ml chloroform was 
% Neutralization  = 
EL !  EP X  100 
EL 
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added to the homogenate, followed by vigorous shaking for 15 sec. The 
mixture was allowed to sit for ~3 min and centrifuged at 12,000 g for 15 min 
at 4°C. Centrifugation resulted in the separation of RNA into an aqueous 
phase, which was removed carefully. RNA was precipitated by adding 0.25 ml 
isopropanol for 10 min, followed by centrifugation at 12,000 g for 10 min at 
4°C. The RNA pellet was washed in 75% ethanol, pelleted by centrifugation at 
7,500 g for 5 min at 4°C and air dried. The pellet was finally resuspended in 
10 %l RNase-free water and incubated at 55°C for 15 min. The concentration 




cDNA was synthesized by reverse transcription using SuperScript® III First-
Strand Synthesis System using oligodT primers. Briefly, RNA was mixed with 
5 %M oligo(dT)20 primer and 1mM dNTP mix in a final reaction volume of 2.5 
%l. The mixture was incubated at 65°C for 5 min and then placed on ice for 2 
min. A cDNA synthesis mix containing 10 mM MgCl2, 0.02 mM DTT, 40 U 
RNase OUT™ and 200 U of SuperScript™ III RT was prepared. 2.5 %l of the 
cDNA synthesis mix was added to the RNA mixture and incubated at 50°C for 
50 min. The reaction was terminated by incubating at 85°C for 5 min and 
chilled on ice. The cDNA product was diluted 1:100 and used for qPCR. 
 
qRT-PCR 
Primers specific for TF and "2-microglobulin (B2M) were designed using the 
primer design tool, QuantPrime (http://www.quantprime.de/). A primer mix 
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for TF and B2M was made by mixing 10 %M each of the respective forward 
and reverse primers. PCR reaction was assembled by mixing 5 %l of SYBR 
Green PCR Master Mix, 3 %l of the 1:100 diluted cDNA and 0.4 %l primer 
mix, and was made up to a final volume of 10 %l. qPCR was performed using 
a Roche LightCycler 480 System with initial denaturation at 95°C for 10 min, 
followed by 40 cycles of 95°C for 10 s, 58°C for 15 s and 72°C for 15 s, and 
fluorescent measurements were recorded during each annealing step. All 
amplification reactions were performed in triplicates. Data were analyzed 
using the ''Ct method and the results were reported as the fold expression of 
TF compared with the expression of B2M. 
 
2.3.10 Scanning Electron Microscopy  
Binding of Hb peptide, B59, to the surface of gram-negative bacteria was 
visualized using immuno-gold labeling coupled with scanning electron 
microscopy (SEM). The bacteria were prepared as for flow cytometry analysis 
(see Section 2.3.7). Cells were treated with primary rabbit anti-Hb antibody 
(40 µg/ml) for 1 h, followed by gold-conjugated goat anti-rabbit antibody 
(1:50). Primary anti-C3d antibody (40 µg/ml) was used as an isotype control. 
Cells were post-fixed in 1% aqueous solution of osmium tetroxide for 30 min, 
followed by dehydration in increasing concentrations of ethanol, and subjected 
to standard procedures of infiltration and carbon coating. The samples were 
viewed under XL-30 FEG SEM (Philips) at an accelerating voltage of 10 keV. 
The backscattered electron mode was used to observe colloidal gold particles 
on the bacteria. 
 
Chapter 2: Materials & Methods 
65 
 
2.3.11 SDS-PAGE and Western blotting 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out to resolve proteins according to their molecular sizes. Protein 
samples were boiled at 95°C for 5 min in reducing sample loading buffer. 
Samples were electrophoresed in 12% SDS-PAGE gel and detected by 
staining with Coomassie Blue. For immunodetection of proteins, semi-dry 
electrophoretic transfer was performed using Mini TransBlot Electrophoretic 
Transfer Cell (Biorad). Proteins were transferred to a PVDF (BioRad) 
membrane at a constant current of 10 mA for 1 h, after which the membrane 
was incubated for 2 h at room temperature in ‘blocking buffer’ containing 3% 
(w/v) skimmed milk in PBST. The membrane was rinsed 3 times in PBST, 
and incubated overnight at 4°C with primary rabbit anti-Hb antibody (0.4 
µg/ml) in blocking buffer. Following 3 washes to remove unbound antibody, 
HRP-conjugated secondary antibody (0.025 µg/ml) in blocking buffer was 
then added to the membrane and incubated for 2 h at room temperature with 
gentle shaking. The antigen-antibody complex was detected using 
SuperSignal® West Pico chemiluminescent substrate.  
 
2.3.12 Site-directed mutagenesis 
 Site-directed mutagenesis of Hb subunits was carried out using the 
QuikChange® XL Site-Directed Mutagenesis kit according to the 
manufacturer’s instructions. Mutagenic primers were designed using PrimerX 
(http://bioinformatics.org/primerx/). PCR was carried out with initial 
denaturation at 95°C for 1 min, followed by 18 cycles of denaturation at 95°C 
for 50 s, annealing at 60°C for 50 s and extension at 68°C for 6 min, and a 
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final extension step at 68°C for 7 min. The PCR product was then treated with 
10 Units of DpnI endonuclease, at 37°C for 1 h, to digest the parental DNA 
template. The nicked vector DNA incorporating the desired mutation was 
transformed into TOP10 competent cells and plated on LB/Amp plates. 
Colonies were randomly selected and mutants were verified by sequencing. 
 
2.3.13 Surface Plasmon Resonance Analysis  
Principle  
Surface plasmon resonance (SPR) was used to demonstrate real-time 
biointeraction of LPS with tetrameric Hb and Hb peptides using a BIAcore 
2000 instrument (BIAcore AB, Uppsala, Sweden). SPR is an optical detection 
method that can study macromolecular interactions directly, in real-time and 
in a label-free mode, in contrast with indirect methods such as ELISA 
(Homola et al., 1999; Karlsson, 2004; Lee et al., 2005). SPR requires 
comparatively smaller amounts of the biomolecules, and allows both 
qualitative and quantitative analysis of the molecular interactions. In addition, 
as the measurements are made in real-time, both affinity and kinetic data can 
be obtained.  
SPR uses a sensor chip made of gold film, on which the ligand of interest is 
covalently immobilized. The interacting molecular partner or ‘analyte’ is 
injected over the surface of the ligand-immobilized chip. Interaction between 
the ligand and the analyte is detected optically by changes in the refractive 
index at the surface of the sensor chip (Figure 2.2). The changes in refractive 
index are measured in real-time, and converted to a ‘sensorgram’, which is a 
plot of response or resonance units (RU) versus time. 






Figure 2.3: Principle of SPR assay. (A) The ligand (LPS) is covalently 
immobilized on the surface of a sensor chip. The angle of reflection of 
polarized light changes in response to the binding of the analyte (Hb) to the 
ligand on the sensor surface. (B) Real-time changes in the angle of reflection 
of light are plotted as response units (RU) versus time. The analyte is injected 
during the ‘association’ phase, while buffer is injected during ‘dissociation’ 
phase. Figure adapted from Nakatani et al. (2001), with modifications. 
 
Sequential fitting of the sensorgrams to interaction models over a series of 
different protein concentrations can be done to compute the binding rate 
constants – association constant and dissociation constants, ka and kd. Two 
parameters are used to judge the quality of fit between experimental data and 
that derived from binding models – residuals and chi-square values. Plots of 
residuals indicate the difference between the experimental and reference data 
for each point in the fit. In general, a good fit has small residuals that 
randomly distribute around the x-axis. The chi-square value represents the 
sum of squared differences between the experimental data and fitted data at 
each data point. Chi-square values less than 10 are indicative of good fits. 
 
 




Three ligands – S. minnesota LPS, ReLPS and lipid A were diluted to 0.25 
mg/ml in PBS, and separately immobilized on the surface of an HPA sensor 
chip (GE Healthcare) according to manufacturer’s specifications. Hb protein 
or peptide solutions were prepared in HEPES-buffered saline (HBS) and 
injected over the immobilized ligands at a flow rate of 30 %l/min. An injection 
of 100 mM NaOH for 1 min was done to remove the ligand-bound proteins 
and regenerate the chip surface. All SPR responses were normalized against 
buffer controls. BIAevaluation software, version 4.1, was used for data 
analysis. The association and dissociation phases of data were separately fitted 
to a 1:1 Langmuir binding model. The equilibrium dissociation constant (KD) 
was then calculated from the averaged values of kd and ka using the equation, 
KD = kd/ka. Residual plots and chi-square were used as a measure of the curve 
fitting efficiency.  
 
2.3.14 TF Coagulation Activity Assay 
Analysis of TF procoagulant activity 
THP-1 macrophages were treated with Hb in serum-free RPMI 1640 for 6 h. 
Macrophages treated with LPS (10 ng/ml) were positive controls. After 6 h of 
treatment, cells were lysed in a buffer of 50 mM Tris-HCl, 100 mM NaCl, 
0.1% Triton X-100, pH 7.4, for 30 min at 37°C. TF functional activity was 
measured using ACTICHROME® TF activity assay kit, as per manufacturer’s 
instructions. Briefly, lysates were incubated with a reaction mixture containing 
factor VIIa, and factor X in the specified assay buffer at 37°C for 15 min. A 
chromogenic substrate, Spectrozyme Xa, was added to quantify the levels of 
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factor Xa generated by the TF-FVIIa complex. After 30 min, glacial acetic 
acid was added to quench the reaction and OD405nm was measured. TF activity 
was calculated from a standard curve generated using known concentrations of 
lipidated TF. 
 
Analysis of TF procoagulant activity in the presence of Hb  
10 pM of lipidated TF was treated with increasing doses of Hb (with or 
without pre-treatment with GSH (20 mM) or human serum (5% and 10%) for 
30 min. The procoagulant activity was then measured using ACTICHROME® 
TF activity assay kit as described above. Additionally, TF+ macrophages were 
subjected to the same treatments as above. Following treatment, cells were 
washed with PBS and lysed. The procoagulant activity in the lysates was 
measured as described. Anti-TF antibody was added to lipidated TF and to 
macrophages to confirm the specificity of the assay. 
 
2.3.15 TF-specific ELISA 
THP-1 macrophages were treated with various doses of Hb in serum-free 
RPMI 1640 for 6 h. Macrophages were additionally treated for 1 h with the 
antioxidants - N-acetyl cysteine (NAC) and glutathione (GSH), and a protein 
synthesis inhibitor, cycloheximide (CHX) prior to addition of Hb. 
Macrophages treated with LPS (10 ng/ml) were positive controls. After 6 h of 
treatment, the level of the TF protein was examined by TF-specific ELISA. 
Cells were lysed in a buffer of 50 mM Tris-HCl, 100 mM NaCl, 0.1% Triton 
X-100, pH 7.4, for 15 min at 37°C. Lysates were centrifuged at 12,000g for 5 
min to remove cell debris. Levels of TF in the lysis supernatants were 
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measured using a TF-specific ELISA kit according to the manufacturer’s 
specifications. 
 
2.4 Statistical analysis 
Data are expressed as means ± standard deviation (SD) of three independent 
experiments with triplicates each. Two group comparisons were performed 
using a two-tailed Student’s t-test. P values of less than 0.05 and 0.01 were 


































RESULTS AND DISCUSSION 
 
3.1     Identification and modification of LPS-binding regions of Hb 
The binding of microbial PAMPs, such as LPS, to Hb is known to induce 
structural alterations in the protein, leading to the activation of its redox 
activity. The propensity for Hb to bind LPS tends towards its recruitment to 
the bacterial surface, thereby enhancing the free radical-mediated 
antimicrobial efficiency in a localized manner. The Hb-LPS interaction thus 
plays a role in the non-self immune response. However, there is a need for 
regulation of the redox-activated Hb as the free radicals generated by Hb may 
cause non-specific oxidative damage to the host. We hypothesized that 
modification of the LPS binding sites may suppress the LPS-induced redox 
behaviour of Hb. Thus, we sought to identify the LPS binding sites of Hb 
using computational predictions coupled with empirical validations. We 
determined the affinity and stoichiometry of the interaction of Hb with LPS. 
We adopted an in silico approach to search for pockets of Hb with electrostatic 
and steric favorability for binding the phosphate groups of the lipid A moiety 
of LPS. Empirical validations were performed using peptides derived from Hb 
to refine the predictions, and eliminate false positives. Mutational analysis of 
the Hb subunits was carried out to further confirm the participation of the 
predicted regions in binding LPS. Finally, the effect of the mutations on the 
redox activity of Hb was measured. 
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3.1.1     Characterization of the interaction of Hb with LPS 
As a first step towards the identification of the LPS-binding sites on Hb, we 
examined the stoichiometry and kinetic parameters of the interaction between 
Hb and LPS. Knowledge of the biophysical parameters of interactions, along 
with structural information, would facilitate the identification of the most 
important regions of the interface. Additionally, it would aid in defining the 
experimental conditions for further experiments such as co-crystallization, and 
ligand binding assays. 
Hb has been shown to bind LPS from various species of gram-negative 
bacteria, such as E. coli, Salmonella minnesota, S. typhimurium, 
Actinobacillus pleuropneumoniae and Proteus mirabilis (Kaca et al., 1994a; 
Archambault et al., 1997; Currell & Levin, 2002; Howe et al., 2008). Here, S. 
minnesota LPS was used for characterizing the interactions of tetrameric Hb, 
isolated Hb subunits and Hb peptides with LPS. In order to dissect the binding 
of Hb with the specific components of LPS, three S. minnesota LPS molecules 
with different lengths were used: full-length LPS, ReLPS and lipid A (see 
Figure 1.13 and 1.14).  
  
3.1.1.1     Stoichiometry and kinetics of the Hb-LPS interaction 
The stoichiometry of interaction of Hb with LPS and its truncated forms, 
collectively referred to as PAMPs, was determined using ELISA. S. minnesota 
LPS, ReLPS and lipid A were immobilized on a 96-well microtitre plate at a 
concentration of 1 µM, and their binding to increasing doses of Hb was 
quantified. Figure 3.1 shows that the extent of interaction of Hb with LPS and 
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its variants increased linearly at low Hb:PAMP molar ratio. Saturation of the 
extent of binding of Hb to the PAMP-immobilized surface was observed at a 
molar ratio of 1:4. The binding stoichiometry may suggest that there exists one 
binding site per subunit of the tetrameric protein. The results further confirm 




Figure 3.1: Stoichiometry of Hb-PAMP interaction as shown by ELISA.  
1 µM each of (A) LPS, (B) ReLPS, and (C) lipid A were immobilized, and the 
indicated concentrations of Hb were added. OD405 was measured to indicate 
the extent of complex formed. Data are mean±S.D. of three independent 
experiments.  
 
Real-time biointeraction analysis of Hb with the various PAMPs was 
performed using surface plasmon resonance (SPR) (Figure 3.2). Hb was able 
to bind to the PAMP-immobilized surface in a dose-dependent manner. Using 
a 1:1 Langmuir binding model, the affinity of interaction of the Hb with the 
various PAMPs was calculated to be in the sub-nanomolar range (Table 3.1). 
The accuracy of the fitting was evaluated by the residual plots and chi-square 
values, which were within acceptable limits. Chi-square values of less than 10 
are considered to be acceptable according to the BIAevaluation handbook. 
Residual plots depict the differences between the observed data and the 
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calculated fit, and were within ±5 RU. Although the binding stoichiometry 
calculated from ELISA indicated that one molecule of Hb interacts with four 
molecules of LPS, the 1:1 Langmuir binding model fit the experimental data 
with good (2 values. This may be because in the SPR assay, LPS molecules 
were immobilized on the sensor chip surface. It is likely that each Hb 
molecule is only able to interact with a single LPS molecule at a time. The 
binding of one Hb molecule to more than one LPS molecule may be hindered 





Figure 3.2: Real-time interaction analysis of Hb with LPS. Hb was injected 
over the LPS-immobilized chip surface at a flow rate of 30 µl/min. 
Sensorgrams for the interaction are shown in black. Red lines represent the fits 
obtained using 1:1 Langmuir binding model. Lower panel shows the residual 
plots. Data are representative of three independent experiments. 
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Table 3.1: Kinetic parameters for binding of Hb to the various PAMPs. 
Sensorgrams for the interaction of Hb with LPS, ReLPS and lipid A were 
fitted to a 1:1 Langmuir binding model using the separate fit module of the 
BIAevaluation software, version 4.1. (2 values of less than 10 are indicative of 
reliable fitting. ka: association rate constant, kd: dissociation rate constant, KD: 




3.1.1.2    " and # subunits of Hb bind LPS with nanomolar affinity 
After characterizing the interactions of tetrameric Hb with the PAMPs, we 
examined whether the isolated subunits of human Hb could also bind LPS. 
The ! and " chains of Hb were recombinantly expressed and purified (Figure 
3.3).  
 
Figure 3.3: Purification of recombinant Hb subunits. GST-tagged 
recombinant Hb! and Hb" proteins were expressed in E. coli. Proteins in the 
uninduced cell lysate (lane 1), induced cell lysate (lane 2), flowthrough (lane 
3), washes (lanes 4,5), protein-bound beads (lane 6), and supernatant after on-
bead cleavage by thrombin (lane 7), were resolved by 12% SDS-PAGE and 
stained with Coomassie Brilliant Blue. Purified Hb! and Hb" are indicated in 
a red box. The purified proteins (lane 7) were concentrated and used for SPR. 
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Real-time interaction analysis using SPR showed that both Hb! and Hb" 
bound S. minnesota LPS, ReLPS and lipid A (Figure 3.4) in a concentration-
dependent manner. This indicates that binding sites for LPS are located on 
both subunits, and confirms the existence of more than one binding site per 
tetramer of Hb, in accordance with the stoichiometry observed using ELISA 
(Section 3.1.1.1). The affinities of both the subunits for the various PAMPs 
were in the nanomolar range (Table 3.2), indicating that they interact with 




Figure 3.4: SPR analysis of the interaction of recombinant Hb subunits 
with LPS. Hb! and Hb" were individually injected over the PAMP-
immobilized chip surface at a flow rate of 30 µl/min. Sensorgrams for the 
interaction of (A) Hb! and (B) Hb" with LPS are shown in black. Red lines 
represent the corresponding kinetic fits using a 1:1 Langmuir binding model. 
Plots of residuals corresponding to the differences between the experimental 
and best-fit curves are shown in the lower panel. Data are representative of 
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Table 3.2: Kinetic parameters for binding of Hb" and Hb# to the various 
PAMPs. Sensorgrams for the interaction of Hb with LPS, ReLPS and lipid A 
were fitted to a 1:1 Langmuir binding model using the separate fit module of 
the BIAevaluation software, version 4.1. ka: association rate constant, kd: 




3.1.2     X-ray crystallography of the Hb-LPS complex 
To identify the LPS binding sites on Hb and to obtain details of the residues 
constituting the binding interface, attempts were made at co-crystallization of 
the complex of Hb with LPS. Initial efforts to co-crystallize Hb with LPS did 
not achieve success. It was reasoned that the purity of the commercially 
obtained Hb probably did not conform to the standards required for 
crystallization. So, Hb was further purified by anion-exchange chromato- 
graphy (Sun & Palmer, 2008) (Figure 3.5A). The purity of the eluted fractions 
was analyzed by SDS-PAGE (Figure 3.5B). Pure Hb fractions (peak E1, 
Figure 3.5B) were pooled together and subjected to crystallization trials. 




Figure 3.5: Purification of Hb. (A) Chromatogram for the purification of Hb 
by anion-exchange chromatography. (B) SDS-PAGE of the various fractions 
collected during the chromatography run. Hb: unpurified Hb, FT: flowthrough, 
E1: eluant 1, E2: eluant 2. 
 
For co-crystallization, Hb was mixed with LPS in a molar stoichiometry of 1:4 
(see Section 3.1.1.1) to allow complex formation. Commercially available 
crystallization screening kits from Hampton Research and Qiagen were used 
for the initial screening. Crystals were obtained from buffer #92 (0.1 M Bis-
Tris HCl, pH 5.5, 25% PEG 3350, 0.2 M NaCl) of the JCSG+ suite (Qiagen). 
Initially obtained crystallization conditions were refined using the ‘grid 
screen’ approach (Cox & Weber, 1988). The buffer conditions were 
subsequently optimized to 0.1 M Bis-Tris HCl, pH 5.6 containing 27% PEG 
3350 and 0.2 M MgCl2 to obtain larger crystals (Figure 3.6). However, the 
crystals produced had a poor diffraction quality. Further efforts to optimize the 
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crystal quality by streaking, macro-seeding or searching for different 
crystallization conditions did not generate high quality crystals amenable for 
diffraction studies. For future work, an alternative strategy may be to stabilize 
the tetrameric Hb structure prior to crystallization via cross-linking, or to 
recombinantly express tetrameric Hb or isolated Hb subunits for co-
crystallization with LPS.  
 
 
Figure 3.6: Crystals of Hb in complex with LPS. Co-crystals were obtained 
using 5 mg/ml purified Hb, mixed with LPS in a molar ratio of 1:4. Buffer 
conditions were 0.1 M Bis-Tris HCl, pH 5.6 containing 27% PEG 3350 and 
0.2 M MgCl2.   
 
3.1.3     Computational prediction of LPS-binding sites on Hb 
As attempts to co-crystallize Hb with LPS did not yield favorable results, an in 
silico analysis was carried out for the prediction of LPS binding sites on Hb.  
A tiered computational approach was implemented to identify LPS-binding 
sites on the surface of the Hb molecule. LPS molecules are anchored on the 
surface of gram-negative bacteria with the acyl chains of lipid A embedded in 
the membrane bilayer. We envisaged that for cell-free Hb to dock onto the 
bacterial surface and mediate localized free radical production via its redox 
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activity, it should be able to bind to LPS proximal to the membrane. Previous 
studies have shown that Hb does not interact strongly with dephosphorylated 
ReLPS, suggesting the importance of the phosphate residues in these 
interactions (Kaca et al., 1994b). Moreover, electrostatic forces project a force 
field farther into space, and are thus more effective than other chemical 
interactions at recruiting binding partners across long distances (Honig & 
Nicholls, 1995). This prompted us to initiate a search for phosho-group 
binding sites on Hb. The phospho-group binding prediction algorithm 
(Joughin et al., 2005) was applied to the structure of human metHb (PDB id: 
1HGB). It resulted in many ‘hits’, which could potentially participate in 
binding to the phosphate groups of LPS (Figure 3.7A). The algorithm was 
additionally run for two control proteins, FhuA (PDB id: 1QFG) and MD2 
(PDB id: 2E59), whose structures in complex with LPS are known (Ferguson 
et al., 1998; Ohto et al., 2007). The prediction algorithm identified the binding 
sites correctly for these proteins, thus indicating the potential utility of this in 
silico approach (Figure 3.7B, C). However, additional ‘false positive’ binding 
sites were also predicted, necessitating additional criteria to eliminate false 
positive predictions. 
 





Figure 3.7: Prediction of phospho-group binding patches. Binding site 
prediction algorithm was applied for (A) Hb, (B) FhuA protein in complex 
with LPS, and (C) MD2 protein with bound lipid A. Surface coloring varies 
linearly from white to blue over favorable propensity values from 1 to 30, and 
from red to white over the unfavorable propensity values from -1 to 0. The 
phosphate atoms of the ligands in (B) and (C) are outlined in yellow. Insets 
show magnified images of the phospho-group binding sites. 
 
Besides human Hb, Hb from other vertebrate species such as sheep, cow and 
pig is also known to interact with LPS (Bélanger et al., 1995; Jürgens et al., 
2001; Howe et al., 2008). Hence, we incorporated an additional criterion of 
conservation of binding sites, to help eliminate false positives. We used a 
structure-based sequence comparison to narrow down the predictions to 
residues for which the binding propensity has been conserved evolutionarily. 
From the SCOP (Structural Classification of Proteins) database classification 
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(Lo Conte et al., 2000), twenty vertebrate Hb structures were selected for the 
analysis (Table 3.3). Using this analysis, residues with conserved propensity 
of phospho-group binding were identified (Figure 3.8). 
 
Table 3.3: Hb structures used for computational analysis. Structures for 
only wild-type proteins, derived by X-ray crystallography were included. 


















Figure 3.8: Structure-based sequence alignment of vertebrate Hb" chains. 
Color-shading indicates predicted binding propensity in a decreasing order 
from green to red to blue. Residues with no propensity of contact are in black. 
Buried residues are in yellow. Helix designations, A-F, are according to 
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Further visual analysis of the Hb structure served to shortlist eight cationic 
pockets, which were located at the protein surface with an appropriate 
separation distance to bind the head group phosphates of the lipid A. Docking 
of the lipid A disaccharide head group (Figure 3.9) to these sites was 
performed to assess the possible interactions with LPS. The docked structures 
exhibited strong networks of hydrogen bonds between the phosphates of the 
ligand and positively charged or partially charged residues of the protein 
(Figure 3.9). Docking produced non-ideal hydrogen bonds in some cases, 
such as between the Arg141 and a phosphate of lipid A (Figure 3.9F); and 
between the backbone carbonyl of Leu3 and the amine group on the ligand 
(Figure 3.9G). The affinity of the ligand was highest for the binding sites 
located at the !-! and the "-" interfaces (Figure 3.9F, I). This is in agreement 
with the prediction algorithm, which showed these two interfaces to have a 
high propensity of phospho-group binding (Figure 3.7A). 
 




Figure 3.9: Molecular docking to the predicted LPS-binding sites. (A) The 
diglucosamine head group of lipid A was used for docking to the predicted 
LPS-binding sites. (B-I) Top-ranking docked poses. Dockings were performed 
using GLIDE, v5.0 (Schrodinger, LLC, 2007). Residues participating in 
hydrogen bonding with the ligand and the computed binding energies are 
indicated. Hb! subunits are in gold, and Hb" subunits are in violet. Heme 
moiety is in stick representation, while the polypeptide chains are shown as 
ribbons. Hydrogen bonds are indicated as dashed lines. 
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3.1.4     Verification of candidate LPS-binding regions using Hb peptides 
Having deciphered the LPS-binding sites on Hb using in silico predictions, we 
set out to experimentally validate the binding sites using synthetic Hb 
peptides.  
 
3.1.4.1     Design of peptides harboring predicted LPS-binding sites 
Peptides were designed to harbor the computationally predicted binding sites 
for empirical validation of LPS-binding (Figure 3.10). The peptide length and 
region surrounding the predicted LPS-binding residues was chosen based on 
the hydrophilicity and solubility of the peptides. To substantiate the 
computational prediction methods, a control peptide A111 was designed from 
the surface residues of the Hb!, which were predicted to be non-LPS binding. 
To query the plausible effects of the length of the 36-mer B59 on its 
interactions with LPS, we analyzed an 18-mer peptide, B59s. To corroborate 
the importance of the positively charged lysine residues in binding the 
negatively charged phosphates of the lipid A head group, a mutant peptide 
B59sm with base-to-acid substitutions was synthesized by replacing the 
predicted phosphate-binding lysine residues of B59s with aspartate. Except for 
B1 and A111, the Hb peptides that have been used in this study were cationic 









Figure 3.10: Hb peptides used for empirical validations. (A) Nine Hb 
peptides were designed to incorporate the putative LPS-binding residues 
(underlined in the sequence). The peptides are designated ‘A’ and ‘B’ 
corresponding to the Hb ! and " subunits, respectively. The underlined 
residues indicate those residues which were predicted from the computational 
studies to be involved in binding LPS.Two additional control peptides were (i) 
A111, composed of the stretch of residues which were predicted to be non-
LPS binding, and (ii) B59sm, mutant peptide obtained by replacing the 
predicted LPS-binding residues of B59s with aspartic acid. (B) Tetrameric Hb 
showing the peptides designed to incorporate the predicted LPS-binding sites. 
! subunits are in gold, and " subunits are in violet. The heme moiety is 
represented by sticks, while the polypeptide chains are shown as ribbons. The 
peptides are labelled for ! and " subunits. The figure was generated using 
PyMOL (v1.0, DeLano Scientific). 
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3.1.4.2     Hb peptides exist in random coil conformations 
The secondary structure of the Hb peptides was determined in the absence and 
presence of LPS (Figure 3.11A, B). The CD spectra of the peptides are 
characterized by a negative peak near 200 nm, indicating that these peptides 
are unstructured in solution. Although LPS is known to cause structural 
perturbations in the Hb tetramer (Du et al., 2010), it does not affect the 
conformation of the peptides, as indicated by the unchanging CD spectra in 
the presence of LPS (Figure 3.11C, D). 
 
 
Figure 3.11: Secondary structure of Hb peptides. Far-UV CD spectra of 40 
µM Hb peptides: (A-B) without LPS; (C-D) mixed with equimolar LPS. A 
negative peak near 200 nm represents a random coil structure. Data are 
representative of three independent experiments. 
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3.1.4.3     Surface Plasmon Resonance analysis differentiates LPS-binding 
peptides from non-binders 
To mimic the binding of peptides to LPS displayed on the surface of gram-
negative bacteria, Hb peptides were flown over LPS, ReLPS or lipid A 
immobilized on the surface of an HPA sensor chip.  
Initial experiments required optimization of the buffer conditions to obtain 
consistent kinetic data for the binding of the peptides to the PAMPs. Various 
running buffers such as PBS, Tris-buffered saline, pyrogen-free water and 
HBS were tried. Of these, HBS gave the most consistent results and was the 
buffer of choice for all SPR experiments. The buffering species in HBS is 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), which is a 
zwitterion, and may pose minimum interference with the binding of peptides 
to the negatively charged phosphate groups of LPS. The buffering species is 
known to have profound effects on the Hb molecule. A comparative study of 
HEPES, Tris and Bis-Tris buffers has shown HEPES to be the more suitable 
buffer for functional and structural studies on Hb (Weber, 1992), and this 
lends support to the choice of buffer in our experiments.  
Analysis of the SPR data revealed high affinity interactions between six 
peptides and LPS (Figure 3.12). B59 displayed the strongest affinity for LPS, 
with a KD value of 6.35 x 10-8 M. The LPS-binding affinity of the 18-mer 
B59s was ~60-fold lower than that of B59 (Table 3.4). All LPS-binding 
peptides except B59 displayed a slow on-rate (~ 102 M-1s-1). Peptide B59 had 
double the on-rate as compared to other peptides. This indicates that this 
peptide binds to LPS much faster than the other peptides. The off-rate of B59 
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(~10-8 s-1) was also much lower than for the other peptides (~10-5 to 10-6 s-1). 
The off-rate suggests that B59 dissociates from LPS 100-times slower 
compared to the other peptides. These indicate that B59 forms a stable 
complex with LPS, while other peptides may associate weakly. 
The peptides that showed binding to LPS were also able to bind to ReLPS and 
lipid A, suggesting that the peptides interact with the lipid A component of 
LPS, conceivably via electrostatic interactions with the phosphates. The ability 
of peptides A131 and B1 to bind LPS was in agreement with the 
computational prediction of the high propensity of LPS-binding at the 
interface of the Hb subunits (Figure 3.7). The peptides generally displayed 
weaker LPS-binding affinity as compared to the Hb subunits. This difference 
in the binding affinity could also be attributed to the presence of multiple 
binding sites in the Hb chains, whereas the peptides each contained a single 
LPS-binding site. Another interpretation may be that the three-dimensional 
structure influences the affinity for LPS. The peptides were randomly coiled 
(see Figure 3.11), as opposed to the native protein, and this could be 
responsible for their lower LPS-binding affinities.  




Figure 3.12: Sensorgrams for binding of Hb peptides with LPS. Peptides 
concentrations were 50, 100, 150 and 200 µM (except for B59, for which the 
concentrations were 0.01, 0.05, 0.1 and 0.5 µM). (A-F) Representative 
sensorgrams are shown in black. The corresponding fits are in red. Plots of 
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Table 3.4: Kinetic parameters for binding of Hb peptides to the various 
PAMPs. ka: association rate constant, kd: dissociation rate constant, KD: 
equilibrium dissociation constant. 
 
 
Three peptides, A1, A16 and B139 did not bind LPS (Figure 3.13). These 
peptides were probably misidentified as false positives from the computational 
predictions. The negative control, A111 peptide, showed no specific binding 
activity, but displayed a bulk response upon injection. These results validate 
the modeling strategy, as the predicted non-binder A111 did not show any 
binding. Mutations of the putative LPS-binding lysine residues to aspartate in 
B59sm abolished its LPS-binding activity, thus emphasizing the importance of 
electrostatic interactions in LPS-binding. Our results are in consistence with 
previous reports showing that electrostatic interactions are crucial for binding 
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LPS. Several proteins such as CD14 (Cunningham et al., 2000), MD2 
(Man)ek et al., 2002), LPS-binding protein (Lamping et al., 1996), Hsp60 
(Habich et al., 2005), and FhuA (Ferguson et al., 2000) have been shown to 
interact with LPS via both electrostatic interactions with the polar head group 




Figure 3.13: Sensorgrams for peptides that did not bind LPS. 
Representative sensorgrams of peptides at a concentration of 200 µM – A1 
(brown), A16 (green), A111 (black), B59sm (red) and B139 (purple). The 
response indicates a bulk shift without any binding activity. Data are 
representative of three independent experiments. 
 
3.1.4.4     Fluorescence-based displacement assay for LPS binding 
After identifying the LPS-binding Hb peptides from SPR analysis, we 
analyzed the ability of the Hb peptides to bind to LPS in free form. During 
infection, LPS is shed from the bacterial surface and can bind to host plasma 
proteins. Using an assay based on the fluorescent probe, dansylcadaverine 
(DC), we examined whether the Hb peptides would interact with lipid A in 
solution, with potential to inhibit its endotoxicity. DC is a cationic fluorescent 
probe that interacts with the acidic phosphate groups and hydrophobic acyl 
components of lipid A (David et al., 1992). Binding to lipid A results in a 
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progressive quenching of fluorescence of DC. DC bound to lipid A may be 
competitively displaced by Hb peptides that display an affinity for lipid A. 
The displacement is accompanied with a proportional dequenching of 
fluorescence.  
Figure 3.14 shows the plots of the occupancy of DC on lipid A in the presence 
of increasing doses of the peptides. The peptides, B59 and B59s, showed the 
greatest decrease in probe occupancy, with dose-dependent displacement of 
DC from lipid A. The other peptides were also able to reduce the occupancy of 
DC from lipid A in a dose-dependent manner, albeit less drastically. Since 
peptides B59 and B59s were able to displace the probe from lipid A 
considerably, it suggests that they interact with lipid A via similar interactions 
as DC. The peptides A56, A131 and B1 appear to have a weak binding affinity 
for lipid A, as they could not completely displace the probe bound to lipid A.  
DC occupancy in the presence of the negative control peptide, A111, and the 
other non-binding peptides did not decline in a concentration-dependent 
manner (Figure 3.14B). The non-binding peptide, B139, could however 
reduce the occupancy to levels similar to the LPS-binding peptide, A81. This 
could imply that the peptide binds to LPS in solution phase, rather than to 
immobilized LPS.  




Figure 3.14: Dansylcadaverine (DC) displacement assay for interaction of 
Hb peptides with lipid A in solution. The occupancy of DC (50 µm) on lipid 
A (20 µg/ml) was measured in the presence of 0, 0.1, 1, 10, 50 and 100 µM of 
the various peptides. The fluorescence intensity was measured by excitation at 
340nm and emission at 560nm. The occupancy was calculated as (FP-FD)/(FL-
FD); where, FD is the fluorescence intensity of DC in the absence of lipid A; 
FL is the fluorescence intensity of DC in the presence of lipid A; and FP is the 
fluorescence intensity of the solution of DC and lipid A upon the addition of 
the different concentrations of the peptides. The occupancy is inversely related 
to the affinity of the peptide for lipid A. Occupancy is plotted against the log-
peptide concentrations for peptides that: (A) bind LPS; (B) do not bind LPS. 
Data are mean ± S.D. of three independent experiments.  
 
3.1.4.5     LPS-binding peptides neutralize the endotoxicity of LPS 
During infection, ‘free’ LPS molecules that are shed from the bacterial surface 
are recognized by effector proteins such as LPS-binding protein (LBP) 
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(Ulevitch & Tobias, 1999), and result in the activation of the immune system. 
We inquired whether the binding of Hb peptides to LPS could potentially 
mask LPS from the innate immune effector proteins and thus inhibit the 
endotoxic potential of LPS. To probe for such functional implications of the 
binding of the peptides to LPS, a quantitative assay termed PyroGene assay 
was used. PyroGene assay relies on the LPS-induced activation of a 
recombinant horseshoe crab coagulation protein, Factor C (rFC). The assay is 
highly sensitive to endotoxin, being able to detect levels as low as 0.01 EU/ml. 
Prior to the assay, the endotoxin levels in the peptide solutions were measured, 
and were found to be minimal (Table 3.5). 
Table 3.5: Levels of LPS contamination in the Hb peptides. Endotoxin 
levels were measured in three different concentrations of the peptides by the 
PyroGene Assay, and are expressed as EU/ml. 
 
 
The assay was conducted at an LPS concentration of 10 ng/ml. The 
endotoxicity levels of the LPS solution at this concentration were measured to 
be ~50 EU/ml. The endotoxicity of the LPS solutions was further measured 
after incubation with the various peptides. The peptides that bound LPS were 
able to neutralize it in a dose-dependent manner (Figure 3.15A). The peptides, 
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A56 and B59, were the most potent in neutralizing the endotoxicity by more 
than 80%. The peptide B59s neutralized the endotoxicity by more than 60%. 
The peptides A81, A131 and B1 neutralized LPS up to 50%. This 
neutralization effect could be attributable to sequestration of the LPS by the 
peptides, thus blocking LPS from recognition by rFC.  
 
Figure 3.15: Neutralization of LPS endotoxicity by Hb peptides. S. 
minnesota LPS was treated with 1, 10 and 100 µM concentrations of peptides. 
The endotoxicity of the solutions was measured using rFC-based PyroGene 
assay. The extent of neutralization of LPS by the peptides is plotted as a 
percentage of the ‘LPS only’ control for: (A) LPS-binding peptides; and (B) 
non LPS-binding peptides. Data are mean ± S.D. of three independent 
experiments.  
 
Poor neutralization of the LPS was seen for the control peptide A111 (< 20%), 
consistent with the binding assays. The mutant peptide, B59sm, was unable to 
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neutralize LPS. Similarly, the non-binding peptides, A1 and A16, displayed 
poor anti-endotoxic activity.  
Surprisingly, peptide B139 could neutralize LPS to an extent comparable to 
the peptide B1. This suggests that B139 possibly binds ‘free’ LPS in solution, 
as was also observed by the decrease in occupancy of DC in the fluorescence-
displacement assay (see Section 3.14). This peptide, however, showed no 
binding to LPS in the SPR assay. These results suggest that B139 probably 
binds to the hydrophobic acyl chains of the lipid A moiety. In the SPR assay, 
the acyl chains may not be accessible for binding as the LPS molecules were 
immobilized. Interaction may take place in solution as the acyl chains of lipid 
A would be accessible for binding to the peptide. 
 
3.1.4.6     High affinity LPS-binding peptide, B59, associates with the 
surface of gram-negative bacteria 
Based on the SPR results wherein the peptides interact with LPS immobilized 
on a sensor chip surface (see Figure 3.12), we asked whether the peptides 
could also associate with the LPS molecules in situ on the live bacteria. The 
B59 peptide, which displayed the highest binding affinity for LPS, was tested 
further for its attachment to the surface of E. coli and P. aeruginosa. Using 
flow cytometry, we observed the binding of the peptide B59 to the surface of 
gram-negative bacteria, indicated by the positive shift in the median 
fluorescence intensity (MedFI) of the peptide-treated samples compared to the 
untreated control (Figure 3.16). Pre-treatment of the peptide with LPS 
resulted in a negative shift in the MedFI, indicating a decrease in binding of 
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the peptide to the bacteria. This result suggests that binding of the peptide to 
the bacterial surface is via LPS.  
 
 
Figure 3.16: LPS-binding peptide, B59, associates with gram-negative 
bacteria. The binding of B59 to GNB was analyzed by flow cytometry. E. coli 
and P. aeruginosa were treated with 1 mM B59 for 30 min, with (white) or 
without (stripes) pre-treatment with 100 ng/ml LPS. The peptide bound to the 
bacterial surface was detected using primary rabbit anti-Hb antibody (1:400) 
and secondary phycoerythrin-conjugated goat anti-rabbit IgG (1:200). The 
fluorescence intensity is plotted in log-fluorescence units versus counts. The 
negative control bacteria incubated without the peptide are indicated in gray. 
Results are representative of three independent experiments.  
 
Scanning electron microscopy (SEM) enabled visualization of the peptide 
associated with the bacterial surface in the form of colloidal gold labeling 
(Figure 3.17). To confirm the specificity of the rabbit anti-Hb antibody for the 
peptide B59, control experiments were performed in which the primary rabbit 
anti-Hb was separately replaced with rabbit pre-immune serum and an isotype 
control rabbit anti-C3d antibody. The bacteria showed negligible labeling in 
both the cases, thus proving the specificity of the primary antibody used.  
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Taken together, the flow cytometry and SEM experiments demonstrate that 
Hb peptide B59 bound to the bacterial surface, specifically by its association 
with LPS.  
 
 
Figure 3.17: Visualization of B59 on the bacterial surface using scanning 
electron microscopy. The association of B59 to the bacterial surface was 
visualized using SEM coupled with immunogold-labeling. Specific binding of 
the peptide is demonstrated by the colloidal gold (arrows) observed under 
backscattered electron (BSE) mode. Untreated bacteria were negative control. 
Pre-immune rabbit serum and rabbit anti-C3d Ab were used instead of the 
primary rabbit anti-Hb antibody as additional negative controls. Magnification 
is 15,000x. Scale, 1 %m. 
 
3.1.5     Mutational analysis of recombinant Hb subunits  
After predicting the LPS binding sites computationally and identifying the Hb 
peptides that bind LPS with high affinity, we were prompted to further 
substantiate the LPS binding sites in the context of the native 3D structure of 
the protein. Peptide-based binding assays served as a good starting point for 
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eliminating false positive predictions of the binding sites. LPS binding assays 
and rFC-based LPS neutralization assay identified Hb peptides B59 and A56 
to possess strong LPS binding and neutralization abilities. Guided by the 
information gained from the in silico analysis and the subsequent peptide-
based assays, we carried out site-directed mutagenesis experiments to further 
validate the LPS binding sites. 
 
3.1.5.1     Hb subunits with mutations display diminished binding to LPS 
For further substantiation of the LPS-binding sites, selected residues in the 
A56 and B59 peptides were mutated to generate recombinant Hb ! and " 
subunits with mutations from lysine to aspartate (Figure 3.18A). Two mutant 
subunits carrying triple mutations each were constructed - Hb![K56/60/61D] 
and Hb"[K59/66/95D]. Separately, mutant Hb"[K17D], which was not 
predicted to be an LPS-binding site was also constructed as an internal control 
for the LPS-binding assays. Wild-type and mutated proteins were expressed 
and purified (Figure 3.18B). CD spectral analysis of the subunits was carried 
out to confirm the proper folding of the proteins (Figure 3.18C). The spectra 
are representative of an !-helical protein, with negative peaks at 208 and 222 
nm. 




Figure 3.18: Mutational analysis of recombinant Hb subunits. (A) 
Location of the mutated residues on the tetrameric Hb. ! subunits are in gold, 
and " subunits are in violet. The mutated residues are represented as spheres. 
The figure was generated using PyMOL (v1.0, DeLano Scientific). (B) 
Western blot of reducing SDS-PAGE showing the purified wild-type and 
recombinant subunits. (C) Far-UV CD spectra of the wild-type and 
recombinant subunits. 
 
The binding of the mutant subunits to LPS was compared with that of the 
wild-type subunits by ELISA (Figure 3.19). The mutations resulted in a 
weakening of the LPS-binding ability of the Hb subunits, with two-fold and 
four-fold reductions for the mutated Hb ! and Hb " subunits, respectively. The 
decline in LPS binding upon mutations in the A56 and B59 peptides 
corroborates their LPS-binding capabilities in the context of the native folded 
structure of the protein. However, the mutant subunits retained partial LPS-
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binding activity. This may indicate that other residues also participate in LPS 
recognition. Indeed, peptide-based assays identified other peptides from the 
Hb subunits to possess LPS binding abilities. As the LPS binding residues in 
these peptides were not mutated here, they may be participating in binding to 
LPS. Nevertheless, the results prove that the mutated residues of Hb are the 
main binding sites for LPS. The control mutation, K17D, did not significantly 
affect the LPS-binding of Hb" subunit.  
 
 
Figure 3.19: LPS-binding activities of wild-type and mutant Hb subunits. 
ELISA was performed for quantifying the LPS-binding activity of the mutant 
Hb subunits – (A) Hb !, and (B) Hb ". 96-well microtitre plates were coated 
with S. minnesota LPS. Increasing concentrations of the recombinant proteins 
were added to each well. The peroxidase enzyme activity was determined at 
405 nm. Data are means ± S.D. of three independent experiments.  
**, p< 0.01; ns: not significant. 
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3.1.5.2     The redox activity of mutated Hb subunits is desensitized to LPS 
To investigate the effect of mutations in the LPS-binding sites on the ROS 
production from Hb subunits, a superoxide-sensing chemiluminescent probe 
was used. The redox activities of wild-type and mutant subunits were 
measured in the presence and absence of LPS. As compared to the native 
tetrameric Hb (!2"2), the recombinant Hb! (Figure 3.20A, C) and Hb" 
subunits (Figure 3.21A, C) displayed a lowered production of superoxide. 
While tetrameric Hb has four heme molecules, each subunit contains only one 
heme, which is the reaction centre for the pseudoperoxidase activity. This may 
account for the lower superoxide production by the subunits. Furthermore, the 
redox activity of the mutated subunits was similar to the wild-type subunits in 
the absence of LPS. However, when the subunits were first incubated with 
LPS, there was a marked difference in the redox activities of the wild-type and 
the mutant subunits for both Hb! (Figure 3.20B, C) and Hb" (Figure 3.21B, 
C). The Hb tetramer and wild-type subunits showed a significantly higher in 
superoxide production upon treatment with LPS. On the other hand, the 
subunits carrying mutations in their LPS-binding sites did not undergo a 
change in the superoxide production in the presence of LPS, indicating that the 
mutations had desensitized them to LPS. These results indicate that alterations 
in the LPS-binding activities of Hb subunits lead to a suppression of their 
LPS-induced redox behaviour. Thus, mutations of the LPS-binding sites of Hb 
could be a potential strategy to be considered for the improvement of Hb-
based blood substitutes, so as to acquire the properties of lower endotoxin 
binding and minimal oxidative behaviours. 






Figure 3.20: Comparison of redox activity of wild-type and mutant Hb" 
subunits. Equal concentrations of Hb tetramer, wild-type Hb! and mutant 
Hb! (Hb!-M) were mixed separately with cypridina luciferin analog (CLA) 
and H2O2. The superoxide production was measured as the 
chemiluminescence generated by CLA, and is expressed as relative light units 
(RLU). (A) Superoxide production curves by proteins without LPS treatment, 
(B) Superoxide production curves by proteins after LPS treatment, (C) Plot of 
the peak chemiluminescence intensity for the various proteins. Hb!-M: 
Hb!(K56/60/61D). Data are representative of three independent experiments. 











Figure 3.21: Comparison of redox activity of wild-type and mutant Hb# 
subunits. Equal concentrations of Hb tetramer, wild-type Hb" and mutant 
Hb" were mixed separately with cypridina luciferin analog (CLA) and H2O2. 
The superoxide production was measured as the chemiluminescence generated 
by CLA, and is expressed as relative light units (RLU). (A) Superoxide 
production curves by proteins without LPS treatment, (B) Superoxide 
production curves by proteins after LPS treatment, (C) Plot of the superoxide 
levels (peak chemiluminescence intensity) for the various proteins. "-M: 
Hb"(K59/66/95D), "-17: Hb"(K17D). Data are representative of three 
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To summarize, in Section 3.1 we have delineated the LPS binding hotspots on 
the Hb molecule using an integrated approach of computational predictions 
and biophysical characterizations. Using SPR, we found that both the Hb ! 
and " subunits possess high affinity LPS-binding sites. In silico analysis of Hb 
including phospho-group binding site prediction, structure-based sequence 
comparison, and docking to model the protein-ligand interactions showed that 
Hb possesses evolutionarily conserved surface cationic patches that could 
function as potential LPS-binding sites. Synthetic Hb peptides harboring 
predicted LPS-binding sites served to validate the computational predictions. 
SPR analysis differentiated LPS-binding peptides from non-binders. Peptides 
spanning residues 56-72, 81-92 and 131-141 of Hb! and residues 1-10 and 59-
76 of Hb" were shown to bind LPS with affinity in the range of 10-8 to 10-5 M. 
The LPS-binding peptides effectively neutralized the endotoxicity of LPS in 
vitro, demonstrating the anti-endotoxic potential of the peptides. Additionally, 
peptide B59 attached to the surface of gram-negative bacteria, presumably via 
LPS, as shown by flow cytometry, and visualized by immunogold-labelled 
scanning electron microscopy. Site-directed mutagenesis of LPS-binding 
residues in the Hb subunits further confirmed the role of the predicted residues 
in binding to LPS. Selective mutations of lysine to aspartate at positions 56, 60 
and 61 in Hb!; and positions 59, 66 and 95 in Hb" led to partial loss of the 
LPS-binding ability of the subunits. We have further shown that mutations in 
the LPS-binding sites of Hb abated the LPS-induced enhancement of the 
pseudoperoxidase activity of Hb subunits. The results have advanced our 
understanding of the molecular basis of Hb-LPS interactions, and yield 
insights for the potential improvement of Hb-based blood substitutes. 
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3.2     Tissue factor (TF) safeguards against redox-active Hb 
Having elucidated the LPS-binding hotspots on Hb and the effects of 
modifications of LPS-binding sites on the redox activity of Hb, we next 
investigated the role of the coagulation factor, tissue factor (TF), as an 
endogenous anti-oxidant mechanism.  
TF is the key initiator of the vertebrate coagulation cascade. Its expression on 
monocytes and endothelial cells is induced in response to infection and 
inflammation. During infection, extracellular Hb levels rise due to hemolysis 
triggered by coagulation, infection-triggered inflammation or microbial 
haemolytic toxins. There exists a positive feedback loop between coagulation 
and hemolysis, as factors released upon hemolysis promote coagulation. 
Crosstalk between coagulation, innate immunity, and hemolysis may include 
ancient mechanisms evolved from the invertebrate respiratory protein 
hemocyanin. In an infection, hemocyanin binds to the coagulation protease, 
Factor B, which triggers the latent activity of hemocyanin to generate free 
radicals that kill microbes (Nagai & Kawabata, 2000). The existence of a 
similar mechanism of interaction between a coagulation protease and a 
respiratory protein is yet unknown in vertebrates. Siddiqui et al. have 
previously reported binding between TF derived from melanoma cells and Hb 
(Siddiqui & Francis, 2002). This prompted us to explore whether TF exerts a 
regulatory influence on the redox activity of Hb. The evolutionary significance 
of the Hb-TF interactions was gauged from co-evolutionary analysis using in 
silico methods. We examined the ability of Hb to interact with TF in a cell-
free system, as well as on the surface of macrophages. Next, we investigated 
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the effect of TF on the pseudoperoxidase activity of Hb. Furthermore, the 
effects of Hb on the expression and function of TF were examined.   
 
3.2.1     Insights into Hb-TF interaction via computational analysis  
Seeking a potential linkage between a coagulation protease and a respiratory 
protein in the vertebrates, we looked for bioinformatic evidence of an 
evolutionary relationship between Hb and TF sequences. 
 
3.2.1.1     Co-evolutionary analysis of Hb and TF 
Co-evolution is a process whereby species that interact drive genetic changes 
in one another to maintain their interaction. At a molecular level, proteins that 
bind each other to accomplish a beneficial function often evolve at a similar 
rate (Fraser et al., 2002). Interacting proteins exhibit correlated mutations, 
because when one mutation occurs by chance and disrupts the binding, the 
host will have an evolutionary advantage if it adopts a compensatory mutation 
in the other protein to restore the binding (Pazos & Valencia, 2008). Co-
evolutionary analysis of amino acid variation has been employed for the 
identification of interaction partners (Goh et al., 2000; Pazos & Valencia, 
2002), and binding interfaces between known interacting proteins (Pazos et 
al., 1997; Filizola et al., 2002; Madaoui & Guerois, 2008). 
Co-evolutionary analysis of TF and Hb was performed using ComplexCorr 
(Gershoni et al., 2010), with two prediction algorithms – explicit likelihood of 
subset covariation (ELSC) (Dekker et al., 2004) and observed minus expected 
squared (OMES) (Larson et al., 2000; Kass & Horovitz, 2002). No interaction 
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was predicted for TF and Hb! as their scores (ELSC score: 11.95, OMES 
score: 2.74) were below the interaction threshold specified by ComplexCorr. 
The ELSC and OMES scores for the co-evolution of TF and Hb" were 
calculated to be 16.37 and 3.53, respectively, indicating direct interactions of 
TF with Hb". To estimate a false discovery level that is specific for the amino 
acid composition and mutation frequencies of Hb and TF, we performed 
multiple iterations of ComplexCorr after scrambling the mapping between 
species and protein sequences for Hb". This control experiment with a 
nonsense evolutionary record yielded a maximum expected ELSC score of 
10.12 and an OMES score of 2.03 for an apparent covariation that arises from 
these sequences by coincidence.  
Fourteen residue pairs were predicted to be strongly co-evolving between TF 
and Hb" by both the algorithms (Figure 3.22). These included both surface-
exposed and buried residues. While the surface residues may constitute the 
binding interface between the proteins, the buried residues may play an 
allosteric role by facilitating the interactions between TF and Hb". It is 
conceivable that these residues may be energetically coupled to the functional 
binding site via side chain or backbone interactions. Such co-evolving residue 
pairs that are important allosterically but do not constitute the binding 
interface have been identified between GroEL and GroES (Kass & Horovitz, 
2002). In various other instances, co-evolving residues that play a role in 
allosteric recognition and function have been identified in the proteins Hsp70, 
G-protein coupled receptors, serine proteases and ligand-gated ion channels 
(Süel et al., 2002; Chen et al., 2006; Smock et al., 2010). 




Figure 3.22: Co-evolutionary analysis of TF and Hb#. Co-evolving residue 
pairs between TF and Hb" were predicted by ComplexCorr, using ELSC and 
OMES algorithms. The top scoring residue pairs identified by both the 
algorithms are mapped onto the structures of TF (PDB id: 1BOY) and Hb" 




The co-evolving residues mutated to another amino acid at a similar time in 
evolution (Table 3.6). For example, position 110 of TF showed strong co-
evolution with residues at positions 61 and 108 of Hb". These residues 
underwent a simultaneous change during the vertebrate evolution from non-
mammals to mammals. The presence of co-evolving residues between Hb" 
and TF implies that these proteins have undergone parallel, correlated amino 
acid mutations over evolutionary history. The co-evolutionary analysis may 
facilitate the identification of a potential binding interaction between Hb and 
TF. 
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Table 3.6: Two highly co-evolving residue pairs between TF and Hb#. 
Position 110 of TF displayed strong co-evolution with residues 61 and 108 of 
Hb". Red box indicates simultaneous change in the amino acids during 




3.2.1.2     Molecular docking of Hb with TF 
Next, molecular docking was performed to predict the binding poses of Hb 
and TF. A combination of co-evolutionary analysis and docking has been 
applied previously to identify interaction sites between the proteins HIV 
reverse transcriptase and integrase (Wang & DeLisi, 2006). The combinatorial 
approach has also been demonstrated to successfully identify the correct 
interface between the ! and " of Hb (Pazos et al., 1997) and a predictive 
pipeline based on this approach has been validated on a large number of 
protein complexes of known structures (Madaoui & Guerois, 2008). 
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We used the PatchDock server to execute docking simulations. Using the 
FireDock server, the docking solutions were refined, assigned a FireDock 
score on the basis of their binding energies and ranked accordingly. The 
docking analysis revealed plausible energetically favorable modes of 
interaction between TF and Hb. The top 10 docking models are shown in 
Figure 3.23. Although being energetically favorable, docking solutions VI and 
VIII (Figure 3.23) may not be physiologically feasible, as the Hb molecule 
would be sterically hindered by the presence of the cell membrane. The 
docking solutions II, V, VII, and IX (Figure 3.23) involved interactions of TF 
with the Hb! subunits, predominantly. On the basis of the co-evolutionary 
analysis, which predicted that TF does not interact with Hb!, these docking 
solutions (II, V, VII, and IX) may be ruled out.  




Figure 3.23: Molecular docking of Hb with TF. Docking was performed 
using PatchDock, and refined using FireDock. The top 10 binding poses are 
shown along with their FireDock scores (in red). Higher negative scores 
indicate higher binding energy and thus higher interaction probability. Hb! 
subunits are colored gold, Hb" subunits are colored violet, and TF is colored 
cyan. The figure was generated using PyMOL (v1.0, DeLano Scientific). 
 
 
Chapter 3: Results & Discussion 
115 
 
It was expected that docking would indicate a binding interaction that would 
involve the co-evolved residue pairs (Figure 3.22) predicted from the co-
evolutionary analysis. However, the docked structures did not include any 
interactions between the co-evolved residue pairs. Figure 3.24 shows the 
details of the molecular interactions between Hb and TF in the docking 
solution with the highest FireDock score (Figure 3.23, solution I). TF was 
positioned within the groove formed by an ! and two " subunits of Hb. The 
binding was characterized by an extensive hydrogen bonding network between 
TF and Hb. The binding site contained residues Glu90 and Asp94 of Hb" in 
the binding site (Figure 3.23), which were among the top scoring co-evolved 
residues from the co-evolutionary analysis. However, their interaction partners 
in the docking model were different from those seen from the co-evolutionary 
analysis. It may be argued that the residue pairs that have co-evolved between 
Hb and TF may not interact directly, but function as allosteric determinants of 
binding by facilitating or stabilizing conformational changes accompanying 
the binding of Hb to TF.  
 




Figure 3.24: Molecular interactions between Hb and TF. The residues in 
the binding site are shown for the best ranked binding pose. Residues 
participating in hydrogen bonding are labelled in black for Hb, and in red for 
TF. Hb! subunits are colored gold, Hb" subunits are colored violet, and TF is 
colored cyan. Hydrogen bonds are indicated as black dashed lines. The figure 
was generated using PyMOL (v1.0, DeLano Scientific). 
 
3.2.2    Complex formation between Hb and TF    
In order to examine the physiological significance of the binding between Hb 
and TF, we first explored conditions for the formation of a complex between 
Hb and TF in vitro in the absence of any cellular factors, and in situ on the cell 
surface.  
 
3.2.2.1     TF binds Hb and competes with LPS for binding  
We probed the interaction between Hb and TF in a cell-free system, using 
commercial recombinant TF (extracellular domain, residues 1-218) that was 
obtained using a eukaryotic expression system. ELISA showed a dose-
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dependent binding of TF to Hb immobilized on Maxisorp™ plates (Figure 
3.25), indicating that the interaction of Hb with TF did not require the 
presence of any cellular factors.  
 
 
Figure 3.25: ELISA demonstrates complex formation between Hb and 
TF. ELISA was performed with 0.2 µg of Hb immobilized on a Maxisorp™ 
plate. The unbound sites were blocked with 2% BSA, and TF was then added. 
Bound protein was detected with primary anti-TF antibodies and HRP-
conjugated secondary antibody. OD405 was read to indicate the extent of 
complex formation. Data are mean±S.D. of three independent experiments. 
 
Upon reversal of the order of binding, by immobilization of TF and addition of 
Hb in the fluid phase, there was an increase in the amount of Hb-TF complex 
formed, suggesting stronger interactions between the proteins (Figure 3.26, 
black bars). It may be reasoned that immobilization of Hb had altered the 
structural conformation of the protein or concealed the TF-binding interface, 
thereby resulting in weaker binding to TF. In the physiological scenario, 
membrane-bound TF would encounter free Hb circulating in the plasma. 
ELISA demonstrates this mode of interaction between the proteins to be 
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favorable as opposed to the interaction between immobilized Hb and free TF 
(Figure 3.25).  
During infection, the levels of extracellular Hb rise due to hemolytic toxins or 
inflammation-triggered hemolysis. Hb binds to LPS and generates cytotoxic 
ROS in the microbial vicinity, thus functioning as an immune effector protein. 
We questioned whether the interaction of Hb with TF would be affected by its 
binding to LPS. On the basis of the previous results, which showed a binding 
stoichiometry of 1:4 for Hb:LPS (Figure 3.1, Section 3.1.1.1), Hb was pre-
treated with a 4-fold molar excess of LPS. We observed that binding of Hb to 
TF was suppressed when Hb was pre-incubated with LPS (Figure 3.26, grey 
bars). This shows that TF and LPS compete for binding Hb, as TF is unable to 
bind Hb that exists in a complex with LPS. Moreover, TF is unable to displace 
LPS that is bound to Hb, suggesting that the Hb-LPS interaction is stronger 
than the Hb-TF interaction.   
 
 
Figure 3.26: Competition between LPS and TF for binding Hb. 0.2 µg of 
TF was immobilized, and Hb (with or without pre-treatment with a 4-fold 
molar excess of LPS) was added. Bound protein was detected using primary 
anti-Hb antibody and HRP-conjugated secondary antibody. OD405 was read to 
indicate the extent of complex formation. Data are mean±S.D. of three 
independent experiments. 
Chapter 3: Results & Discussion 
119 
 
To examine whether TF was able to bind with LPS, ELISA was performed by 
immobilizing LPS on a 96-well microtitre plate. Addition of increasing doses 
of Hb led to the formation of a complex between Hb and LPS (Figure 3.27, 
black bars). However, no complex formation was observed between TF and 




Figure 3.27: ELISA for the interaction of Hb and TF with LPS. 1 µg of 
LPS was immobilized on a microtitre plate. The unbound sites were blocked 
with 2% BSA, and Hb or TF were added. Bound proteins were detected using 
the respective primary antibodies and HRP-conjugated secondary antibodies. 
OD405 was read to indicate the extent of complex formation. Data are 
mean±S.D. of three independent experiments. 
 
Taken together, we have confirmed the interactions between Hb and TF in a 
cell-free system. In addition, we have shown that Hb may form binary 
complexes with either TF or LPS. The possibility of the formation of a ternary 
complex between Hb, LPS and TF has been ruled out, as TF did not show 
binding to LPS.  
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3.2.2.2    Model cell system for TF expression  
For the in situ analysis of Hb-TF interactions, we have used a TF-expressing 
human macrophage model system. The rationale for using macrophages to 
study TF expression and function was based on a previous report showing that 
Hb did not induce TF expression in endothelial cells (Roth, 1994). Moreover, 
aberrant TF expression by monocytes and macrophages has been implicated in 
coagulopathies associated with sepsis and endotoxemia (Osterud & Flaegstad, 
1983; Drake et al., 1993; Dohrn et al., 1998). Recent work with an animal 
model of sickle-cell disease (SCD) showed that TF contributed to the 
pathological state by activating inflammation and vascular injury, and these 
effects of TF could not be abrogated with endothelium-specific knockout of 
TF (Chantrathammachart et al., 2012). In xenograft transplantation with 
disseminated intravascular coagulation and hemolysis, the cells responsible for 
excessive TF expression were found to be circulating cells, not endothelial 
cells (Ekser et al., 2012). These studies suggest that non-endothelial sources of 
TF contribute significantly to the pathologies associated with 
hypercoagulation and inflammation. 
Macrophages derived from THP-1 monocytes were used as they share greater 
similarity with human monocyte-derived macrophages, as compared to those 
derived from U937, HEL or HL-60 cells (Auwerx, 1991). THP-1 monocytes 
were treated with PMA to induce their differentiation into macrophages 
(Tsuchiya et al., 1982). Treatment with 10 ng/ml LPS (~100 EU/ml) was used 
as a positive control, as LPS is known to induce TF expression in monocytes 
(Niemetz & Morrison, 1977; Gregory et al., 1989). A time-course analysis of 
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mRNA and protein expression was done to determine the optimal time for 
stimulation of the cells for future experiments. TF mRNA levels were seen to 
peak from 1-2 h (Figure 3.28A). A stimulation time of 2 h was used for the 
later experiments, in accordance with previous reports (Norris et al., 2006; 
Kasthuri et al., 2012) and the observed results. For TF protein expression, the 
optimal stimulation time was observed to be 6 h, as the TF protein 





Figure 3.28: Time-course of TF expression by macrophages in response to 
LPS. THP-1 macrophages were stimulated with 10 ng/ml LPS and cells were 
harvested at the indicated time-points. (A) Total TF mRNA was measured 
using qRT-PCR. (B) TF protein levels were measured using TF-specific 
ELISA. The mRNA and proteins levels are expressed as fold-change with 
respect to LPS-untreated cells. Data are mean±S.D. of three independent 
experiments. 
 
Using flow cytometry, we probed the expression of TF on the surface of 
macrophages that had been stimulated with LPS for 6 h. Macrophages that had 
not been treated with LPS expressed TF at a basal level (Figure 3.29). 
Compared to the LPS-untreated cells, the cells that had been treated with LPS 
Chapter 3: Results & Discussion 
122 
 
displayed a significantly increased surface expression of TF, as indicated by 
an increase in their mean fluorescence intensity (MFI). These cells are referred 





Figure 3.29: Flow-cytometric analysis of TF surface expression by 
macrophages after LPS stimulation. Macrophages were left untreated or 
stimulated with 10 ng/ml LPS for 6 h. TF levels were assessed by staining 
with goat anti-TF antibody and Alexa Fluor 488-conjugated secondary 
antibody. (A) Representative histograms for LPS-treated and -untreated cells. 
The grey curve represents the background signal from the isotype control. 
Data are representative of three independent experiments. (B) Surface TF 
expression levels are expressed as the mean fluorescence intensity (MFI), 
normalized with respect to the control. Data are mean±S.D. of three 
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3.2.2.3    Hb associates with TF on the surface of macrophages 
Having observed the interaction between Hb and TF in vitro (Section 3.2.2.1), 
we asked whether Hb could associate with TF displayed on the macrophage 
surface. We examined the binding of Hb to the TF+ macrophages using flow 
cytometry. Addition of Hb to the cells resulted in a dose-dependent increase in 
MFI, indicating binding of Hb to the macrophage surface (Figure 3.30).  
The specificity of the interaction between Hb and TF was examined by 
blocking TF using anti-TF antibody. Indeed, prior treatment of cells with anti-
TF antibody led to a decline in the levels of Hb associated with the 
macrophage surface (Figure 3.30). This confirmed that the binding of Hb on 
the macrophage surface was via its association with TF. Blocking of TF 
however did not abolish the binding of Hb to the macrophage surface 
completely. This may be attributable to the binding of Hb to other cell-surface 
proteins such as SR-B1. Recent findings from our lab have identified SR-B1 
in macrophages as a receptor for binding and internalization of free Hb or Hb-
Apolipoprotein A-1 complex (Du et al., 2012). The well-known Hb scavenger 
receptor, CD163, that is found on macrophages is absent from THP-1 
macrophages (Bächli et al., 2006; Fabriek et al., 2009), and hence is irrelevant 
here. 
Prior incubation of Hb with a 4-fold molar excess of LPS led to a decline in 
the binding of Hb to TF+ macrophages (Figure 3.31). This demonstrates that 
TF is unable to bind Hb that exists in a complex with LPS, and confirms the 
previous observations from ELISA (see Figure 3.26) that TF and LPS compete 
for binding Hb. 




Figure 3.30: Hb forms a complex with TF on the macrophage surface. The 
binding of Hb to TF was analyzed by flow cytometry. TF+ macrophages, with 
or without pre-treatment with anti-TF antibody, were treated with increasing 
doses of Hb for 30 min. Hb bound to the cell surface was detected by staining 
with mouse anti-Hb antibody and Alexa Fluor 488-conjugated secondary 
antibody. (A) Representative histograms of binding of Hb (2 mg/ml) to cells. 
The grey curve represents the background signal from the isotype control. 
Data are representative of three independent experiments. (B) Levels of 
surface-associated Hb are expressed as mean fluorescence intensity (MFI), 
normalized with respect to the control. Data are mean±S.D. of three 
independent experiments. *, p< 0.05; **, p< 0.01. 
 





Figure 3.31: Flow cytometry analysis confirms competition between TF 
and LPS for binding Hb. TF+ macrophages were incubated with varying 
doses of Hb or Hb-LPS complex for 30 min. (A) Representative histograms of 
binding of Hb (2 mg/ml) to cell surface are shown. The grey curve represents 
the background signal from the isotype control. Data are representative of 
three independent experiments. (B) Levels of surface-associated Hb are 
expressed as the mean fluorescence intensity (MFI), normalized with respect 
to the control. Data are mean±S.D. of three independent experiments. *, p< 
0.05. 
 
3.2.3     TF protects Hb from LPS-induced activation of Hb redox activity 
After establishing the interactions between Hb and TF, we investigated 
whether TF influenced the redox activity of Hb. Using cypridina luciferin 
analog (CLA) as a chemiluminescent sensor of superoxide, we measured the 
extent of superoxide production by Hb that had been pre-treated with 
recombinant TF. It was seen that the superoxide production for the Hb-TF 
complex was the same as Hb alone (Figure 3.32A, C), indicating that TF 
alone had no effect on the redox behaviour of Hb. Proteins such as 
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haptoglobin and apolipoprotein A1 have been demonstrated to suppress the 
redox activity of Hb in the CLA based assay (Du et al., 2012) . However, no 
such effect was exerted by TF on the redox activity of Hb. 
Based on our earlier findings that TF and LPS compete for binding LPS, we 
examined whether binding of TF to Hb regulated the LPS-induced redox 
activity of Hb. First, we found that the redox activity of Hb was doubled in the 
presence of LPS (Figure 3.32C). This was in accordance with previous 
reports that showed an increase in the superoxide production by Hb upon 
treatment with LPS (Jiang et al., 2007; Du et al., 2010). To test whether the 
LPS-induced redox behaviour of Hb could be regulated by TF, Hb was 
incubated with TF, either before or after its treatment with LPS. We found that 
addition of TF to Hb prior to LPS led to an inhibition of the superoxide 
production by Hb (Figure 3.32B, C). In contrast, when TF was added after 
LPS, it did not inhibit the increase in the superoxide production by Hb. This 
implies that binding of TF to Hb before it encounters LPS could prevent LPS-
induced redox activity of Hb. Moreover, addition of BSA to Hb prior to LPS 
did not affect its redox activity, thus indicating the specificity of TF-mediated 
suppression of superoxide production.  




Figure 3.32: Effect of TF on superoxide production by Hb. (A) Hb was 
incubated with equimolar TF, or with BSA as a control. H2O2 and CLA were 
added, and the kinetics of superoxide production by Hb was measured as the 
chemiluminescence emitted by CLA. The extent of superoxide formed is 
expressed as relative luminescence units (RLU). Data are representative of 
three independent experiments. (B) Hb was treated with TF and LPS in 
varying orders of addition, and the kinetics of superoxide production was 
measured. Hb:TF:LPS – TF was added before LPS, Hb:LPS:TF – TF was 
added after LPS, Hb:BSA:LPS – LPS added before BSA. Data are 
representative of three independent experiments. (C) Plot of the superoxide 
levels for the various combination treatments, obtained from the superoxide 
production curves was plotted. Data are mean±S.D. of three independent 
experiments. *, p< 0.05; **, p< 0.01; ns – not significant. 
 
Next, we tested whether binding of Hb to TF anchored on the macrophage 
surface could dampen the LPS-mediated redox activity. Macrophages were 
treated with LPS to upregulate TF expression (see Section 3.2.2.2). These cells 
are referred to as TF+ cells. Macrophages expressing TF were additionally 
treated with anti-TF antibody to block the availability of TF. These 
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macrophages, henceforth referred to as TF$, would bind Hb non-specifically 
and serve as negative controls.  
We observed a dose-dependent increase in the superoxide production by Hb 
bound to TF+ cells (Figure 3.33A, white bars). As seen from the in vitro assay 
(Figure 3.32), TF alone does not suppress the redox activity of Hb. Hence, Hb 
bound to TF+ cells displayed redox activity in a concentration-dependent 
manner. Hb bound to TF$ cells also displayed some redox activity, indicating 
that Hb was bound to these cells, albeit non-specifically (Figure 3.33B, white 
bars). This was also seen in the flow cytometry experiments (see Section 
3.2.2.3, Figure 3.30), and may be attributed to the binding of Hb to the cell 
surface receptor SR-B1 (Du et al., 2012). Addition of LPS to Hb bound to TF$ 
cells led to a significant increase in its redox activity (Figure 3.33B, grey 
bars), while only a slight increase was observed with Hb bound to TF+ cells 
(Figure 3.33A, grey bars). These results imply that while non-specific binding 
of Hb to the macrophage surface does not suppress its redox behaviour, 
binding to TF results in a dampening of the LPS-induced redox activity of Hb. 
To quantitate the inhibitory effect of cell-anchored TF on the redox activity of 
Hb, the fold change in superoxide produced by Hb in the presence of LPS was 
compared with that of Hb alone (Figure 3.33C). Hb bound to TF$ cells 
displayed a 6- to 10-fold increase in its redox activity in the presence of LPS. 
However, upon binding to TF on TF+ cells, Hb displayed only a 2-fold 
increase in the redox activity (Figure 3.33C).  




Figure 3.33: Effect of surface-expressed TF on superoxide production by 
Hb. (A) TF+ macrophages were treated with Hb (1 and 2 mg/ml). Cells were 
washed and left untreated or treated with LPS, followed by addition of H2O2 
and CLA. The superoxide production by Hb was measured as the 
chemiluminescence emitted by CLA. The superoxide levels are expressed as 
relative luminescence units (RLU). (B) Macrophages expressing TF were first 
treated with anti-TF antibody to block availability of TF. These TF$ 
macrophages were then treated as in (A), with Hb+/-LPS and the superoxide 
production was measured after addition of H2O2 and CLA. (C) The fold-
change in the superoxide formed by the cells treated with Hb and LPS, versus 
those treated with Hb alone was plotted. TF+ indicates cells expressing TF, 
TF$ indicates cells treated with anti-TF antibody to block TF. Data are 
mean±S.D. of three independent experiments. *, p< 0.05, **, p< 0.01. 
 
 
We speculate that cell-surface TF may be binding to Hb to induce a 
conformational change or a steric hindrance that blocks LPS from binding to 
Hb. The resulting suppression of the LPS-induced oxidative effects may serve 
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to protect the host from the cellular damage that may ensue if plasma Hb were 
to encounter LPS near a host cell during a Gram-negative infection. Residual 
redox activity remained with the non-specifically bound Hb, since the other 
receptors like SR-B1 may not directly block the LPS-binding sites of Hb. 
 
3.2.4     Hb upregulates and preserves the procoagulant function of TF 
Having observed the effects of TF on the redox behaviour of Hb, we asked 
whether Hb mediated a regulatory influence on the expression and activity of 
TF in macrophages. Intravascular coagulation is known to inflict mechanical 
damage on erythrocytes, and hemolysis releases factors that in turn promote 
coagulation (Setty et al., 2008; Ataga, 2009) (see Section 1.2.5, Figure 1.24). 
Such a ‘positive feedback’ nature of the coagulation-hemolysis interplay 
creates inherent vulnerability toward excess. Hb constitutes 97% of the dry 
content of erythrocytes (Weed et al., 1963) and its impact on TF merits closer 
study.  
 
3.2.4.1     Effects of Hb on TF transcription 
To investigate the influence of Hb on the expression of TF by macrophages, 
we treated macrophages with increasing doses of Hb and measured the 
changes in the levels of TF mRNA. Real-time PCR measurements showed that 
TF mRNA was expressed at low levels in unstimulated macrophages. 
Treatment with 10 ng/ml LPS as a positive control, led to a significant 
increase in the mRNA levels. Stimulation with Hb led to a concentration-
dependent increase in TF mRNA levels (Figure 3.34).  





Figure 3.34: Hb upregulates TF mRNA expression in macrophages. 
Macrophages were treated with the indicated concentrations of Hb for 2 h. As 
a positive control, cells were treated with LPS (10 ng/ml). Following 
incubation, total RNA was isolated and analyzed for TF mRNA by qRT-PCR. 
TF mRNA levels were normalized using "2-microglobulin (B2M). Results are 
expressed as fold change relative to untreated control using the ''Ct method, 
with B2M as an internal control. Data are mean±S.D. of three independent 
experiments. **, p<0.01 
 
3.2.4.2     Effects of Hb on TF protein expression and function 
We further measured the changes in TF protein levels and procoagulant 
activity upon Hb treatment. Stimulation of macrophages with Hb led to an 
upregulation of TF protein expression in a concentration-dependent manner 
(Figure 3.35A). There was a concomitant increase in the procoagulant activity 
of TF in Hb-treated cells (Figure 3.35B), indicating that the TF protein, being 
expressed by the macrophages, was functionally active. Cells treated with 10 
ng/ml LPS were positive controls. LPS-treatment led to a 5-fold increase in 
the levels of TF protein and activity. On the other hand, at the highest 
concentration of Hb used (1 mg/ml), there was a 9-fold increase in the TF 
protein and activity. To exclude the possibility that the observed effects were 
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due to endotoxin contamination of Hb, the levels of endotoxin present in the 
Hb solutions were measured using PyroGene Assay. The level of endotoxin 
present was minimal (3 EU per mg protein) as compared to the LPS solutions 
used as positive control (10 ng/ml; 100EU/ml). This confirmed that the 
upregulation of TF expression and function was triggered by Hb. Treatment of 
cells with a protein synthesis inhibitor, cycloheximide (CHX), prior to 
addition of Hb abolished the upregulation mediated by Hb (Figure 3.36). This 
confirmed that de novo protein synthesis was required for the upregulation of 
TF by Hb. 
 
 
Figure 3.35: Hb increases TF protein expression and function.  
(A) Macrophages were treated with Hb for 6 h, and total cellular proteins were 
extracted. Cell lysates were assayed for TF protein levels using ELISA. (B) 
Macrophages were treated with Hb for 6 h, and TF activity in the cell lysates 
was measured. Results are expressed as fold change with respect to the 
untreated control. Data are mean±S.D. of three independent experiments. **, 
p<0.01 




Figure 3.36: Protein synthesis is required for Hb-induced expression of 
TF. Macrophages were treated CHX for 1 h, followed by Hb for 6 h, and total 
cellular proteins were extracted. Cell lysates were assayed for TF protein 
levels using ELISA. Results are expressed as fold change with respect to the 
untreated control. Data are mean±S.D. of three independent experiments. **, 
p<0.01 
 
The induction of TF by Hb observed here suggests a potentially central 
mechanism for hemolysis to activate coagulation. The presence of Hb-TF 
induction in macrophages, and not in endothelial cells (Roth, 1994), suggests 
an intriguing parallel with published instances where hemolytic 
coagulopathies were caused by a non-endothelial source of excessive TF 
(Dohrn et al., 1998; Chantrathammachart et al., 2012).   
 
3.2.4.3     Anti-oxidants suppress Hb-induction of TF expression 
Hb, with its potential for generating reactive oxygen species (ROS) via its 
endogenous pseudoperoxidase activity, was highly effective at upregulating 
TF expression. The role of ROS in Hb-induced TF expression was assessed by 
using the antioxidants, N-acetylcysteine (NAC) and glutathione (GSH). 
Exogenous GSH acts by quenching extracellular oxidants, while NAC acts by 
entering the cells and increasing the levels of intracellular GSH. Pre-treatment 
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of macrophages with the antioxidants caused a significant decrease in the 
upregulation of TF by Hb (Figure 3.37). Attenuation of Hb-mediated TF 
expression by the cell-permeable antioxidant, NAC, suggests that oxidative 
stress induced by Hb triggers redox-sensitive downstream signaling events for 
TF expression, which may be blocked by NAC. GSH, on the other hand, may 
sequester external sources of oxidants, resulting in the inhibition of TF 
expression. Despite the presence of antioxidants, there was a dose-dependent 
increase in the TF protein levels, suggesting that Hb may also activate TF 
expression in a non-redox manner and the levels of oxidation in the 
environment could be permissive for that signal to proceed downstream.    
The role of oxygen free radicals in the TF expression by monocytes has been 
demonstrated previously, as treatment with hydrogen peroxide led to an 
increase in TF expression, which was abrogated upon treatment with anti-
oxidants such as NAC and PDTC (pyrrolidine dithiocarbamate) (Cadroy et al., 
2000). LPS-induced TF expression by monocytes and endothelial cells has 
also been shown to be inhibited by treatment with NAC and PDTC (Brisseau 
et al., 1995; Orthner et al., 1995). It has been suggested that the anti-oxidants 
suppress TF expression in monocytes at the post-transcriptional level via 
inhibition of translation or degradation of translated protein (Brisseau et al., 
1995). Lessening of the Hb-induced TF expression by NAC treatment may be 
attributed to a similar mechanism. 
 




Figure 3.37: Anti-oxidant treatment suppresses Hb-induced TF 
expression. Macrophages were treated NAC and GSH for 1 h, followed by Hb 
for 6 h, and total cellular proteins were extracted. Cell lysates were assayed for 
TF protein levels using ELISA. Results are expressed as fold change with 
respect to the untreated control. Data are mean±S.D. of three independent 
experiments. **, p<0.01 
 
3.2.4.4     Hb preserves the procoagulant activity of TF 
Having observed that Hb upregulates TF expression on macrophages and 
binds to TF on the macrophage surface, we next probed the effects of Hb on 
the procoagulant activity of TF. During infection, the upregulation of TF 
expression on endothelial and monocytic cells by LPS (Niemetz & Morrison, 
1977), pro-inflammatory cytokines (Conkling et al., 1988; Herbert et al., 
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1992) and immune complexes (Lyberg et al., 1982) initiates the coagulation 
cascade (see Figure 1.22). We asked whether Hb could play a role in the 
regulation of the coagulation processes mediated by TF. 
The effects of Hb on the procoagulant activity of TF were investigated in cell-
free and macrophage experiments. In a cell-free system without anti-oxidants, 
Hb caused a dose-dependent decline in the TF activity (Figure 3.38A, black 
bars). At the maximum Hb concentration (2 mg/ml), there was a 40% 
inhibition of TF activity (Figure 3.38A). Previous studies have found TF 
activity to be strongly suppressed by antioxidants (Ahamed et al., 2006; 
Reinhardt et al., 2008; Ruf & Versteeg, 2010). In accordance with these 
reports, we too observed a dramatic inhibition of TF activity by glutathione 
(GSH) (Figure 3.38, white bars). The combination of Hb and GSH showed a 
cancellation effect – in the presence of Hb, TF activity was unaffected by 
GSH. Additionally, we tested the TF activity upon addition of serum as a 
source of antioxidants. At 5% and 10% concentration, serum attenuated TF 
activity drastically (Figure 3.38, grey bars). A high dose of Hb (2 mg/ml) 
rendered the activity of TF insensitive to serum-induced inhibition. Thus, Hb 
increased the activity of TF in the presence of antioxidants, even though it had 
the opposite effect without antioxidants. In TF+ macrophages, we observed 
similar trends (Figure 3.38B). Hb stabilized the activity of TF at ~80% of 
untreated control, regardless of the presence of GSH or serum.   
 





Figure 3.38: Effect of Hb on the procoagulant activity of TF. (A) Hb was 
left untreated, or pre-treated with GSH or serum. Hb was then incubated with 
lipidated TF. The change in the activity of TF was measured using 
ACTICHROME® TF activity assay kit, and plotted as a percentage of the Hb-
untreated control. (B) TF-expressing macrophages were treated in a similar 
way with Hb, with or without pre-treatments with GSH or serum. Cells were 
lysed and TF activity of the lysates was measured. Activity is expressed as a 
percentage of the untreated control samples. Data are mean±S.D. of three 
independent experiments. **, p<0.01 
 
 
One interpretation of our results is that Hb-binding causes a change in the 
redox microenvironment of TF that restores its procoagulant activity. 
Alternatively, Hb-binding probably induces a contextual or conformational 
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change that alters the redox sensitivity of TF. The procoagulant activity of TF 
has been proposed to be regulated by the redox environment, as impairment of  
the extracellular disulfide bond between Cys186 and Cys209 abolishes TF 
procoagulant activity (Ahamed et al., 2006; Ruf & Versteeg, 2010). It is 
conceivable that in contexts that lack anti-oxidants, such as severe hemolysis, 
Hb would blunt the procoagulant activity of TF. This could be homeostatic in 
a highly stressed environment (Figure 3.39, right panel). In mild hemolytic 
contexts, where plasma anti-oxidants are not depleted, Hb would increase TF 
activity as well as promote TF expression, thus contributing to host defense 




Figure 3.39: Schematic depicting the dual effects of Hb on TF 
procoagulant activity. Under mild hemolysis, plasma antioxidants are present 
at sufficient levels to inhibit TF procoagulant activity. Extracellular Hb binds 
to TF to overcome the inhibitory effects of antioxidants, and may promote 
coagulation for maintaining host defense. In severe oxidative stress, plasma 
antioxidants are depleted and their control of TF procoagulant activity would 
be lost. Hb would then bind to TF to downregulate and stabilize TF activity, 
which may contribute to maintaining homeostasis. Thus, in both oxidizing and 
reducing conditions, Hb would preserve the TF procoagulant activity to 
maintain the coagulation processes for host defense. M*: macrophage; red 
arrows: experimental findings; green arrows: proposed implications. 
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To summarize, in Section 3.2 we have identified a novel endogenous 
mechanism of regulation of the redox activity of Hb by the coagulation 
protein, TF. 
The innate immune and blood coagulation systems are triggered concurrently 
in response to infection, and these two systems crosstalk to maintain host 
immune defense. The invertebrate respiratory protein, hemocyanin, binds to 
the coagulation protease Factor B, and this binding triggers the latent redox 
activity of hemocyanin to generate microbicidal free radicals (Nagai & 
Kawabata, 2000). In vertebrates with hemolysis, a similar effect occurs when 
bacterial LPS activates the redox activity of extracellular Hb (Jiang et al., 
2007; Du et al., 2010). Our computational analysis identified pairs of highly 
co-evolving residues between TF and Hb", suggesting direct interaction 
between the proteins over evolutionary history. Plausible modes of binding of 
Hb with TF were suggested via molecular docking. Empirically, the ability of 
Hb to form a complex with TF was demonstrated by ELISA. Furthermore, 
binding of Hb with TF on the macrophage surface was confirmed using flow 
cytometry. Flow cytometry and ELISA showed that Hb pre-treated with LPS 
was unable to bind TF effectively, indicating that LPS and TF compete for 
similar binding sites on Hb. 
We found that the TF-Hb interaction dampened the LPS-mediated redox 
activity of Hb, both in cell-free assays and in situ on the macrophage surface. 
Further investigations revealed that Hb increased the expression of 
functionally active TF in THP-1 macrophages. In addition, Hb induced an 
unexpected stabilization of TF activity, removing its sensitivity to 
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environmental antioxidants. Specifically, Hb boosted TF activity in the 
presence of glutathione and serum, but attenuated TF activity when the 
environment did not have antioxidants. Based on these findings, we propose 
that Hb-TF interaction would upregulate coagulation in most instances of 
hemolysis, but dampen extreme TF activity during an oxidative crisis.  
Overall, our findings reveal a multi-functional interplay between Hb and TF, 
which may constitute a novel link between coagulation and innate immunity, 
as illustrated in Figure 3.40. The interaction between Hb and TF may help 
limit oxidative damage to the host, while stabilizing the coagulation processes 
that contribute to host defense.  
 
Figure 3.40: A model to illustrate the multi-functional interplay between 
Hb and TF. Infection elicits crosstalk between inflammation, hemolysis and 
coagulation. Infection-triggered hemolysis elevates extracellular Hb, which is 
redox-active. LPS binds extracellular Hb and activates it to generate ROS, that 
result in microbial killing. Our findings (red arrows) reveal a novel link 
between hemolysis and coagulation. TF, upregulated in response to 
inflammation, inhibits the LPS-induced redox activity of Hb. Hb upregulates 
TF expression on macrophages, and further binds to cell-anchored TF, and 
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CHAPTER 4  
GENERAL CONCLUSIONS 
 
The main goal of this thesis was to explore mechanisms for the regulation of 
the redox activity of extracellular Hb. Hb is a redox-active molecule, with its 
oxidative activity tightly down-regulated within the reducing environment of 
the erythrocytes. Extracellular Hb mediates uncontrolled redox reactions that 
inflict cellular oxidative injury. The work presented here shows that 
modifications of the LPS-binding sites of Hb may be a means of regulating its 
redox activity. Moreover, we have identified modulation of the redox 
behaviour of Hb by TF as an endogenous mechanism that may play an 
important role during infection. 
Computational analysis of Hb showed the presence of evolutionarily 
conserved cationic patches on the surface of the tetramer. We identified 
bioactive residues in these cationic patches that had a high propensity of 
binding the phosphate groups of LPS. We validated their capacity for binding 
LPS and its truncated active forms – ReLPS and lipid A, using various 
biochemical and biophysical approaches. Hb peptides were designed to 
include the LPS binding residues. SPR analysis indicated a high affinity LPS- 
binding peptide, B59, spanning residues 59-95 of the Hb" subunit. B59 
peptide displayed sub-nanomolar affinity for LPS. Other peptides were 
identified that bound LPS with micromolar affinity. Binding studies using 
SPR and fluorescence-based displacement assays served to screen the peptides 
on the basis of their ability to bind LPS. The anti-LPS efficacies of these 
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peptides were further confirmed via functional assays of endotoxin 
neutralization in vitro and binding to gram-negative bacteria in situ.  
Site-directed mutagenesis studies were carried out by mutating the LPS 
binding residues of the peptides, B59 and A56, that displayed the highest 
affinity for LPS binding. Recombinant Hb subunits carrying mutations in the 
LPS binding residues displayed weaker LPS binding abilities, thus 
corroborating the in silico predictions and peptide-based assays. More 
importantly, LPS failed to amplify the redox activity of the mutated Hb 
subunits, as compared to the wild-type subunits. Thus, mutations in the LPS 
binding regions rendered the redox activity of Hb insensitive to the presence 
of LPS. Modification of LPS-binding sites of Hb is thus a potential strategy 
for producing an improved Hb-based blood substitute which is LPS-
insensitive and hence poses minimal risks of endotoxicity and redox reactivity. 
This is important as LPS is an indomitable and ubiquitous contaminant that 
could be readily present in pharmaceutical preparations.  
The mechanism of generation of free radicals by Hb upon contact with 
microbial factors shares similarity with an ancient host defense mechanism 
found in invertebrates. In horseshoe crabs, the respiratory protein, 
hemocyanin, is activated by microbial PAMPs to generate cytotoxic quinones. 
An activated host coagulation protease also induces the redox activity of 
hemocyanin during infection. In a similar vein, we showed that in the 
vertebrates, there exists a functional interaction between Hb and TF, the 
primary initiator of the coagulation cascade. Hb was able to bind membrane-
bound TF expressed on the cell surface, as well as to isolated TF in the 
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absence of the cellular environment. There was a competition between TF and 
LPS for binding to Hb. Moreover, the redox activity of Hb, which has been 
pre-complexed with TF, was insensitive to the presence of LPS. This may be a 
strategy employed by the host to protect itself from oxidative damage and to 
entrap invading microbes during an immune response to injury or infection. 
The role of Hb in influencing TF-mediated coagulation was revealed by 
probing the effects of Hb on the TF expression and function. Hb was seen to 
upregulate the expression of functionally active TF on macrophages. In the 
presence of anti-oxidants, there was a decline in the potency of Hb to trigger 
TF expression. Moreover, binding of Hb with TF served to maintain the 
procoagulant function of TF at a moderate level. Importantly, in the presence 
of Hb, the coagulation activity of TF was not sensitive to the presence of anti-
oxidants, hence Hb seems to preserve the procoagulant activity of TF. 
The crosstalk between Hb and TF may function to divert Hb from pathogen 
recognition, and direct it towards preserving coagulation. In silico co-
evolutionary analysis of Hb and TF identified several strongly co-evolved 
residue pairs between TF and Hb". The existence of correlated mutations 
amongst residues between Hb and TF suggest the evolutionary significance of 
the molecular crosstalk between the proteins. 
Taken together, we have identified means of regulation of the redox activity of 
extracellular Hb. The identification of LPS binding regions of Hb may be 
applicable for the development of safer Hb-based blood substitutes. Moreover, 
the identification of LPS-binding peptides from Hb offers potential for 
development of new therapeutic strategies against bacterial infection. Our 
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elucidation of the crosstalk between Hb and TF provides new insights into the 
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CHAPTER 5  
FUTURE PERSPECTIVES 
 
The research findings presented in this thesis open up several interesting 
directions for future work. Experimental studies could be designed for 
exploring the following avenues: 
 
I. Suitability of Hb peptides as potential therapeutic agents 
In this study, we have identified peptides derived from Hb that bind LPS and 
its variants, ReLPS and lipid A, with high affinity. The Hb peptides were 
found to function as LPS-antagonists by decreasing the endotoxic potential of 
LPS in vitro. However, these studies only investigated the interaction of the 
peptides with S. minnesota LPS. Further studies will be needed to characterize 
the binding of these peptides to LPS from other species of gram-negative 
bacteria, such as E. coli and P. aeruginosa. LPS binding assays such as SPR 
and fluorescence displacement assay may be employed. This will help to 
ascertain the potential application of these peptides as general LPS-targeting 
agents for therapeutic use. The biological activity of these peptides may be 
explored further by assays that investigate the effects of these peptides on the 
release of pro-inflammatory cytokines from immune cells. These studies will 
help establish the role of these peptides in dampening the immune responses to 
LPS during pathogen invasion. The antimicrobial activity of these peptides 
towards a spectrum of microbes – gram-positive and gram-negative bacteria, 
and fungi, also remains to be explored. The results of these studies may reveal 
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the potential dual action of the Hb peptides, as LPS-antagonists and 
antimicrobial agents.  
 
II. LPS-binding Hb mutants as blood substitutes 
Hb-based oxygen carriers (HBOC) have found limited use as blood substitutes 
owing to their intrinsic toxicity (Alayash, 2010). The toxic effects have been 
attributed to the contamination of Hb with LPS, and the uncontrolled oxidative 
reactions of cell-free Hb (Alayash, 1999). Here, we have identified and 
characterized Hb mutants that display a weakened LPS-binding ability, and 
are insensitive to the redox-enhancing effects of LPS. Hb carrying these 
mutations may find potential use as a blood substitute. In this study, mutations 
were introduced in the isolated Hb subunits, and their LPS-binding abilities 
further characterized. Future studies may aim to generate recombinant 
tetrameric Hb carrying these mutations, and explore their potential as HBOCs. 
The requirements for a Hb-derived molecule to be used as a blood substitute 
are that it should be able to bind to oxygen reversibly and cooperatively; and 
display minimum toxicity. As the mutations in the Hb subunits are close to the 
heme binding pocket in the Hb molecule, they may have some effects on the 
oxygen binding ability of heme. These effects may be measured by 
characterizing the oxygen binding abilities of the mutant subunits versus the 
wild type subunits. Spectroscopy based assays that measure the oxygenated 
form of Hb may be performed, and the oxygen-dissociation curve may be 
plotted.  Co-operativity of oxygen binding may be gauged from the Hill 
coefficient determined from the oxygen-dissociation curve. 
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III. Identification of the interaction site of Hb and TF  
Computational analysis of Hb and TF identified co-evolving residues between 
the proteins. Molecular docking results provided plausible models of the 
interaction of Hb with TF. The docking results, in conjunction with the co-
evolutionary analysis, provide a valuable starting point for guiding further 
structural experimental work to conclusively determine the native binding 
interaction of Hb and TF. X-ray crystallography of the complex of Hb with TF 
may be carried out to determine the exact binding site residues. This would 
provide mechanistic insights into the functional interplay between Hb and TF. 
Delineation of the binding site may help understand the experimentally 
observed competition between LPS and TF for binding Hb. Steered molecular 
dynamics simulations could be performed using the co-ordinates of the 
proteins from the complex, to investigate the recognition and binding events 
guiding the interactions. These studies may also provide clues for the roles of 
the predicted co-evolving residues in the initiation or stabilization of the 
interactions of Hb and TF. Additionally, the role of the co-evolved residue 
pairs in the Hb-TF interactions may be further probed via site-directed 
mutagenesis studies. 
 
IV. Elucidation of the effects of Hb on the downstream signaling 
events mediated by TF 
We have observed that Hb is able to interact with TF, a key protein in the 
coagulation cascade. Besides a role in coagulation, TF may activate receptors 
on the cell surface to trigger signaling events that promote inflammation (Chu, 
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2005). As Hb was found to bind with TF on the cell surface, it is reasonable to 
test whether Hb also influences the signal transduction initiated from TF 
(Figure 5.1). This may be done by determining the effects of Hb on the 
production of known pro-inflammatory mediators that are upregulated by TF. 
If Hb indeed influences the immune-related activities of TF, it would indicate 
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Background: Redox activity of hemoglobin (Hb) is augmented by lipopolysaccharide (LPS) to boost immune defense.
Results: Computational analysis of Hb identified LPS-binding hot spots, which were further defined via peptide-based binding
assays and confirmed by mutagenesis of Hb subunits.
Conclusion: Regions of Hb that interact with LPS have been delineated.
Significance: Knowledge of LPS-binding residues on Hb may be exploited for designing antimicrobial peptides.
Hemoglobin (Hb) functions as a frontline defense molecule
during infection by hemolyticmicrobes. Binding to LPS induces
structural changes in cell-free Hb, which activates the redox
activity of the protein for the generation of microbicidal free
radicals. Although the interaction between Hb and LPS has
implications for innate immune defense, the precise LPS-inter-
action sites onHb remain unknown. Using surface plasmon res-
onance, we found that both the Hb ! and " subunits possess
high affinity LPS-binding sites, withKD in the nanomolar range.
In silico analysis of Hb including phospho-group binding site
prediction, structure-based sequence comparison, and docking
to model the protein-ligand interactions showed that Hb pos-
sesses evolutionarily conserved surface cationic patches that
could function as potential LPS-binding sites. SyntheticHbpep-
tides harboring predicted LPS-binding sites served to validate
the computational predictions. Surface plasmon resonance
analysis differentiated LPS-binding peptides from non-binders.
Binding of the peptides to lipid Awas further substantiated by a
fluorescent probe displacement assay. The LPS-binding pep-
tides effectively neutralized the endotoxicity of LPS in vitro.
Additionally, peptide B59 spanning residues 59–95 of Hb"
attached to the surface of Gram-negative bacteria as shown by
flow cytometry and visualized by immunogold-labeled scanning
electron microscopy. Site-directed mutagenesis of the Hb sub-
units further confirmed the function of the predicted residues in
binding to LPS. In summary, the integration of computational
predictions and biophysical characterization has enabled delin-
eation of multiple LPS-binding hot spots on the Hb molecule.
Gram-negative bacteria (GNB)2 are the predominant cause
of clinical sepsis (1). A major constituent of their outer mem-
brane is LPS (2), which is a potent stimulator of the immune
system. LPS molecules shed from the bacterial surface contrib-
ute to the pathology of GNB sepsis (3). LPS has been called
“endotoxin” because of its pyrogenic properties in humans and
other mammals. LPSmolecules from different species of GNBs
share a common general architecture (Fig. 1) (4), consisting of a
hydrophobic domain known as lipid A, a non-repeating core
oligosaccharide, and a distal polysaccharide called O-antigen.
Lipid A, also known as the “endotoxic principle” of LPS (5),
anchors LPS to the bacterial surface by insertion of its fatty acyl
chains into the outer membrane.
The ability to acquire iron from the host is crucial for the
survival of invading pathogenic bacteria (6). The mammalian
host sequesters most of its iron in the form of heme (7). The
respiratory protein Hb is a potentially rich source of iron and as
a result is targeted by many bacterial pathogens, which have
evolved specialized heme-Hbuptake systems for capturing cell-
free Hb, free heme, andHb complexed with other host proteins
(8). For instance, virulent strains of Staphylococcus aureus
secrete extracellular hemolytic toxins upon invasion, which
rupture the erythrocytes extensively to release Hb (9). The
extracellular bacterial proteases then cleave theHb polypeptide
chains and release the prosthetic heme. It has been shown that
the redox activity of Hb (10, 11) is significantly enhanced in the
presence of bacterial proteases and pathogen-associated
molecular patterns (LPS and lipoteichoic acids) (12). The sub-
sequent generation of free radicals by the redox-active Hb can
kill the invading pathogen at the site of infection (12–14).
Hb has long been recognized as an LPS-binding protein (15).
Hb from various species such as humans, sheep, and pig has* Thisworkwas supportedby the Singapore-Massachusetts Institute of Tech-
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□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental “Materials and Methods,” Tables S1–S3, Figs. S1–S4, and an
additional reference.
1 To whom correspondence should be addressed: Dept. of Biological Sci-
ences, National University of Singapore, 14 Science Drive 4, Singapore
117543. Tel.: 65-6516-2776; Fax: 65-6779-2486; E-mail: dbsdjl@nus.edu.sg.
2 Theabbreviationsusedare:GNB, gram-negativebacteria; ReLPS, LPS from S.
minnesota Re595; SPR, surface plasmon resonance; HBS, HEPES-buffered
saline; DC, dansylcadaverine; rFC, recombinant factor C; SEM, scanning
electron microscopy.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 286, NO. 43, pp. 37793–37803, October 28, 2011
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
OCTOBER 28, 2011•VOLUME 286•NUMBER 43 JOURNAL OF BIOLOGICAL CHEMISTRY 37793
been shown to interact with LPS (16–19). The invertebrate
respiratory protein, hemocyanin, which is a functional homo-
logue of Hb also binds LPS (12–14), indicating the evolutionary
significance of such interactions. Previous studies have charac-
terized the interactions of Hb and LPS through biophysical
methods such as isothermal titration calorimetry and Fourier-
transform infrared spectroscopy (17, 18), which suggested that
Hb intercalates into and alters the aggregate structure of LPS
polymers, transitioning it from a relatively dormant multila-
mellar structure to a bioactive cubic structure. It has been
shown that Hb interacts predominantly with the acyl chains
and phosphate moieties of lipid A (20). However, the precise
interaction hot spots on the Hb remain unknown.
Here, we demonstrated that both the subunits of Hb contain
LPS-binding sites. We implemented a methodical computa-
tional analysis to predict the LPS-binding sites on the surface of
theHbmolecule. An algorithm to predict phospho-group bind-
ing sites was applied, followed by structure-based sequence
comparisons of the vertebrate Hbs and docking analysis of pro-
tein-ligand interactions. The predictions were tested experi-
mentally by investigating the binding of synthetic Hb peptides
to LPS in immobilized and free form and to the bacterial sur-
face. The LPS-binding peptides displayed binding affinity in the
range of 10!8 to 10!5 M in SPR analysis. Moreover, these LPS-
binding peptides neutralized the endotoxicity of LPS, indicat-
ing the functional significance of binding. Selective mutations
of lysine to aspartate at positions 56, 60, and 61 in Hb !; and
positions 59, 66, and 95 in Hb " led to partial loss of the LPS-
binding ability of the subunits. Taken together, we have
mapped LPS-binding sites on Hb using an integrated approach
of computational predictions and empirical validations. Our
work advances the understanding of themolecular basis of Hb-
LPS interactions.
EXPERIMENTAL PROCEDURES
Reagents—LPS and lipid A of Salmonella minnesota were
purchased from Sigma. S. minnesota ReLPS was from List Bio-
logical Laboratories (Campbell, CA). PyroGene kit for the
quantification of LPS was from Lonza Biosciences Pte Ltd.
QuikChange® XL site-directed mutagenesis kit was purchased
from Stratagene (La Jolla, CA). All other chemicals were of
molecular biology grade obtained fromSigma, unless otherwise
stated.
SPR Analysis of Recombinant Hb Subunits with LPS—The
binding of the recombinantHb subunits, rHb! and rHb" to the
ligands, LPS, ReLPS, and lipidA, was characterized by real-time
interaction analysis using BIAcore 2000 (BIAcore AB, Uppsala,
Sweden). Details on the expression and purification of the rHb
proteins are in the supplemental “Materials andMethods.” For
SPR, S. minnesota LPS, ReLPS, and lipid A were diluted to 0.25
mg/ml in 10mMPBS, pH 7.4, and immobilized on the surface of
an HPA sensor chip (GE Healthcare) according to the manu-
facturer’s specifications. Binding studies were performed with
HEPES-buffered saline (HBS) as the running buffer. The pro-
teins were injected over the immobilized ligand at a flow rate of
30 #l/min. Regeneration of the chip surface was achieved by
injection of 100 mM NaOH for 1 min. All SPR responses were
normalized against the buffer. The association and dissociation
phases of data were separately fitted to a 1:1 Langmuir binding
model provided in the BIAevaluation software (version 4.1).
The dissociation constant (KD) was then calculated from the
averaged values of kd and ka using the equation, KD " kd/ka.
Residual plots and chi-square were used as a measure of the
curve fitting efficiency.
Prediction of LPS-binding Sites on Hb—A search for LPS-
binding sites on Hb was initiated by using an algorithm that
computes the propensity of phospho-group binding for a pro-
tein surface (21). Briefly, the algorithm computes a joint pro-
pensity for phospho-group contact based on the amino acid
identity, surface curvature, and electrostatic potential at every
point of the discretized protein surface. The computed propen-
sities for each surface point weremapped onto the correspond-
ing surface amino acid residues, and an average propensity for
each residuewas computed. Todetermine the binding sites that
have been conserved across Hb, 20 vertebrate Hb structures
were selected from the Structural Classification of Proteins
database classification (supplemental Table S1) (22). The pro-
pensity calculation algorithm was repeated on each of these
structures. Independently, structural alignment of these pro-
teins was performed using theMultiSeq tool of Visual Molecu-
lar Dynamics (VMD) (23), with human aquomet Hb as the
index structure for the alignment. The structure-based align-
ments were examined for the phospho-group binding propen-
sities of the aligned residues and the degree of conservation of
the favorable propensity was computed for the residues, yield-
ing predicted binding sites with combined propensity and con-
servation. The predicted binding sites were further prioritized
by seeking paired patches at an appropriate distance to interact
with the two phosphates of the lipid A head group.
To comprehend the interactions between the ligand and
these binding sites, docking was performed using GLIDE (ver-
sion 5.0; Schrodinger, LLC, 2007). The crystal structure of
human aquomet Hb (Protein Data Bank code 1HGB) was used
FIGURE 1. Schematic representation of the structure of LPS (38). GlcN, glucosamine; P, phosphate; KDO, 2-keto-3-deoxyoctulosonic acid; Hep, D-glycero-D-
manno-heptose; Gal, galactose; Glc, glucose; NGa, N-acetyl galactosamine; NGc, N-acetyl glucosamine.
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as the receptor. The protein structure was prepared using the
Maestro protein preparationwizard (Schrodinger). The solvent
molecules were deleted, bond orders were assigned, and hydro-
gen atoms were added to the protein. The orientation of the
hydroxyl groups and the protonation states of the amino acid
residues were optimized. The protein structure was then min-
imized using the OPLS 2001 force field. The ligand (1,4!-bis-
phospho-!-(1,6)-2,2!-N-acetyl-3,3!-O-acetyl-D-glucosamine
disaccharide) was prepared by replacing the long acyl chains of
lipidAwithmethyl groups asGLIDE limits themaximumnum-
ber of atoms for a ligand. The Ligprep utility of Maestro was
used to generate the protonation and tautomeric states. One
low energy ring conformation and 32 stereoisomers were gen-
erated. Prior to docking, grids were generated for each of the
potential binding sites. For each site, the center of each grid was
defined as the centroid of the residues of the patch. Additional
constraints for hydrogen bonding to the ligand were imposed
on the residues in each patch. The standard precision mode of
GLIDE was used for docking. The ligand was flexible, whereas
the protein was held rigid. Default parameters specified in
GLIDE were used for docking. The resulting structures from
each docking were compared on the basis of their GlideScore.
Peptide Design and Synthesis—Based on the computational
predictions, various Hb peptides were synthesized commer-
cially by Genemed Synthesis, Inc. and purified to"95% under
pyrogen-free conditions. The purity and quality of the peptides
were assessed by HPLC and mass spectrometry. The peptides
were annotated A and B, indicating their derivation from the
Hb" or! subunit, respectively. The numbers correspond to the
start of their amino acid positions in the Hb sequence.
CDMeasurements—The secondary structure of the peptides
was determined by recording their CD spectra at a concentra-
tion of 40 #M in PBS, pH 7.4, using a Jasco J-810 spectropola-
rimeter. The temperature within the sample chamber was
maintained at 25 °Cwith a continuous flow of nitrogen. Spectra
were recorded in quartz cuvettes of 1-mm path length, at data
pitch of 0.1 nm, bandwidth of 2 nm, response time of 1 s, and
scanning speed of 20 nm/min. Data from three independent
scans were averaged. Buffer alone was used as the control for
baseline subtraction.
Interaction of Peptides with Immobilized LPS—SPR analysis
was performed to examine the binding of Hb peptides to LPS,
ReLPS, and lipid A, as described earlier. Different concentra-
tions of the peptides were injected over the immobilized ligand
at a flow rate of 30 #l/min using HBS, pH 7.4, as the running
buffer. Data analysis was performed as described earlier.
Dansylcadaverine Displacement Assay—The binding of pep-
tides to lipid A in solution was measured using dansylcadaver-
ine (DC) as a fluorescent displacement probe. The assay is
based upondifferences in the fluorescence emission intensity of
lipid A-bound and -unbound forms of DC. Upon binding to
lipid A, there is an increase in the emission intensity of DC
accompanied by a blue shift in the wavelength of maximum
emission. Here, if a peptide binds lipid A, the bound DC will be
displaced, resulting in a quenching of fluorescence. Equal vol-
umes (50#l) of 100#MDCand 40#g/ml lipidA inHBS, pH7.4,
weremixed and incubated for 5min. This was followed by addi-
tion of 50 #l of various concentrations of the peptides. The
fluorescence of the samples was then measured using a
BIOTEK plate reader. Excitation and emission wavelengths
were set at 340 and 560 nm, respectively. To quantitatively
compare the interaction of the peptides with lipid A, the occu-
pancy of DC on lipid A was calculated using the following for-
mula: occupancy# (FP$ FD)/(FL$ FD), where FD is the fluo-
rescence intensity of DC in the absence of lipid A; FL is the
fluorescence intensity of DC in the presence of lipid A; and FP is
the fluorescence intensity of the solution of DC and lipid A
upon the addition of the different concentrations of the pep-
tides. The occupancy varies from 0 for DC solution without
lipid A, to 1 for DC and lipid A solution without the added
peptides.
PyroGene Assay for LPSNeutralization—The endotoxicity of
S. minnesotaLPS in the presence or absence of the peptideswas
measured using the PyroGene kit. This kit employs recombi-
nant factor C (rFC) from horseshoe crab to quantify the endo-
toxicity of LPS (24). In the presence of LPS, rFC becomes acti-
vated and hydrolyzes a synthetic substrate to release a
fluorescent product. The amount of product formed is quanti-
fiable at excitation and emission wavelengths of 380 and 440
nm, respectively. Various concentrations of peptides were pre-
incubated with 10 ng/ml of S. minnesota LPS at 37 °C for 1 h.
Each test sample was diluted 20 times, and 100#l was aliquoted
into the wells of a 96-well plate. The assay was performed
according to the manufacturer’s specifications. The relative
change in the endotoxicity of the solutions was measured by
comparison with the peptide-free LPS samples. The extent of
neutralization of the endotoxicity of LPS in the presence of
peptideswas calculated using the formula [(EL$EP)/EL]% 100,
where EL is the endotoxicity of LPS solution and EP is the endo-
toxicity of the solution in the presence of the peptide.
Flow Cytometry Analysis—The binding of peptide B59 to
GNB was assessed using flow cytometry. Cultures of Esche-
richia coli and Pseudomonas aeruginosa (&107 cells/ml) grow-
ing at exponential phasewere treatedwith 1mMB59 in PBS, pH
7.4, with or without pre-treatment with 100 ng/ml LPS, for 30
min at room temperature. The bacteria were then fixedwith 4%
paraformaldehyde for 30 min, followed by blocking with 5%
BSA for 1 h. The bound peptide was detected by incubating the
samples for 1 h each with primary rabbit anti-Hb antibody
(1:400) and secondary phycoerythrin-conjugated goat anti-rab-
bit IgG (Invitrogen) (1:200). Untreated samples served as neg-
ative controls. The bacteria were resuspended in 0.5% parafor-
maldehyde-PBS, and data were collected using the Dako
Cytomation CyAn ADP system.
Scanning Electron Microscopy—The B59 peptide, which was
shown to bind and neutralize LPS, was visualized on the bacte-
rial surface using immunogold labeling coupled with SEM. The
bacteria were prepared as for flow cytometry analysis. The sam-
ples were treated with primary rabbit anti-Hb antibody (1:50)
for 1 h. Samples were incubatedwith pre-immune rabbit serum
or an isotype control antibody (anti-C3d) alone instead of the
primary antibody as a negative control. For immunogold label-
ing, 20 nm colloidal gold-conjugated goat anti-rabbit IgG (Ted
Pella, Inc.) (1:50) was used. The samples were post-fixed in 1%
aqueous solution of osmium tetroxide for 30 min, followed by
dehydration in increasing concentrations of ethanol. The sam-
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ples were then subjected to standard procedures of infiltration
and carbon coating. The samples were viewed under a XL-30
FEG SEMmicroscope (Philips) at an accelerating voltage of 10
keV. The backscattered electronmode was used to observe col-
loidal gold particles on the bacteria.
Site-directed Mutagenesis—Lysine-to-aspartate mutations
were introduced into specific sites of both the Hb ! and " sub-
units. The mutant proteins are designated as Hb!(K56D/
K60D/K61D) and Hb"(K59D/K66D/K95D). In addition, a
K17D singlemutationwas introduced at a non-LPS binding site
in Hb" to serve as an internal control. Mutagenic primers were
designed using PrimerX and are listed in supplemental Table
S2. Mutagenesis was carried out using the QuikChange® XL
Site-directed Mutagenesis kit according to the manufacturer’s
instructions. All mutants were verified by sequencing and
transformed into E. coli BL-21 (DE3) for protein expression.
Protein expression and purification was carried out as
described previously for the wild-type subunits (supplemental
“Materials and Methods”).
ELISA-based LPS Binding Assay—The ability of the mutant
Hb subunits to bind LPS was probed using ELISA. Briefly, 1 #g
of S. minnesota LPS was immobilized on the surface of the
96-well microtiter plates by overnight incubation at room tem-
perature. The excess ligands were washed off, and the unbound
sites were blocked with 2% BSA at 37 °C for 2 h. Various con-
centrations of the proteins, prepared in HBS, were added to the
wells and incubated at 37 °C for 2 h. Following three rinses with
PBST (PBS containing 0.05% (v/v) Tween 20), the bound pro-
teins were detected by incubating the samples with primary
rabbit anti-Hb antibody (1:5000) and horseradish peroxidase-
conjugated goat anti-rabbit antibody (1:2000) at 37 °C for 2 h.
After washing the wells three times with PBST, 100 #l of per-
oxidase substrate, (2,2!-azino-di-[3-ethylbenzothiazoline sul-
fonate]) (Roche Diagnostics) was added, and A405 was read.
RESULTS
! and " Subunits of Human Hb Harbor LPS Binding Sites—
Previous studies have shown that tetrameric Hb from various
species, as well as the ! subunit of sheep Hb, can bind bacterial
LPS (18). Here, we examined whether the isolated subunits of
human Hb could also bind LPS. The ! and " chains of Hb were
expressed recombinantly and purified (supplemental Fig. S1).
Real-time interaction analysis using SPR showed that both
rHb! and rHb" bind S. minnesota LPS (Fig. 2,A and B), ReLPS,
and lipid A (Fig. 2C) in a concentration-dependent manner.
This indicates that binding sites for LPS are located on both
subunits, suggesting the existence ofmore than one binding site
per tetramer of Hb. TheKD values were in the nanomolar range
for the ligands (Fig. 2C). The accuracy of the fitting was indi-
cated by the residual plots and chi-square values, which were
within acceptable limits (chi-square below 10 is acceptable).
Hb Possesses Evolutionarily Conserved Cationic Surface
Patches for Binding LPS—Having observedmore than one LPS-
binding site on theHb tetramer, it was pertinent for us to exam-
FIGURE 2.Hb subunits possess high affinity for bacterial LPS. S. minnesota LPSwas immobilized on anHPA sensor chip. rHb! and rHb" at 0.1, 0.25, 0.5, and
0.75#M inHBSwere individually injectedover the ligand-immobilized chip surface at a flow rate of 30#l/min.Datawere fitted to a 1:1 Langmuir bindingmodel
using the separate fitmodule of the BIAevaluation software (version 4.1). Sensorgrams for the interaction of rHb! (A) and rHb" (B) with LPS are shown in black.
The red lines represent the corresponding fits. Plots of residuals corresponding to the differences between the experimental and best-fit curves are shown in
the lower panel. RU, response units. C, kinetic parameters for binding of rHb! and rHb" to the various ligands.
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ine the structure of Hb for potential LPS-binding sites. Hb has
been shown to associate with LPS via electrostatic interactions
with the 2-keto-3-deoxyoctulosonic acid sugars of ReLPS and
the phosphate residues of lipid A and via hydrophobic interac-
tions with the lipid A acyl chains (20, 25, 26). Because LPS
molecules are anchored on the surface of GNB with the acyl
chains of lipid A embedded in the membrane bilayer, we envis-
aged that for the cell-free Hb to dock onto the bacterial surface
and mediate localized free radical production via its redox
activity, it should be able to bind to LPS proximal to the mem-
brane. Electrostatic forces project a force field farther into
space, and are thus more effective than other chemical interac-
tions at recruiting binding partners across long distances (27).
Studies have shown that Hb does not interact strongly with
dephosphorylated ReLPS, suggesting the importance of the
phosphate residues in these interactions (20). This prompted us
to undertake a computational approach to search for phospho-
group binding sites onHb. The phospho-group binding predic-
tion algorithm for the humanHb resulted inmany “hits,” which
could potentially participate in binding to LPS (Fig. 3A). The
algorithm was additionally run for two control proteins, FhuA
and MD2, whose structures in complex with LPS are known
(28, 29). The prediction algorithm identified the binding sites
correctly, thus indicating the reliability of this in silico approach
(Fig. 3A). However, additional “false positive” binding sites
were also predicted.
Because Hb from species as distantly divergent as sheep, pig,
andhumans is known to bindLPS (16–19), we used a structure-
based sequence comparison to narrow down the predictions to
residues for which binding propensity has been conserved evo-
lutionarily (Fig. 3B). Further analysis of the Hb structure served
to shortlist eight cationic pockets, which were located at the
protein surface with an appropriate separation distance to bind
the head group phosphates of lipid A.
Docking of the lipid A disaccharide head group (Fig. 3C) to
these sites was performed to assess the possible interactions
with LPS. For most of the binding sites, the docked structures
exhibited strong networks of hydrogen bonds between the
phosphates of the ligand and positively charged or partially
charged residues of the protein (Fig. 3C, panels I–IV and VIII).
Docking produced non-ideal hydrogen bonds in some cases,
such as between the Arg-141 and a phosphate of lipid A (Fig.
3C, panel V); and between the backbone carbonyl of Leu-3 and
the amine group on the ligand (Fig. 3C, panel VI). The affinity of
the ligand was highest for the binding sites located at the !-!
and the "-" interfaces (Fig. 3C, panels V and VIII). This is in
agreementwith the prediction algorithm that showed these two
interfaces to have a high propensity of phospho-group binding
(Fig. 3A).
Hb Peptides Harboring Predicted LPS-binding Sites—Pep-
tides were designed to harbor the computationally predicted
binding sites for empirical validations of LPS binding (Fig. 4, A
and B). The peptide length and region surrounding the pre-
dicted LPS-binding residues was chosen based on the hydro-
philicity and solubility. To substantiate the computational pre-
dictionmethods, a control peptide A111was designed from the
surface residues of the Hb!, which were predicted to be non-
LPS binding. To query the plausible effects of the length of the
36-merB59 on its interactionswith LPS,we analyzed an 18-mer
peptide, B59s. To corroborate the role of the predicted residues
in binding LPS, amutant peptide B59smwith base-to-acid sub-
stitutions was synthesized by replacing the predicted phos-
phate-binding lysine residues of B59s with aspartate.
Hb Peptides Exist in Random Coil Conformations—The sec-
ondary structure of the Hb peptides was determined in PBS in
the absence and presence of LPS (Fig. 4C). The CD spectra of
the peptides are characterized by a negative peak near 200 nm,
indicating that these peptides are unstructured in solution.
Although LPS is known to cause structural perturbations in the
Hb tetramer (14), it does not appear to affect the conformation
of the peptides, as indicated by the unchanging CD spectra in
the presence of LPS (supplemental Fig. S2).
HbPeptides Bind Immobilized LPS—Tomimic the binding of
peptides to LPS displayed on the surface of GNB, Hb peptides
were flown over LPS, ReLPS, or lipid A immobilized on the
surface of an HPA sensor chip. Analysis of the SPR data
revealed high affinity interactions between six peptides andLPS
(Fig. 5, A–F). Three peptides, A1, A16, and B139 did not bind
LPS (Fig. 5G). B59 displayed the strongest affinity for LPS, with
a KD value of 6.35 ! 10"8 M. The LPS-binding affinity of the
18-mer B59swas#60-fold lower than that of B59 (Fig. 5H). The
negative control, A111 peptide, showed no specific binding
activity but displayed a bulk response upon injection (Fig. 5G).
These results validate the modeling strategy, as the predicted
non-binder A111 did not show any binding. Similarly, the
mutant peptide B59sm displayed no affinity for LPS. It proves
the importance of the lysine residues for LPS-binding ability.
Hb Peptides Interact with LPS in Free Form—LPS shed from
invading bacteria can interact with host plasma proteins. Using
an assay based on the fluorescent probe DC, we examined
whether theHbpeptideswould interactwith lipidA in solution,
with the potential to inhibit its endotoxicity. Fig. 6 shows the
plots of the occupancy of DC on lipid A in the presence of
increasing doses of the peptides. The peptides, B59 and B59s,
showed the greatest decrease in probe occupancy, with dose-
dependent displacement from lipid A. The other peptides were
also able to reduce the occupancy of DC from lipid A in a dose-
dependent manner, albeit less drastically. The control peptide
A111 and the other non-binding peptides did not significantly
affect DC occupancy (Fig. 6B). Moreover, DC occupancy in the
presence of the non LPS-binding peptides did not decline in a
concentration-dependent manner. The non-binding peptide,
B139, could however reduce the occupancy to levels similar to
the LPS-binding peptide, A81. This could imply its binding to
LPS in solution phase rather than to immobilized LPS.
Hb Peptides Bind to LPS and Neutralize Endotoxicity—The
functional implications of the binding of the peptides to LPS
were probed by investigating their ability to neutralize the
endotoxicity of LPS solutions via a quantitative assay based on
recombinant factor C. This assay is highly sensitive to endo-
toxin, being able to detect levels as low as 0.01 endotoxin units/
ml. Prior to the assay, the endotoxin levels in the peptide solu-
tions were measured and were found to be minimal
(supplemental Table S3). The assay was conducted at an LPS
concentration of 10 ng/ml. The endotoxicity levels at this con-
centration were measured to be #50 endotoxin units/ml. The
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results show that the peptides, which bound LPS, were able to
neutralize it in a dose-dependent manner (Fig. 7). The peptides
A56 and B59 were consistently the most potent in neutralizing
the endotoxicity by !80%. The peptide B59s neutralized the
endotoxicity by !60%. The peptides A81, A131, and B1 neu-
tralized LPS up to 50%. Poor LPSneutralizationwas seen for the
control peptide A111 (" 20%), consistent with the binding
assays. The mutant peptide, B59sm, was unable to neutralize
LPS. Similarly, the non-binding peptides A1 and A16 displayed
poor anti-endotoxic activity. Surprisingly, the non-binding
peptide B139 could neutralize LPS to an extent comparable
with the peptide B1. This suggests that B139 binds LPS in solu-
tion, which was also observed in the dansylcadaverine assay.
B59 Associates with Bacterial Surface—Based on the SPR
results wherein the peptides interact with LPS immobilized on
a sensor chip surface, we asked whether the peptides could also
associate with the LPS molecules in situ on the live bacteria.
The B59 peptide, which displayed the highest binding affinity
for LPS, was tested further for its attachment to the surface of
E. coli and P. aeruginosa. Using flow cytometry, we observed
the binding of the peptide B59 to the surface of GNB, indicated
by the positive shift in the median fluorescence intensity of the
peptide-treated samples compared with the untreated control
(Fig. 8A). Pre-treatment of the peptide with LPS resulted in a
negative shift in the median fluorescence intensity, indicating a
reduction in binding of the peptide to the bacteria. This result
suggests the binding of the peptide to bacteria via LPS. SEM
enabled visualization of the peptide associated with the bacte-
rial surface in the form of colloidal gold labeling (Fig. 8B). To
confirm the specificity of the rabbit anti-Hb antibody for the
peptide B59, control experiments were performed in which the
primary rabbit anti-Hbwas separately replacedwith rabbit pre-
immune serum and an isotype control rabbit anti-C3d anti-
body. The bacteria showed negligible labeling (supplemental
Fig. S3) in both the cases, thus proving the specificity of the
primary antibody used.
Mutations in Hb Subunits at LPS-binding Sites Diminish
Their LPS-binding Ability—For further substantiation of the
LPS-binding sites, selected residues in the A56 and B59 pep-
tides were mutated to generate recombinant Hb ! and " sub-
units withmutations from lysine to aspartate. Twomutant sub-
units carrying triple mutations were constructed: Hb!(K56D/
K60D/K61D) and Hb"(K59D/K66D/K95D). Separately,
mutant Hb"(K17D), which was not predicted to be an LPS-
binding site was also constructed as an internal control for the
FIGURE 3. Computational prediction of LPS-binding sites on Hb. A, prediction of phospho-group binding patches. An algorithm for computing phospho-
group binding propensity was applied on human Hb (Protein Data Bank code 1HGB). FhuA protein in complex with LPS (Protein Data Bank code 1QFG) and
MD2 protein with bound lipid A (Protein Data Bank code 2E59) served as positive controls. The binding propensity is represented by surface coloring, which
varies linearly fromwhite to blue over favorable propensity values from1 to 30, and from red towhite over the unfavorable propensity values from#1 to 0. The
ligands, LPS and lipid A, are shown in a licorice representation, with the phosphate atoms colored green. The phosphate atoms of the ligands in FhuA andMD2
are outlined in yellow. Insets showmagnified images of the phospho-groups of the ligand along with the surface coloring for the proteins. B, structure-based
sequence alignment of vertebrateHb! chains. VertebrateHbproteinswere alignedon thebasis of structure using theMultiSeq tool of VMD. The alignment for
Hb! is shown here. Residues are color-shaded on the basis of predicted propensity of phospho-residue contact in a decreasing order from green to red to blue.
Residues with no propensity of contact are indicated in black. Buried residues are indicated in yellow. The helix designations, A–F, for Hb (according to
Kendrew’s nomenclature (39)) are shown above the alignment. C, molecular docking of the ligand to the predicted LPS-binding sites. The diglucosamine head
group of lipid A (1,4$-bisphospho-"-(1,6)-2,2$-N-acetyl-3,3$-O-acetyl-D-glucosamine disaccharide) was used for docking analysis to the predicted LPS-binding
sites. Panels I–VIII, top ranking docked poses of the ligand to the predicted LPS-binding sites. Dockings were performed using GLIDE (version 5.0; Schrodinger,
LLC, 2007). The residues participating in hydrogenbondingwith the ligand and the computedbinding energies are indicated. The! subunits are colored gold,
and the " subunits are colored violet. The ligand is in stick representation, whereas the polypeptide chains are shown as ribbons. The hydrogen bonds are
indicated as dashed lines.
FIGURE 4.Hb peptides used for empirical validations. A, designations and
sequences of the Hb peptides. Nine peptides were designed to incorporate
the putative LPS-binding residues (underlined in the sequence). The peptides
are designated A and B corresponding to the Hb ! and " subunits, respec-
tively. Twoadditional control peptideswere (i) A111, composedof the stretch
of residues which were predicted to be non-LPS binding, and (ii) B59sm,
mutant peptide obtained by replacing the predicted LPS-binding residues of
B59s with aspartic acid. B, mapping of the Hb peptides on the tetrameric
structure. Tetrameric Hb showing the peptides designed to incorporate the
predicted LPS-binding sites. The ! subunits are colored gold, and the " sub-
units are colored violet. The heme moiety is represented by sticks, whereas
the polypeptide chains are shown as ribbons. The peptides are labeled for
chainsAandB.C, secondary structureofHbpeptides. Far-UVCDspectraofHb
peptides in PBS, pH7.4, at 298K. Peptide concentrationwas 40#M.Anegative
peak near 200 nm represents a random coil structure. Panel I, ! subunit pep-
tides: A1 (green), A16 (blue), A56 (red), A81 (aqua), A131 (brown), A111 (cyan);
and panel II," subunit peptides: B1 (green), B59 (aqua), B59s (red), B139 (blue),
B59sm (black).
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LPS-binding assays. The binding of the mutants to LPS was
compared with that of the wild-type subunits by ELISA (Fig. 9).
Themutations resulted in a weakening of the LPS-binding abil-
ity of the Hb subunits, with 2- and 4-fold reductions for the
mutated Hb ! and Hb " subunits, respectively. The LPS-bind-
ing of Hb" was unaffected by the K17D mutation.
DISCUSSION
The binding of microbial pathogen-associated molecular
patterns to Hb is known to induce structural alterations in the
protein, leading to the activation of its redox activity (12, 14).
The propensity forHb to bind LPS tends toward its recruitment
to the bacterial surface, thereby enhancing the free radical-me-
diated antimicrobial efficiency in a localizedmannerwhilemin-
imizing damage to the host. The Hb-LPS interaction thus plays
a role in the non-self immune response. Here, we have mapped
LPS-binding hot spots on the surface of the Hb tetramer using
computational predictions coupled with empirical validations.
Using real-time interaction analysis of the recombinantHb!
and " chains, we showed that the isolated subunits of Hb bind
strongly to LPS, ReLPS, and lipidA (Fig. 2). This implies that the
Hb tetramer (!2"2) contains multiple LPS-binding sites. Sev-
eral proteins such asCD14 (30),MD2 (31), LPS-binding protein
(32), Hsp60 (33), and FhuA (34) have been shown to interact
with LPS via both electrostatic interactions with the polar head
group of the lipid A, and hydrophobic interactions with the
lipid A acyl chains. It has been proposed that the structural
requirements for LPS binding include the presence of a cluster
of cationic residues and a hydrophobic pocket (35). In the pres-
ent study, we adopted an in silico approach to search for pock-
ets on Hb with electrostatic and steric favorability for binding
the phosphate groups of the lipid A moiety of LPS. This led to
the identification of sites comprised of cationic residues, appro-
priately positioned to engage in electrostatic interactions with
the phosphates of lipid A. It has been suggested that respiratory
proteins have evolved over hundreds of millions of years, from
the invertebrate protein hemocyanin to the vertebrate Hb, with
a secondary role of immune defense via interaction with patho-
gen-associated molecular patterns (12, 13). Thus, evolutionary
conservation of binding site residues was used as an additional
search criterion. The binding energy between LPS and these
sites was obtained by docking the head group of lipid A (the
FIGURE 5. Surface plasmon resonance measurements of the interaction of Hb peptides with LPS. Peptides in HBS were injected over the immobilized
ligands at a flow rate of 30#l/min. Sample concentrationswere 50, 100, 150, and 200#M (except for B59, for which the concentrationswere 0.01, 0.05, 0.1, and
0.5#M). The association anddissociationphases of datawere separately fitted to a 1:1 Langmuir bindingmodel in theBIAevaluation software (version 4.1).A–F,
sensorgrams for the interaction of the peptides with LPS are shown in black. The red lines represent the corresponding fits. Plots of residuals corresponding to
the differences between the experimental and best-fit curves are shown in the lower panel. RU, response units. G, representative sensorgrams of the peptides
that did not bind LPS at a concentration of 200 #M: A1 (brown), A16 (green), A111 (black), B59sm (red), and B139 (purple). The response indicates a bulk shift
without any binding activity. H, kinetic parameters for interaction of peptides with the various ligands.
FIGURE6.DCdisplacementassay for interactionofHbpeptideswith lipid
A in solution. The occupancy of DC (50#m) on lipid A (20#g/ml) was meas-
ured in the presence of 0, 0.1, 1, 10, 50, and 100#M of the various peptides at
pH 7.4 in HBS. The fluorescence intensity was measured by excitation at 340
nmandemission at 560nm. Theoccupancywas calculatedusing the formula:
occupancy! (FP" FD)/(FL" FD), where FD is the fluorescence intensity of DC
in the absence of lipid A, FL is the fluorescence intensity of DC in the presence
of lipid A; and FP is the fluorescence intensity of the solution of DC and lipid A
upon the addition of thedifferent concentrations of thepeptides. Occupancy
is plotted against the log-peptide concentrations for peptides that bind LPS
(A) anddonotbind LPS (B). Results are themeans# S.D. of three independent
experiments done in triplicate.
FIGURE 7.Neutralizationof LPSendotoxicity byHbpeptides. S. minnesota
LPSwas treatedwith 1, 10, and 100#M concentrations of peptides. The endo-
toxicity of the solutions was measured using rFC-based PyroGene assay. The
extent of neutralization of LPS by the peptides is plotted as a percentage of
the “LPS only” control for the LPS-binding peptides (A) and non LPS-binding
peptides (B). Results are themeans# S.D. of three independent experiments
done in triplicate.
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diglucosamine phosphatemoiety) to each of the predicted sites.
The docking analysis showed interactions of the phosphates
with the cationic residues in the protein.
Real-time interaction studies of the Hb peptides served to
assess the computational predictions and eliminate false posi-
tives. Overall, out of the nine peptides analyzed, six demon-
strated binding to LPS, ReLPS, and lipid A (Fig. 5). The pep-
tides, which showed binding to LPS, were also able to bind to
ReLPS and lipid A, suggesting that the peptides interact with
the lipid A component of LPS, conceivably via electrostatic
interactions with the phosphates. The ability of peptides A131
and B1 to bind LPS was in agreement with the computational
prediction of the high propensity of LPS-binding at the inter-
face of the Hb subunits. SPR analysis at low pH of 6.5 and 5.5
was performed to investigate the importance of electrostatic
interactions in binding of the peptides to LPS. At a pH of 5.5,
peptide B59 displayed 10! stronger affinity for lipid A (supple-
mental Fig. S4A). This could be due to the greater net positive
charge on the peptide at this pH.The affinity for LPS andReLPS
were, however, unchanged.Moreover, the affinity at pH 6.5was
the same as that at pH 7.4 (supplemental Fig. S4B). Except for
B1, the peptides that have been used in this study are cationic at
physiological pH (isoelectric points" 8). Thus, lowering of the
pH would increase their net positive charge, which may not
alter the binding affinity significantly. The peptides generally
displayedweaker LPS-binding affinity as comparedwith theHb
subunits, indicating that the three-dimensional structure influ-
ences the affinity for LPS. This difference in the binding affinity
could also be attributed to the presence of multiple binding
sites in theHb chains, whereas the peptides each harbor a single
LPS-binding site. Studies are underway for the precise struc-
tural determination of the crystal structure of Hb in complex
with LPS so as to ascertain the molecular details of their
interactions.
Fluorescent probe displacement assays corroborated the
observations on the binding of the peptides with lipid A. The
cationic fluorescent probe DC interacts with the acidic phos-
phate groups and hydrophobic acyl components of lipid A (36).
Because peptides B59 and B59s were able to displace the probe
fromDC completely (Fig. 6), it indicates that they interact with
lipid A via similar interactions as DC. The peptides A56, A131,
and B1 have a weak binding affinity for lipid A as they could not
completely displace the probe bound to lipid A. It may be
argued that these peptides participate only in ionic interactions
with lipid A; hence, they were unable to disrupt the hydropho-
bic interactions between lipidA andDC.Mutations of the puta-
tive LPS-binding lysine residues to aspartate in B59sm abol-
ished its LPS-binding and -neutralizing activity, thus
emphasizing the importance of electrostatic interactions in
LPS-binding.
During infection, LPSmolecules shed from the bacterial sur-
face lead to immune activation upon their recognition by effec-
tor molecules such as LPS-binding protein (37). We inquired
whether the LPS-binding peptides could mask LPS from the
innate immune effector proteins. This was probed by testing
the anti-endotoxic potential of the peptides using an rFC-based
assay. Consistent with the binding studies, the peptides B59,
B59s, and A56 neutralized the endotoxicity of LPS drastically
FIGURE 9. LPS-binding activities of wild-type and mutant Hb subunits.
ELISA was performed for quantifying the LPS-binding activity of the mutant
Hb subunits: Hb! (A), andHb" (B). 96-WellMaxisorpTMmicrotiter plateswere
coated with S. minnesota LPS. The unbound sites were blocked with 2% BSA,
and increasing concentrations of the recombinant proteins were added to
each well. Anti-Hb antibody was added followed by horseradish peroxidase-
linked secondary antibody. The peroxidase enzyme activity was determined
at 405 nm. Results are the means # S.D. of three independent experiments
done in triplicate.
FIGURE 8. LPS-binding peptide, B59, associates with Gram-negative bac-
teria.A, thebindingof B59 toGNBwas analyzedby flowcytometry. E. coli and
P. aeruginosawere treated with 1 mM B59 for 30 min, with (white) or without
(stripes) pre-treatment with 100 ng/ml LPS. The peptide bound to the bacte-
rial surface was detected using primary rabbit anti-Hb antibody (1:400) and
secondary phycoerythrin-conjugated goat anti-rabbit IgG (1:200). The fluo-
rescence intensity is plotted in log-fluorescence units versus counts. The neg-
ative control bacteria incubated without the peptide are indicated in gray.
The results are representative of three independent experiments. B, the asso-
ciation of B59 to the bacterial surface was visualized using scanning electron
microscopy coupled with immunogold labeling. Specific binding of the pep-
tide is demonstrated by the colloidal gold (arrows) observed under backscat-
tered electron (BSE) mode. Untreated bacteria served as negative control.
Magnification is 15,000!. Bar, 1 #m.
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(Fig. 7). This neutralization effect could be attributable to
sequestration of the LPS by the peptides, thus blocking LPS
from recognition by rFC. The other peptides with weak binding
affinity did not confer endotoxin neutralization. These results
are suggestive of the functional role of these peptides in hinder-
ing the recognition of LPS by immune effector proteins.
Consistent with the high affinity seen in SPR binding studies,
wewere able to demonstrate the attachment of the LPS-binding
peptide B59 to the surface ofGNB. Flow cytometry showed that
pre-treatment of the peptide with LPS reduced the binding of
this peptide to bacterial cells, proving that the peptide possibly
binds to LPS molecules anchored on the bacterial surface. Fur-
thermore, B59 was observed on the surface of GNB, visualized
by immunogold-labeled SEM. It should be noted that we can-
not preclude the possibility of the interaction of Hb peptides
with pathogen-associated molecular patterns on the surface of
Gram-positive bacteria, as it is known that Hb can bind with
lipoteichoic acids (12, 14).
Mutational analysis of the Hb subunits supported the com-
putational predictions and peptide-based experiments. Mutant
Hb subunits, Hb!(K56D/K60D/K61D) and Hb"(K59D/K66D/
K95D), had diminished LPS-binding activities. However, the
mutant subunits retained partial LPS-binding activity. This
may indicate that other residues also participate in LPS recog-
nition. Nevertheless, the results confirm the contribution of the
mutated residues of Hb in binding LPS and corroborate the
LPS-binding capability of the Hb peptides.
To summarize, we have delineated LPS-interacting regions
on the surface of the Hb tetramer by rational computational
predictions accompanied with biophysical characterization.
Our computational approach of integrating phospho-binding
propensity with evolutionary conservation identified potential
LPS-binding hot spots. Empirical investigations enabled filter-
ing of true positive binding sites obtained from the computa-
tional analyses. Peptides spanning residues 56–72, 81–92, and
131–141 of Hb! and residues 1–10 and 59–76 of Hb" were
shown to bind LPS. We have shown that the Hb peptides can
bind to both immobilized and soluble forms of LPS. The func-
tional implications of the binding were revealed by the anti-
endotoxic potential of the peptides. Mutagenesis studies of the
recombinantHb subunits validated the participation of the pre-
dicted residues in binding LPS. In conclusion, ourwork extends
the understanding of the structure-function relationships of
Hb-LPS interactions. The results from this study may find
implications in the design of antimicrobial peptides.
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During infection, the redox activity of cell-free Hb is augmented upon its interaction 
with bacterial lipopolysaccharide (LPS). The free radicals thus generated contribute 
to the innate immune defense of the host. Despite the importance of Hb-LPS 
interactions, their interaction sites have not been elucidated. Here, we mapped LPS-
binding sites on Hb using a systematic approach of computational predictions and 
empirical validations. Surface plasmon resonance (SPR) analysis showed LPS-
binding activities present on both the Hb-! and -" subunits, indicative of multiple 
interaction sites on the tetrameric Hb. Since the diphosphorylglucosamine head group 
of LPS is known to bind avidly to LPS-binding proteins, we applied a propensity 
computation algorithm to predict phospho-group binding sites on Hb. Evolutionarily 
conserved binding sites were identified by analysis of structure-based sequence 
alignments of Hbs. Eight LPS-binding sites were determined by ligand docking to the 
conserved, high propensity sites followed by a comparison of their binding energies. 
Based on the in silico predictions, synthetic Hb peptides were designed for 
experimental validations. True positive LPS-binding peptides were identified by SPR 
and further confirmed using a fluorescent probe displacement assay. Flow cytometry 
and scanning electron microcopy using Gram-negative bacteria showed that a peptide 
comprising residues 59-95 of Hb" associated with the bacterial surface, probably via 
LPS. The LPS-binding property of the Hb peptides was corroborated by mutational 
analysis of Hb subunits. Lysine to aspartate mutations were introduced at positions 
56, 60 and 61 in Hb!, and positions 59, 66 and 95 in Hb". Mutations led to two-fold 
and four-fold drops in LPS-binding activities of the Hb-! and -" subunits, 
respectively. The experimental results, together with the molecular modeling, have 
thus delineated LPS-binding regions on the Hb tetramer, and this finding has potential 
application for the development of antimicrobial therapeutics. 
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Lipopolysaccharide (LPS) or endotoxin, a bacterial cell wall component, plays a key 
role in the pathology of gram-negative septic shock. During infection, bacterial 
hemolytic activity releases hemoglobin (Hb) into the plasma. Proteolytically activated 
cell-free Hb binds LPS and functions as an ‘antibacterial effector’ by generating toxic 
free radicals in the vicinity of bacteria. Here, we identified LPS-binding regions of 
Hb by in silico prediction, which included phospho-group binding propensity 
calculation algorithm, structure-based sequence alignments, and docking analysis of 
the protein-ligand interactions. The analysis revealed eight conserved cationic patches 
as potential LPS-binding sites. Synthetic Hb peptides were designed to contain the 
predicted LPS-binding regions. Surface plasmon resonance analysis and a fluorescent 
probe displacement assay involving dansylcadaverine confirmed that five peptides 
harbored LPS-binding activities. Flow cytometry analysis showed that peptide B59 of 
Hb!, spanning residues 59-95, bound to the bacterial surface. This association was 
plausibly mediated via LPS, since pre-treatment with LPS led to a decrease in 
binding. Peptide B59 neutralized the endotoxicity of LPS solutions, showing up to 
90% anti-endotoxic activity. Other LPS-binding peptides had neutralization efficacies 
of 40-90%. Taken together, we have predicted and validated LPS-binding sites on the 
surface of the Hb tetramer, and characterized the synthetic Hb peptides (comprising 
residues 56-72, 81-92 and 131-141 of Hb"; and residues 1-10 and 59-95 of Hb!) that 
could bind and neutralize LPS in vitro. It will be pertinent to test these peptides for 
their inhibition of LPS-mediated pro-inflammatory effects, and their potential 
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Extensive hemolysis during sepsis leads to a surge in levels of cell-free Hb. The 
heme-bound ferrous iron in cell-free Hb is readily oxidized to the ferric state, forming 
methemoglobin (metHb). The redox-active metHb participates in a catalytic 
pseudoperoxidase (POX) cycle, wherein ferric and ferryl heme interconvert, 
eliminating hydrogen peroxide in a peroxidase-like manner. Upon microbial invasion, 
LPS and microbial proteases enhance metHb-POX activity, for the release of 
microbicidal free radicals. There is a need to regulate free radical production by Hb 
POX activity to minimize oxidative damage to the host. To explore mechanisms for 
the regulation of redox-active Hb during innate immune response, we delineated the 
LPS-binding sites on Hb via computational predictions and biochemical 
characterizations. Mutations in the LPS-binding site on Hb subunits led to a decline in 
their redox activity, suggesting that Hb mutants lacking LPS-binding may have 
weakened redox activity. We also investigated whether metHb POX activity might be 
regulated by the host protein TF (Tissue Factor). TF is upregulated by LPS, and plays 
a central role in coagulation and inflammation during sepsis. Our preliminary data 
show that recombinant TF suppresses the redox activity of LPS-activated Hb. The 
interactions of Hb with TF expressed on the surface of macrophages are currently 
being investigated. Insights gained from this study may supplement our 
understanding of the oxidative damage that occurs during septic shock and may have 
therapeutic implications in the development of safe Hb-based blood substitutes.  
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The human hemoglobin (Hb) functions as a frontline defense molecule in the face 
of attack by microbial pathogens. The pseudoperoxidase activity of Hb is potentiated 
upon binding to PAMPs such as bacterial lipopolysaccharide (LPS), triggering the 
generation of free radicals, which kill the pathogen. It has been shown that LPS 
induces structural changes in cell-free Hb. Although the interaction between Hb and 
LPS has implications on the innate immune defense, the precise LPS-binding sites on 
Hb have not yet been elucidated. Here, we applied computational predictions in 
conjunction with biochemical characterization, to map the LPS-interaction sites of 
Hb. Using a phosphate-binding prediction algorithm, potential LPS binding sites on 
the surface of Hb were predicted, showing that Hb possesses various conserved 
cationic patches, and may function as LPS binding sites. Peptides harboring the 
predicted sites were designed for empirical validations such as surface plasmon 
resonance to measure the binding. The functional analysis of the LPS-binding Hb 
peptides showed that they were able to neutralize LPS in vitro. Scanning electron 
microscopy coupled with immunogold labeling showed that the peptides attach to the 
surface of gram-negative bacteria. Computational modeling and docking are being 
performed to elucidate the mechanism of interaction of the peptides with LPS. In 
summary, our results suggest that peptide fragments released upon microbial 
proteolysis of Hb may effectively associate with and sequester LPS, thus conferring 
protection to the host from severe LPS-induced immune responses.  
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